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SUMMARY
The mammalian pyruvate dehydrogenase complex, located in the 
inner membrane-matrix compartment of mitochondria, is a large multi- 
molecular aggregate, 8.5 x 10^, containing multiple copies of its 
three constituent enzymes, pyruvate dehydrogenase (El), dihydroiipoyl 
acetyltransferase (E2) and lipoamide dehydrogenase (E3).
High-titre, monospecific, polyclonal antibodies against the 
native complex and its indivüial components are characterised and 
employed to study the events involved in the biosynthesis and import 
of the components of this complex into mitochondria.
Antisera are examined with respect to their ability to inhibit 
the overall activity of the complex and of the intrinsic protein kinase. 
Monospecificity of all antisera is demonstrated when challenged with 
crude cell extracts and subsequent immunoblotting analysis. The 
antiserum to native PDC exhibits high reactivity against all components 
of the complex, except E3, which cannot be explained by a low content 
of E3 in the purified antigen or by its inaccessibility to the immune 
system. The significance of,the low immunogenicity of E3 is probably 
related to the conservation of its primary sequence and tertiary 
structure during evolution.
A major observation from this study is that ox heart PDC contains 
an additional polypeptide, M^ 51,000 ± 1,000 of unknown function. This 
protein is called component X and constitutes approx. 6% of the total 
complex. Detailed immunological studies suggest that component X is 
a normal cellular component, located in the mitochondrial compartment 
and does not represent a fragment of subunit E2 or the intrinsic protein 
kinase of the complex.
Additional studies on the subcellular localisation of PDC 
suggest that this enzyme is associated with the inner membrane of rat 
liver and ox heart mitochondria. These and other studies also indicate 
that component X is an integral component of the complex and not a 
membrane protein, which becomes associated with the PDC during its 
isolation. The individuality of protein X is also demonstrated by 
comparison of the peptide maps of the and ^^C-labelled subunits
E2 and X obtained with several proteases. Protein X seems to be 
tightly-associated with the E2 core of the complex and is at least 
partially exposed on the surface of the native assembly, as it is 
accessible to proteases and to antibodies directed against it.
Further studies reveal that, after incubation of the complex in
the presence of [2-^^C] pyruvate, ^^C-label, probably in the form of
acetyl groups is incorporated rapidly into both E2 and component X.
Phosphorylation of the complex causes a parallel decrease in the
acétylation of both proteins, indicating the involvement of the El
component in the acétylation of these groups. Similarly, the transfer
of acetyl groups from E2 and X onto CoA is observed to occur in a
parallel fashion from both proteins. Studies on the effects of NEM
14
on the incorporation of C-labelled acetyl groups also reveal interest­
ing features of the acétylation reaction, which suggest the existence 
of secondary NEM-sensitive acétylation sites on the complex.
Additional studies on the nature of the 'acetylatable' group in 
protein X and the physiological acceptor of acetyl groups are 
required to clarify the function of this component in the acétylation 
reactions of the complex.
Studies on cultured bovine kidney, rat liver and pig kidney cells, 
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incubated with [ S] methionine in the presence of uncouplers of
oxidative phosphorylation, demonstrate the accumulation of larger M 
precursor polypeptides to the subunits E2, E3, El a and El & of the 
complex. Precursor forms for the individual subunits of the PDC 
are identified by immunoprécipitation techniques using antisera against 
the native complex and its SDS-denatured subunits followed by fluoro­
graphic analysis.
These precursors, possessing M values 2,000-8,000 larger than 
their mature counterparts in the mitochondria,are relatively stable 
in the cytoplasm of the cells when monolayers are incubated in the 
presence of uncouplers for several hours. Removal of the uncoupler 
and subsequent chase shows that these precursors are processed into 
their mature forms with a similar lag time. Complete processing is 
observed within 30 min.
Chapter 1: INTRODUCTION
1.1 Multienzyme complexes
Enzymes are biological catalysts which usually function 
sequentially by promoting consecutive chemical reactions linked by 
intermediate products. They range in organisation and complexity 
from enzymes consisting of a single folded polypeptide chain to the 
most highly-organised systems of membrane-bound enzymes such as the 
electron transport chains of mitochondria or microsomes.
The assembly of enzymes in multienzyme complexes is a consequence 
of the possession of quaternary structure by enzymes. These complexes 
represent an answer to some of the problems of organisation and control 
in intermediary metabolism. Multienzyme complexes are aggregates of 
functionally-linked enzymes which catalyse two or more steps in a 
metabolic sequence. Their physical association produces an enzyme 
mosaic which possesses characteristic morphology.
There are several advantages in this type of enzyme'organisationî 
enhancement of catalytic or regulatory efficiency and substrate 
channelling. (Perham, 1975). Complex formation provides a means 
of concentrating enzymes in a cellular compartment rather than having 
them randomly distributed. Interaction of the component polypeptides 
may produce particles that have catalytic properties not present in 
the separate chains. Aggregation of interrelated enzymes also makes 
it physically easier for the products of one enzyme to act as substrate 
for the next enzyme in the sequence. This may well increase the 
efficiency of the overall process, even if the intrinsic catalytic 
activity of each component is not altered by their association.
The increased efficiency of a complex as compared to that of 
the separate enzymes dispersed at random is most obvious when all 
intermediate products are strongly-bound to the complex. In such a 
case, reactions of the intermediate products of one component with
the next are much more probable. Moreover, substrate can be channelled 
through a series of reactions to avoid competition with other enzymes 
for the intermediate products or to reduce sensitivity to inhibitors 
in the surrounding medium. Such a system would function as a mechanism 
for selecting the metabolic fate of the substrate. Another possible 
reason for 'channelling' could be that an intermediate product in a 
reaction sequence might prove to be unstable in aqueous solution and 
therefore not survive the passage between the active sites if diffusion 
was required.
It is now thought that a substantial part of the enzyme 
complement of cells may be present as discrete multienzyme complexes. 
Such organisation may give rise to increased efficiency and new three 
dimensional arrangements with elaborate control mechanism. Isolation 
procedures for the resolution of mixtures of enzymes cannot be assumed 
to preserve the integrity of these aggregates. Therefore, it is 
possible that their natural occurrence is more frequent than reported 
(Reed & Cox, 1966). It is also possible that enzymes may exist as 
smaller aggregates bound to membranes and in the course of isolation 
these aggregates become detached, forming large complexes which are 
not normal cellular components.
Isolated multienzyme complexes consist of 2-6 interrelated 
enzymes with huge values. Some of the most elaborate enzymes 
of this type are the tryptophan synthetase (E. coli). the 2-oxo-acid 
dehydrogenase multienzyme complexes of bacteria and mammals, and the 
fatty acid synthetase from yeast and mammals. A full account of 
several other multienzyme complexes may be found in Reed & Cox (1966).
1.2 2-oxo-acid dehydrogenase complexes
Multimeric enzymes that catalyse oxidative decarboxylation of 
pyruvate, 2-oxoglutarate and branched-chain 2-oxo acids have been
purified to a homogeneous state from microbial and eukaryotic cells, 
as functional assemblies of high M (Reed, 1974; Koike & Koike, 1976;
Reed & Oliver, 1982).
Each complex catalyses a coordinated sequence of reactions that 
can be represented by the overall reaction:
0 0
f + 1 1  +
R-C-CO^ H + CoA + NAD^------ R-C-S-CoA + NADH + + 00%
where R= CH^ (pyruvic acid) or HO^C- [CH^] (2-oxoglutarate) or the
2-oxo-acid derived from the metabolism of valine, isoleucine and leucine
( a -oxoisovaleric, a -oxoisocaproic acid and o-oxo-
B-methylvaleric acids).
Each assembly contains a substrate-specific dehydrogenase (El),
a dihydrolipoyl acyltransferase (E2), specific for each species of complex
and a lipoamide dehydrogenase (E3), a flavoprotein which is a common
component of the three types of complex. The acyltransferase components
constitute the core of the complexes to which the other enzymes are attached
by noncovalent bonds
The pyruvate and 2-oxoglutarate dehydrogenase complexes, which
are about the size of ribosomes, contain 48 to over 190 polypeptide
chains in highly-organised assemblies. These complexes are found in
aerobic prokaryotes and in eukaryotes where they occupy key positions
in carbon and energy metabolism by funnelling the main product of
glycolysis (pyruvate) into the citric acid cycle and by performing
an essential role within this cycle. The preparations from E. coli
are the most well-studied multienzyme complexes. They were
separated into their three oligomeric components, and reassembled into
particles resembling the native complexes, some years before similar
studies were performed on the mammalian enzymes (Reed, 1974).
1.3 The mammalian pyruvate dehydrogenase complex
The mammalian PDC catalyses the intramitochondrial oxidative 
decarboxylation of pyruvate to AcSCoA. This reaction is essentially 
irreversible in cells .occupying a key position in the cellular metabolism 
by controlling the supply of acetyl groups in mitochondria arising 
from the oxidation of carbohydrates and amino aci*(Fig. 1.1 ).
In many tissues, including heart, muscle, brain and kidney, the 
AcSCoA generated is mainly oxidised via the citric acid cycle, but in 
other tissues such as liver, adipose tissue and mammary gland, a 
significant proportion is utilised in the synthesis of fatty acids and 
sterols. Regulation of this step is of critical importance to the 
general metabolic balance and fuel economy in animals. It is perhaps 
not surprising that a range of different regulatory mechanisms appear 
to have evolved to ensure appropriate control of its activity.
Fig. 1.2 shows,schematically, how PDC carries out the successive reactions 
involved in the oxidation of pyruvate: decarboxylation of pyruvate
and subsequent reductive acétylation of the lipoyl moieties by the 
pyruvate dehydrogenase component (EC 1.2.4.1) (El), transfer of the 
acetyl groups by the dihydrolipoyl acetyltransferase component 
(EC 2.3.1.12) (E2) and reoxidation of the lipoyl moieties with NAD* 
as the ultimate electron acceptor by lipoamide dehydrogenase (EC 1.6.4.3)(E% 
The intermediate acetyl dihydrolipoamide possesses an energy-rich 
thioester bond which is conserved when the acetyl group is transferred 
to CoA by the acetyltransferase component (see also Fig. 7.1).
Five different coenzymes and prosthetic groups are involved:
TPP, FAD, CoA, NAD* and lipoic acid. The core of the cluster, the E2 
component, contains lipoic acid bound in amide linkage to the e-amino 
groups of specific lysine residues located near the active site of the 
subunits (Reed, 1974). Movement of the lipoyl groups of the core 
enzyme among the catalytic sites of El and E3 permits thiol-disulphide
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exchange and acetyl transfer reactions between the component proteins. 
These interactions occur within an arrangement in which movement of 
the individual enzymes is limited and from which intermediates do 
not dissociate. Highly-favourable positioning of the three enzyme 
components and their prosthetic groups would permit efficient coupling 
of these reactions.
1.3.1 Structure of the mammalian PDC
Based largely on the insight and experience gained with the 
E. coli pyruvate and 2-oxoglutarate dehydrogenase complexes, the 
mammalian complexes were initially purified from pig heart (Hayakawa 
et al., 1966) and bovine kidney mitochondria (Ishikawa et al., 1966). 
Many later studies resulted in improved purification procedures and 
resolution of the pig heart and ox heart and kidney complexes 
(Hayakawa et al., 1969; Linn et al., 1972). Furthermore, novel 
biochemical features of the mammalian PDC were discovered, including 
the subunit composition of the pyruvate dehydrogenase component and 
its regulation by phosphorylation/dephosphorylation (Linn et al., 
1969a; 1969b; Barrera et al., 1972).
When the geometric organisation of the 2-oxo-acid dehydrogenase 
complexes was studied by their appearance in the electron microscope, 
two polyhedral forms of the E2 component were observed, the cube and 
the dodecahedron, both designs based on cubic point group symmetry.
The former design is exhibited by the E2 components of the 
pyruvate and 2-oxoglutarate components of E. coli and the mammalian 
2-oxoglutarate dehydrogenase complex. In these enzymes, the 
transacetylase and transsuccinylase components are similar in size 
and cube-like appearance as demonstrated by sedimentation equilibrium 
analysis and electron microscopy (Reed & Oliver, 1968). Although
there is some disagreement regarding the number of El and E3 subunits 
that are combined with E2 in the E. coli PDC (Danson et al., 1979),
Reed and his colleagues have proposed a structural model in which 
the 24 identical subunits of the E2 components are arranged with 
octahedral (432) symmetry (Reed, 1974; Reed & Oliver, 1982). In 
this model, eight morphological units formed by trimeric clusters of 
E2 subunits would be centred at the vertices of a cube. Pyruvate 
dehydrogenase (24 subunits) or 2-oxoglutarate dehydrogenase (12 subunits) 
would be uniformly distributed along the twelve edges of the core.
Six E3 dimers are thoughtto be located on the faces of the E2 core 
bound diagonally to opposed units of E2.
This model points to many basic similarities between the 
morphological features of these complexes. The two major differences 
appear to be the presence of 12 additional subunits and 24 lipoyl 
moieties on the E. coli PDC as compared with the microbial or mammalian 
2-oxoglutarate dehydrogenase complexes. An octahedral design is also 
exhibited by the mammalian branched-chain 2-oxo-acid dehydrogenase complex.
On the other hand, the appearance of the E2 component of PDC 
from bovine heart and kidney, avian tissues, Neurospora. yeast and 
some bacteria shows a different design, i.e. icosahedral (532) symmetry.
In this case, the sixty subunits of the transacetylase component would 
be arranged in groups of three about the 20 vertices of a pentagonal 
dodecahedron, with 30 molecules (tetramers) of El and 6 flavoprotein 
dimers aligned on the 30 edges and 12 faces of the dodecahedron, 
respectively (Reed & Pettit, 1981).
The interpretation of the structure and composition of the pig 
heart PDC, based on biochemical data and electron microscopic studies, 
are matter of dispute. From data on the subunit composition and 
coenzyme content of the component enzymes of PDC, Koike & Koike (1976)
6iU
concluded that the pig heart complex is of the octahedral type, 
containing a core of 24 identical E2 polypeptide chains, to which 
about 24 tetramers .( 2 4 3 0  ) of El and 12 chains of E3 (6 dimers) 
are attached noncovalently. Sugden & Randle (1978) suggested a 
similar subunit composition on the basis of studies on the pig heart 
complex by the radioamidination procedure and by quantitative 
densitoraetric scanning of Coomassie Blue-stained polyacrylamide gels.
These data suggested octahedral symmetry and, as mentioned 
above, do not correlate with electron microscopic evidence showing 
similarities with the bovine complex (Junger & Reinausen, 1972; Koike 
& Koike, 1976). The controversy over the structure of the pig heart 
complex may be partly attributed to methodological differences and 
dissimilar values for the of the E2 components of the bovine and 
pig heart enzymes. Hamada et al. (1975) determined an M of 1.8 x lO' 
for the E2 component of the pig heart complex, as compared with the 
value of 3.2 x 10 for the bovine enzyme (Barrera et al., 1972).
Moreover, the former authors reported an M value for the enzyme subunit , 
of 70,000-74,000 by SDS/polyacrylamide gel electrophoresis and gel 
filtration in 6M-guanidinium-HCl. This value was quoted by Sugden 
& Randle (1978) and by Machicao & Wieland (1980) to propose the same 
stoichâometry. An M^ value of 52,000 has been obtained by sedimentation 
equilibrium analysis (Barrera et al., 1972) or gel filtration in the 
presence of guanidinium-HCl (Kresze et al., 1980). The anomalous 
migration of the E2 component on SDS/ polyacrylamide gels apparently 
causes an overestimation of its M^ value. This has been attributed 
to the extended structures of the lipoyl containing regions of these 
polypeptide chains (see section 1.3.3). Therefore, the mass of 
evidence from electron microscopic, sedimentation equilibrium analysis 
and limited proteolysis argues against the proposal that mammalian 
acetyltransferases consist of 24 subunits and favours the model
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proposed by Reed and his colleagues. However, the problem of the 
structure of the pig heart complex has not yet been solved. The 
low content of E2 in the preparations of this complex is too low for 
strict icosahedral symmetry, even if it is assumed to be present as 
dimers.
1.3.2 Subunit composition of the mammalian PDC
PDC isolated from bovine kidney and heart have values
approx. 7 x 10^ and 8.5 x 10^, respectively (Linn et al., 1972).
The M values of the various polypeptide chains and the proposed 
stoichsbmetry of the bovine heart complex are presented in Table 1.1.
The El component consists of nonidentical polypeptide chains a ,
M 42,000 and 6 , 36,000, which form o ^ g ^  tetramers of
154,000. The core enzyme consists of 60 identical polypeptide chains 
of M about 52,000. It is generally accepted that each monomer contains 
one lipoyl residue (White et al., 1980; see also Chapter 7, section 7.1). 
E3 has an M 110,000 and contains two identical subunits 55,000, each 
containing a molecule of FAD.
The bovine kidney PDC contains approx. 20 El tetramers and 6 E3 
dimers, whereas the heart complex contains about 30 El tetramers and 
6 dimers of E3. This accounts for the difference in values between
the two types of complex. The kidney complex can bind 10 additional 
El tetramers but neither complex can bind additional E3 dimers.
The stoichiometries of the pyruvate dehydrogenase kinase and 
phosphatase are not exactly known. In bovine kidney the number is 
between 3 and 5 moles/mol complex (Pettit et al., 1982a, 1982b).
The kinase and the phosphatase have been purified to homogeneity.
Each of these enzymes consists of two subunits which have values of
47,000 and 45,000 for the kinase (designed as a and g , respectively) 
and 97,000-110,000 and 50,000 for the phosphatase (Pratt et al., 1982; 
Stepp et al.. 1983).
Table 1.1
Subunit Composition of Bovine Heart Pyruvate Dehydrogenase Complex
Enzyme No.
Subunits
M
~r
Subunits per 
molecule of 
complex
Native Complex 8,500,000
154,000 4
2 41,000 60
2 36,000 60
2^
3,100,000 60 52,000 60
S 110,000 2 55,000 12
Kinase 100,000 1 47,000
1 45,000
Phosphatase 150,000 1 97,000
1 50,000
Reed & Pettit (1981); Stepp et al. (1983)
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1.3, 3 Functional domains in PDC
Studies of limited tryptic digestion of the E. coli acetyl­
transferase have revealed novel aspects of its structure (Bleile et al., 
1979). These authors cleaved the E2 subunit into two types of domain: 
a compact domain of 30,000 that possessed all the intersubunit 
binding sites as well as the catalytic site and another peptide
32,000, which contained the lipoyl moieties. For these experiments 
lipoyl moieties were labelled after incubation of the complex with 
[2-^^C] pyruvate and N-ethyl [2,3-^^C] maleimide. Under these 
conditions, the lipoic acid becomes acetylated and the thiol groups 
generated in the S-acetyl. dihydrolipoamide are then susceptible to 
selective modification with NEM (Brown & Perham, 1976; see also 
Chapter 7, section 7.1). Results indicated that limited tryptic 
digestion of the complex released polypeptide chains cmtaining the 
radioactively-labelled lipoyl.moieties. These fragments were separated
from the residual modified complex by gel filtration or by ultracentri­
fugation. Electron microscopy showed that, after release of the lipoyl 
groups, the gross cube-like appearance of the complex was not altered, 
which suggested that this assembly conferred quaternary structure on 
the acetyltransferase and provided specific binding sites for El and 
E3 (subunit-specific domain).
Kresze and co-workers have examined the effects of several 
proteases on the overall and component activities of the bovine kidney 
PDC. They concluded that a group of proteases which includes papain, 
elastase and the leupeptin-sensitive lysosomal protease (inactivase), 
inactivate the complex by cleavage of the E2 core, thereby inducing 
the disassembly of the complex into the indivual enzyme components 
(Kresze & Steber, 1979). Proteases of this group do not cleave El a
14
subunit or degrade it very slowly. A second class of proteases 
which includes trypsin, chymotrypsin and clostripain cleave El a 
much faster than E2 and disassembly occurs more slowly than inactivation 
of El. With all the proteases studied, a fragment of approx,
26,000 was formed which contained the acetyl transferase activity 
(JCresze & Ronft, 1980). This fragment formed a high M aggregate 
and did not contain acetyl binding sites. On elastase digestion, a 
fragment of 45,000-42,000 (possibly a duplet) was formed, which was 
resistant to elastase but sensitive to trypsin to give fragments of
36,000 or lower. This fragment contained the lipoyl domains.
Subsequently, Bleile et al. (1981) further characterised the 
fragments arising from limited tryptic digestion. These authors 
observed fragmentation of subunit El a and the cleavage of E2 to a 
fragment of the same size as El g (M^ 36,000) and another fragment 
of 27,000. Release of the lipoyl domain did not affect the state 
of aggregation of the E2 subunit as shown by sedimentation equilibrium 
analysis. In contrast with the results in the E. coli complex, this 
treatment affected the ability of the residual core to bind El and E3. 
Apparently, intact E2 subunits, possessing both binding and lipoyl domains 
were required to bind El and E3. These two fragments were separated 
by gel filtration chromatography on Sepharose 6B columns. Acetyl­
transferase activity was retained in the peak of modified E2 whereas 
the lipoyl domains were inactive. The M value for lipoyl domains 
was about 37,000 as estimated by SDS/polyacrylamide gel electrophoresis. 
This value is larger than that estimated by sedimentation analysis of
28,000.
The apparent isoelectric points for the lipoyl domain and the 
residual E2 subunit were estimated by isoelectric focusing in the 
presence of urea as 4.6 and 7.7, respectively. Amino acid composition
analysis showed a high content of acidic residues, a 
high content of prolyl residues and a low content of histidine, 
arginine and tyrosine in the lipoyl domain. This fragment also 
stained very slightly with Coomassie Blue, The acidic nature of this 
fragment may be responsible for the anomalous electrophoretic migration 
and Coomassie Blue staining properties of the E2 component.
From the sedimentation coefficient and the M values, a 
frictional coefficient value of 1.9 was calculated, which indicated a 
swollen or extended structure for the lipoyl domains. These architec­
tural features of the bovine kidney E2 are remarkably similar to those 
found in the E. coli acetyltransferase and transsuccinylase by Bleile 
et al. (1979).
1.3.A Models of PDC structure
Bates et al. (1977) and Collins & Reed (1977) have presented 
evidence that lipoyllysine "swinging arms" can participate in two types 
of reaction. Each El dimer can interact with the lipoic acid residues 
of a small number of E2 chains, followed by transfer of acetyl groups 
between the lipoic acid moieties of neighbouring E2 chains in the 
E. coli complex. These rapid internal reactions or "transacetylations" 
would occur by means of a network of interacting lipoyl moieties through 
acetyl and electron (thiol-disulphide exchange) transfer reactions.
This system would allow efficient coupling of the sequential reactions 
of the complex, even when the substrates are present in low concentrations 
(Danson et al., 1978)
The lipoyl-lysine residues in the E2 chains act as "swinging 
arms" in the mechanism of the complex. These groups reside in portions 
of the E2 chain that protrude from an inner part of the core (Bleile 
et al., 1979), which contain conformationally mobile polypeptide chains.
J.D
The sites of attachment of the lipoyl groups are therefore not 
included in the folding domains but are likely to be forming exposed 
flexible loops of the polypeptide chain,susceptible to proteolysis by 
trypsin (Hale & Perham, 1979). Mobility of lipoyl-peptides is thought 
to increase the effective radius of the lipoyl-lysyl swinging arms in 
carrying the intermediates between the different catalytic centres of . 
the 3 enzymic components and between different acetyltransferase subunits 
in the complex.
Nearly half of the lipoyl moieties in E. coli PDC can be removed 
before there is appreciable loss of activity (Ambrose-Griffin et al.. 1980; 
Stepp et al., 1981). This has been also found for the bovine kidney 
complex (Stanley et al., 1981). This has been explained by assuming 
that the highly-mobile regions of the E2 polypeptide or lipoyl domains 
detected in n.m.r. studies (Perham & Roberts, 1981; Perham et al., 1981) 
enable a given lipoyl group to serve more than one El active site.
Removal of one of the two lipoyl moieties that serve a particular El 
site by lipoamidase or trypsin allows the catalytic cycle to continue 
via the remaining lipoyl domain(s). An active site coupling (or multiple 
random coupling) mechanism has been proposed to explain the current 
experimental data on the structure and function of the E. coli PDC 
(Roberts et al., 1983; Hackert et al.. 1983).
It is currently believed that the ox kidney PDC also possesses 
a comparable system of interacting lipoic acid residues 
(Wawrzynczak et al., 1981). Roche, Cate and co-workers have presented 
evidence that high levels of acétylation with pyruvate are achieved in 
conditions in which only a few El subunits are functional. For these 
experiments, the bovine kidney PDC was inhibited by treatment with 
thiamine thiazolone pyrophosphate, an essentially irreversible inhibitor
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of El. After adding TPP, they observed a fast incorporation of acetyl 
groups into the complex. They have also examinai whether exchange of 
El components contributed to these high levels of acétylation by conducting 
"mixing experiments" using active PDC mixed with inactive PDC. PDC was 
inactivated by treatment with thiamine thiazolone pyrophosphate or by 
phosphorylation with ATP. After removal of the inactivating reagent, 
the levels of acétylation achieved were greater than the additive levels 
of acétylation measured with active and inactive PDC assayed individually. 
They have explained these results as due to rapid transfer of acetyl 
groups between E2 subunits and migration of the El subunits from one 
molecule of complex to the other. They have also suggested that these 
movements of El components are too slow to make a contribution to the 
catalytic mechanism of the complex, but appear to be fast enough to be 
important in the regulation of the complex by pyruvate dehydrogenase 
kinase (Cate & Roche 1978; 1979).
Gene sequence analysis of the pyruvate and 2-oxoglutarate 
dehydrogenase complexes of E. coli lave been reported (Stephens et al,
1983; Guest et al., 1984; Packman et al., 1984). These studies have 
solved some of the controversal features regarding the size and number 
of domain structures of the acetyltransferase, and have confirmed that the 
apparent for the E2 component as inferred from SDS/polyacrylamide 
gel electrophoresis was significantly overestimated. These studies 
have also helped to clarify the view that there are 3 lipoylated 
segments in E. coli PDC, highly-homogeneous in amino acid sequence 
and connected by intervening regions of high-mobility. Mobility of 
the polypeptide chains is associated with alanine and proline-rich 
sequences. Lipoyl domains are linked to the subunit-binding domains 
located near the C-terminal half of the E2 chain. (Packman et al., 1984),
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At present, it also seems clear that there is heterogeneity 
in the quaternary structure of the PDC complex. Since the overall 
complex reactions can be catalysed by complexes deficient in (although 
not completely lacking) El or E3 components, it is evident that 
structurally complete complex is not necessary for biological activity 
(Perham, 1975). These considerations suggest that PDC is not necessarily 
an exact homogeneous structure in terms of fixed chain ratios although 
the structure is governed by its octahedral or icosahedral symmetry 
(Packman et al., 1984). This property differentiates 2-oxo-acid 
dehydrogenase complexes from simpler oligomeric proteins where subunit 
composition is invariant.
1.3.5 Functions of pyruvate dehydrogenase (El)
Linn et al. (1972) and Barrera et al. (1972) reported the
purification and properties of the bovine kidney and heart El. These
authors demonstrated that purified El catalysed the incorporation of 
14
C-labelled acetyl groups derived from pyruvate into isolated E2 
component. Bleile et al. (1981) obtained similar results with isolated 
lipoyl domains. These results support the conclusion that El catalyses 
both the decarboxylation of pyruvate and the subsequent reductive 
acétylation of the lipoyl moieties bound to E2.
The reaction catalysed by this enzyme can be described as follows:
CH^COCO^H + T P P --------- - CH^CHOH-TPP + CO^ CU
CHgCHOH-TPP + LipS^ --------- CH^CO-S-LipSH + TPP (2)
Roche & Reed (1972) obtained evidence that phosphorylation 
inhibited the ability of the enzyme to catalyse reaction 1 with
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[1“ CJ pyruvate as substrate, but not with [a- C] hydroxyethyl TPP
as substrate (reaction 2). Since phosphorylation occurs at the El a
subunit and not in the $ subunit,they suggested that subunit o
catalyses reaction 1 and subunit B , reaction 2. However, this 
proposal has been questioned by Walsh et al. (1976) who reported that 
phosphorylation of the pig heart enzyme inhibits the NADH-dependent 
transfer of acetyl groups from enzyme-linked acetyldihydrolipoamide 
to TPP (reversal of reaction 2). These results await clarification, 
perhaps when isolated active a and B subunit are available.
Denton et al. (1975) have shown that,besides the a-hydroxyethyl 
TPP, other products of decarboxylation of pyruvate may be formed, 
including acetyldehyde, acetoin and other byproducts. However, the 
extent to which these compounds are formed in vivo is not known.
The equilibrium of the overall PDC reaction is largely in favour of its 
products and would be expected to be irreversible. All partial 
reactions except decarboxylation (reaction 1) are reversible. This 
step has probably the largest negative value of à G" and thus may be 
the rate-limiting step. However, Cate et al. (1980), using flow-quench 
rapid reaction studies,determined that the initial rate of.decarboxylation 
of pyruvate proceeds at a much faster rate than the incorporation of 
acetyl groups. They concluded that reductive acétylation and not 
decarboxylation is the rate-limiting step in the overall reaction.
1.3.6 Studies on the function of lipoamide dehydrogenase (E3)
Lipoamide dehydrogenase belongs to a class of flavoproteins 
which catalyse the transfer of electrons between pyridine nucleotides 
and disulphide compounds. Other members of this group are 
glutathione reductase and thioredoxin reductase with many properties 
in common (Williams, 1976; Arscott et al.. 1982).
Lipoamide dehydrogenase contains in addition to FAD, a reactive 
cysteine disulphide, which functions in catalysis. The two half-cystine 
are separated in the polypeptide chain by only four residues. Evidence
for the involvement of this group in catalysis comes from studies in 
the presence of arsenite and NADH, in which the flavin is oxidised 
completely. As arsenite quite specifically reacts with vicinal 
dithiols, these data suggest that the disulphide group participates in 
the catalysis.
Upon reduction, lipoamide dehydrogenase accepts only two electrons 
from the substrate, but in the presence of arsenite, this intermediate 
is not stable and a 4-electron reduction results, which completely 
inactivates the enzyme. A mechanism of action of lipoamide dehydrogenase 
has been proposed by Massey & Veeger in which the catalytic intermediate 
is one in which the enzyme accepts two electrons and these are shared 
bewteen the FAD group and the reactive disulphide (reviewed by
Williams, 1976).
Lipoamide dehydrogenases have been isolated from many sources, 
both eukaryotic and prokaryotic; they are remarkably resistant to heat 
inactivation, urea treatment and proteolysis. The E. coli and 
Saccharomyces cerevisiae enzymes also resemble the pig heart enzyme in 
size and amino acid composition (Williams, 1976; Heinrich et al.. 1983).
Considerable sequence homology has been found between peptides 
of the pig heart enzyme and the primary sequence of the E. coli lipoamide 
dehydrogenase estimated from nucleotide sequence data (Stephens et al., 
1983). These similarities strongly favour a common ancestry. Also, 
the E1-E2 subcomplexes from mammalian and bacterial sources retain 
sufficient homology to permit exchange of their E3 components. Further­
more, the pig heart lipoamide dehydrogenase couples with the E. coli 
subcomplex to generate overall complex activity and assembles into a 
hybrid multienzyme complex (Perham, 1975; Guest, 1978).
The mammalian enzyme seems to be present in various forms, while 
the E. coli enzyme is a single species encoded by a structural gene
(Stephens et al., 1983). The physiological significance, number 
and origin of these electrophoretically-separable forms have been the 
topic for considerable controversy. The basis for the diversity of 
isoenzymes of E3 (2-13) has been discussed by Guest (1978). Gene 
multiplicity has not yet been discarded although the biochemical 
differences between the isolated forms are very small (Sakurai et al., 
1970; Kenney et al.. 1972). The existence of conformational isomers 
or the generation of secondary isozymes by post-translational 
modification are other possible mechanisms.
1.4 Regulation of mammalian PDC
1.4.1. Introduction
The regulatory properties of mammalian PDC have been studied 
extensively. The conversion of pyruvate in AcSCoA catalysed by PDC 
serves both bioenergetic and biosynthetic roles. In animals, AcSCoA 
cannot be used as a source of carbohydrate and thus metabolism of pyruvate 
through this step represents net losses of carbohydrate reserves (see 
Fig. 1.1).
Garland & Randle (1964) proposed a mechanism for regulation of 
the complex by end product inhibition with high ratios of [AcSCoA]/'[CoA] 
and [NADH]/[NAD’*’]. The end-product inhibition of the complex was first 
observed with a partially-purified preparation of the pig heart PDC.
It was found that if PDC activity was measured spectrophotometrically in 
a system which allowed the products to accumulate, the rate of reaction 
declined to 5-10% of the original value. Addition of -carritLne and 
carnitine acetyltransferase to remove the accumulated AcSCoA, caused 
an increase in the rate to about 70% of the initial value. Subsequent 
studies demonstrated that AcSCoA and NADH are effective competitive 
inhibitors of CoA and NAD^, respectively (Tsai et al., 1973), This 
mechanism of regulation is very important in the control of pyruvate
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oxidation by heart and diaphragm tissue (Denton et al., 1975).
A second type of regulation was reported by Linn et al. (1969a 
} 1969b). These workers showed that the complex exists in an
inactive phosphorylated form and an active non phosphorylated form. 
Interconversion of the two forms was catalysed by an ATP-requiring 
kinase and a phosphatase associated with the complex (Fig. 1.3).
PDC from several mammalian and avian tissues, Neurospora crassa 
and plants and the mammalian branched-chain 2-oxo-acid dehydrogenase 
complex are regulated by covalent modification (Wieland, 1983). There 
is no evidence that PDC in prokaryotic cells or yeast or the 2-oxo- 
glutarate dehydrogenase complex in eukaryotic or prokaryotic cells 
undergo phosphorylation and dephosphorylation.
Changes in the [AcSCoA]/[CoA] and [NADH]/[NAD‘'] ratios also 
influence regulation of PDC by phosphorylation/dephosphorylation,.
The relative importance of these two differing mechanisms of control 
depends, at least in part, on the nature of the oxidisable substrate 
available to the tissue (Wieland et al., 1971).
1.4.2 Pyruvate dehydrogenase kinase. Isolation and properties
Pyruvate dehydrogenase kinase has been purified about 2,700-fold 
to apparent homogeneity from extracts of bovine kidney mitochondria 
(Stepp et al.. 1983). Kidney mitochondria contain at least 4 times 
as much pyruvate dehydrogenase kinase as heart mitochondria and are 
the preferred source for isolation of the enzyme. The amount of kinase 
present is small, and only 2-4 mg are recovered from about 12 Kg 
kidney cortex.
The kinase is tightly-bound to the E2 component and co-purifies 
with the complex. Treatment of the core with p-hydroxymercuriphenyl 
sulphonic acid at alkaline pH promotes release of the kinase (Linn et al., 
1972). Highly-purified preparations of the kinase show a doublet on
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SDS/polyacrylamide gel electrophoresis, provided that
proteolysis is minimal. (Stepp et al., 1983). The two subunits
o and g have values of 47,000 and 45,000, respectively. This
finding and the sedimentation coefficient (s__ ) of 5.5S indicates
zU,w
that kinase has a subunit composition a 8 •
Limited proteolysis with chymotrypsin modified the kinase
subunit selectively and was accompanied by loss of kinase activity ;
whereas limited tryptic digestion cleaved the 8 subunit selectively
without affecting the activity. These observations and peptide
mapping studies suggest that the two proteins are different and that
the catalytic activity resides in the a subunit. The function
of the 6 subunit remains to be established. An attractive possibility
is that it functions as a regulatory subunit.
1.4.3 Sites of phosphorylation
Phosphorylation and concomitant inactivation of pyruvate
dehydrogenase (El) occurs on three serine residues in the a subunit
(Yeaman et al.. 1978; Sugden et al., 1979).
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Tryptic digestion of P-labelled pyruvate dehydrogenase from 
bovine kidney and heart yielded 3 phosphopeptides, a monophosphorylated 
(site 1) , a diphosphorylated (sites 1 and 2) tetradecapetide and a
monophosphorylated nonapeptide (site 3).
Phosphorylation at site 1 proceeds markedly faster than at sites 
2 and 3;inactivation (approx. 95%) is accomplished by phosphorylation 
of only one site (site 1) per tetramer (a P. g and then 2 further 
moles of phosphate may be incorporated (o P^. g ^^(Sugden & Randle, 1978; 
Yeaman et al., 1978).
Randle and co-workers reported that phosphorylation at sites 
2 and 3 on El, in addition to site 1, markedly inhibited the rate of 
its reactivation by pyruvate dehydrogenase phosphatase (Sugden et al.,\978»
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Kerbey & Randle, 1979). Partially-phosphorylated complex was 
reactivated more rapidly than fully-phosphorylated complex. These 
authors have proposed a role for multisite phorphorylation as a 
mechanism for regulating the conversion of inactive complex into active 
complex in rat mitochondria. Hutson et al. (1978) proposed that 
phosphorylation of these additional sites was responsible for the lower 
rate of reactivation of the complex by pyruvate dehydrogenase phosphatase 
in heart mitochondria from diabetic and starved rats (reviewed by 
Randle et al., 1981).
This proposal has been criticised by Reed and his colleagues 
(Reed et al., 1980), since they are at variance with the results of 
Teague et al. (1979), who observed that the presence of phosphoryl 
groups at sites 2 and 3 on bovine kidney El did not significantly affect 
the rate of reactivation by pyruvate dehydrogenase phosphatase.
These authors obtained evidence that dephosphorylation at 
sites 1, 2 and 3 is random and that the relative rates of déphosphory­
lation were in the order site 2 > site 3 > site 1. For these 
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experiments, [y - P] ATP and adenosine 5'-[ y -thio] triphosphate ATP 
(ATP Y S) were used to distinguish between the effects of phosphoryl 
groups at sites 2 and 3. The presence of thiophosphoryl groups at 
sites 2 and 3 did not inhibit the release of phosphoryl groups from 
site 1. However, the dephosphorylated enzyme was inactive. This 
indicated that phosphorylation at sites 2, and possibly at site 3,
function, as well as site 1, as inactivating sites on the enzyme.
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In additional experiments, P-labelled groups were incorporated into 
sites 1 and 2 and a thiophosphoryl group was inserted at site 3.
The phosphatase released the phosphoryl groups from sites 1 and 2 
and the enzyme was active, suggesting that phosphorylation at site 3 
is not inactivating. The rate-limiting step is apparently the
déphosphorylation at site 1. The physiological significance of 
phosphorylation at site 2 in unknown.
The basis for the inconsistencies between the results from 
the two laboratories, although not apparent, has been attributed to 
methodological differences e.g. the molar ratios of phosphatase to 
phosphorylated El and differences in the media of incubation (Randle 
et al.. 1981; Reed & Yeaman, 1985). However, it remains an important 
unanswered question.
Phosphorylation of El results in essentially total loss of its 
enzymic activity. No allosteric activators of the phosphorylated 
enzyme have yet been reported, in spite of a wide search (Hucho et al., 
1972).
1.4.4 Pyruvate dehydrogenase phosphatase. Isolation and properties
Pyruvate dehydrogenase phosphatase has been purified from bovine 
heart and kidney mitochondria to apparent homogeneity (Teague et al., 
1982; Pratt et al..1982). and partially-purified from pig heart (Siess & 
Wieland, 1972). Heart mitochondria contain at least 3 times as much 
phosphatase as kidney mitochondria and are the preferred source for 
isolation of the enzyme. The purification procedure is based on binding 
of the phosphatase to E2 coupled to Sepharose in the presence of Ca^* 
and subsequent release in the presence of EGTA. The phosphatase has 
a sedimentation coefficient of about 7.48 and an of about 150,000 
as determined by several methods. The phosphatase consists of two 
subunits of about 100,000 and 50,000 in SDS/polyacrylamide gels. 
Phosphatase activity resides in the smaller subunit, which is sensitive 
to proteolysis (Teague et al.. 1982; Pettit et al.. 1982b). FAD is 
apparently associated with the larger subunit, the function of which is 
still unknown.
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1.4.5 Control of kinase and phosphatase activities
Pyruvate dehydrogenase kinase activity is simulated by AcSCoA 
and by NADH, products of pyruvate oxidation, in the presence of K"*" or 
NH4 ions. (Cooper et al., 1974; Pettit et al.. 1975; Cooper et al.. 
1975). The coenzyme, TPP and other pyrophosphate compounds, inhibit 
kinase activity, presumably by binding at the catalytic site of El and 
thereby altering the conformation about phosphorylation site 1 so that 
the serine hydroxyl group is less susceptible to the kinase 
(Roche & Reed, 1972).
When El and its kinase are bound to the core enzyme, the rate 
of phosphorylation increases markedly, apparently because of favourable 
topographical positioning of El with respect to the kinase or possibly 
to a change of conformation of either the kinase or El or both enzymes 
induced by binding to the transacetylase (Hucho et al., 1972; Pettit 
et al., 1982a).
Treatment of highly-purified kinase from bovine heart and kidney 
with excess NEM resulted in a loss of kinase activity, but had little 
effect on the oxidation of pyruvate to AcSCoA. It appears that the 
kinase contains a thiol group (or groups) involved in maintaining the 
conformation of the enzyme that facilitates phosphorylation of El.
It is not known if modulation of the activity by thici-disulphide 
exchange has a physiological role.
Pyruvate dehydrogenase kinase is highly-specific for its 
substrate. It exhibits little activity towards casein, approx. 0.5% 
of the activity obtained with pyruvate dehydrogenase (Hucho et al.. 1972). 
Mg^* is required by both the kinase and the phosphatase. However, 
the apparent of the phosphatase for Mg^* (approx. 2 mM) is about 
100 times higher than the of the kinase for the same ion, Ca^* 
markedly stimulates phosphatase activity (Denton et al., 1972;
Pettit et al.. 1972) (K^ in the order of micromolar) provided that E2 
is present (Pettit et al.. 1972; Siess & Wieland, 1972). However, 
phosphatase activity towards phosphopeptide substrates is not affected 
by Ca^ "*", whether or not E2 is present. These observations suggest 
that Ca is not directly involved in phosphatase catalysis. In the 
presence of Ca^^, the phosphatase binds to E2 and its for phosphory- 
lated El is decreased about 20-fold. Favourable positioning of the 
phosphatase and phosphorylated El on the core apparently facilitates 
the Mg^- dependent phosphorylation. Because pyruvate dehydrogenase 
phosphatase and PDG are located in the mitochondrial matrix, changes 
in the intramitochondrial Ca^ "*" concentration could play an important 
role in the regulation of PDC activity (Randle et al., 1974; Denton 
et al.. 1981).
At saturating concentrations of Mg the polyamines spermine, 
spermidine and putrescine stimulated the activity of the phosphatase 
(Darauni et al., 1984). This effect may be relevant to stimulation 
of the complex by insulin in adipose tissue. Pyruvate dehydrogenase 
phosphatase activity is inhibited by NADH and the inhibition is 
reversed by NAD'*’ (Pettit et al., 1975). It exhibits little activity 
toward phosphorylase ^  and phosphorylated branched-chain 2-oxo-acid 
dehydrogenase complex. A broad-specificity phosphatase 34,000 
from rabbit liver cytosol shewed significant activity towards 
phosphorylated PDC from bovine kidney (Reed et al., 1980).
The pyruvate dehydrogenase system is well designed for fine 
regulation of its activity. Interconversion of the active and inactive 
forms of El is a process that leads to the establishment of steady 
states, in which the fraction of phosphorylated El can be varied over 
a wide range by changing the concentrations or molar ratios of the 
effectors that regulate the activities of the kinase and phosphatase
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(Reed & Pettitt,1981). The steady state activity of the complex is 
sensitive to the ratios [ATP]/[ADP], [AcSCoA]/[CoA] and [NADH]/[NAD*]. 
Pyruvate dehydrogenase and its two converter enzymes comprise an 
interconvertible enzyme cascade. The mechanism whereby AcSCoA, CoA,
NAD* and NADH modify the activity of the kinase is an intriguing problem.
It is possible that the kinase or its substrate bears regulatory binding 
sites for these effectors but equally it is possible that these compounds 
act through binding to their substrate sites on E2 and E3. This 
mechanism might involve conformational changes, in view of the importance 
of the attachment to the acetyltransferase for kinase activity. Fig.1.3 
summarises the control of kinase and phosphatase activities by effectors 
observed with the purified enzymes.
A novel mechanism is that lipoate may act as the transmitter of 
regulatory interactions. This suggestion was originally made by Kerbey 
et al. (1976) and subsequently supported by Cate, Roche and co-workers. 
These latter authors have postulated a mechanism in which the 
regulatory effects on pyruvate dehydrogenase are mediated through changes 
in the distribution of the lipoyl moieties of E2 between the oxidised, 
reduced and acetylated forms. Reduction of lipoyl moieties bound to 
E2 would activate the kinase and AcSCoA stimulation of the kinase would 
require acétylation of the lipoyl groups (Roche & Cate, 1977).
The activating effects of low pyruvate concentrations in the 
presence of TPP could thus be explained in terms of acétylation or 
reduction of lipoyl groups (Cate & Roche, 1978; 1979). However, 
this suggestion is in contradiction with the findings of Reed et al. (1980) 
with highly-purified pyruvate dehydrogenase kinase and its dephospho- 
tetradecapeptide substrate. The rate of phosphorylation was stimulated 
by AcSCoA and NADH and inhibited by ADP and pyruvate. As E2 was 
absent in the preparations of enzyme, these results indicate that these
active
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Schematic representation of the covalent modifications 
of pyruvate dehydrogenase and its regulation by various 
metabolites.
(Reed et al., 1980)
effectors act directly on the kinase, and not via lipoyl moieties 
bound to E2. However, the controversy has not yet been solved, since 
Roche and co-workers were unable to reproduce these data (Rahmatullah & 
Roche, 1985).
It is not yet clear how a few molecules of pyruvate dehydrogenase 
kinase, tightly-bound to the core enzyme, can inactivate the full El 
complement of the complex. In this respect, Brandt & Roche (1983) 
have proposed that El molecules migrate on the surface of the E2 core to 
the fixed kinase subunits (see also section 1.3.6).
1.6.6 Role of PDC in the regulation of glucose oxidation
The oxidative decarboxylation of pyruvate by PDC is of special 
importance to glucose homeostasis in man and other animals. Owing 
to the irreversibility of the PDC reaction, an unregulated flux of 
pyruvate through this step would seriously jeopardise the balance of 
body glucose (Wieland, 1983). Glucose conservation is a physiological 
necessity during starvation since glucose reserves are limited. This 
necessity is developed to a pathological extent in diabetes where 
rates of glucose oxidation are inappropriately small for the prevailing 
glucose concentration in the extracellular fluids.
In diabetes and starvation, there is a marked decrease in the 
activity state of the complex in heart, liver and kidney (Wieland et al.. 
1971). Re-feeding or administration of insulin or inhibitors of fatty 
acid oxidation reverse effects of starvation and diabetes. These 
effects tsi PDC activity have been attributed to stimulation of the 
activity of pyruvate dehydrogenase kinase or increased synthesis of a 
protein activator of the kinase or the kinase itself (Hutson & Randle, 
1978; Kerbey & Randle, 1982).
The two best-studied acute effects of hormones on the activity 
of PDC are those of positive inotropic agents such as adrenalin in
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the heart and the effect of insulin on the enzyme in several tissues 
(Denton & Hughes, 1978; McCormack & Denton, 1984).
In perfused rat heart,it has been demonstrated that the initial
PDC activity is increased about 4-fold after the administration of
adrenaline and other inotropic agents (McCormack & Denton, 1981).
These effects have been attributed to increased transport of Ca^* ions
into mitochondria and consequent activation of the pyruvate dehydrogenase
phosphatase. Similarly, stimulation of PDC activity in liver by
vasopressin, angiotensin and adrenaline (o -adrenergic action), which
act via the formation of inositol 1,4,5-tidsphosphate and mobilisation
of cytoplasmic Ca^* may be due to increases in the intramitochondrial 
2+
Ca concentration (Berridge & Irvine, 1984), The most extensively 
studied hormonal effects on PDC activity are those on control of its 
activity in adipose tissue by insulin. Physiological concentrations 
of insulin, increase the basal activity of PDC by 60-200% after 5-10 min 
incubation of fat pads with insulin in the presence of glucose (or 
fructose). This increase is accompanied by dephosphorylation of the 
El a subunit. (Denton et al., 1975).
Elucidation of the mechanism by which insulin exerts its acute 
effects on key target enzymes such as PDC, remains one of the major 
problems in metabolic regulation. The literature on this subject is 
vast as these aspects have attracted considerable attention (Denton 
et al.. 1981).
There have been proposed many hypotheses to explain how a 
signal arising from the interaction of insulin with its receptor in 
the plasma membrane is transmitted to mitochondria. Besides Ca^* 
ions, many other molecules have been proposed to act as mediators of 
the insulin action, e.g. HgOg and various soluble peptide mediators 
(Paetzke-Brunner et al., 1980; Saltiel et al., 1981; Thomson et al., 1984),
At present, it has been difficult to demonstrate the physiological 
,importance of these mediators since their complete structure must be 
elucidated and the purified molecule must be shown to produce insulin 
effects in target tissues. For reviews on this subject, refer to 
Wieland (1983) and Reed & Yeaman (1985).
1.5 Aims and importance of the present study
The large number of research groups involved in studies on short­
term effects of hormones on PDC activity and other regulatory aspects 
of the enzyme contrasts with the few reports on the mechanism that 
influencesPDC levels in the cells (Knowles & Ballard, 1974; Weinberg 
& Utter, 1979). Other aspects of the structure, function and regulation 
of the mammalian PDC still remain to be examined. Little is known 
about biosynthesis, assembly and turnover of the multienzyme within 
the mitochondria. Moreover, the spatial arrangement of the complex 
in situ is not yet understood, bearing in mind the size of the isolated 
complex as estimated by electron microscopy exceeds by far the thickness 
of the mitochondrial inner membrane plus the width of the intracristal 
space. Studies on the organisation of the complex inside the 
mitochondrion would help to clarify this problem.
This study was undertaken to address the problem of the 
biosynthesis of this multimolecular aggregate in the cytoplasm and the 
mechanism of import of the individual polypeptides into the mitochondria 
for the assembly of the complex. Studies on the biosynthesis of 
2-oxo-acid dehydrogenase complexes in eukaryotic cells have not been 
reported.
Although association of enzymes into complexes offers a number 
of advantages for biological organisation (section 1.1) it raises new 
problems of its own. First, because of the disproportionate 
polypeptide composition, biosynthesis of the individual components
must be coordinated for the different polypeptide chains to be in 
the appropriate amounts. In microorganisms, clustering of functionally- 
related genes in opérons are a special form of genetic organisation 
that is assumed to provide efficient and coordinate regulation of gene 
expression. The specific components of PDC from E. coli are encoded 
by two structural genes which form an operon. The complex is independent­
ly regulated by pyruvate and inhibited (but not repressed) during anaerobic 
growth. The E3 component is encoded by a single gene linked to this 
operon (Stephens et al.. 1983).
Less is known about the control of gene expression in eukaryotic 
cells where stablemRNAs emerge from a separate organelle (the nucleus).
Most mitochondrial matrix proteins are synthesised In the cytoplasmic ribo­
somes in the form of larger precursors which are specifically 
recognised and imported inside the organelle. Translocation is an 
energy-dependent process and processing of the precursors is mediated 
by a specific protease located in the mitochondrial matrix.
Studies on the assembly of multienzyme complexes, are important 
in themselves. The role of nucléation and stable intermediates in the 
process has been recognised as important elements in the assembly of 
many oligomeric proteins. In the case of PDC, studies of the self- 
assembly of the structure inside the mitochondrion from the individual 
components are an important issue.
1.6 Synthesis of mitochondrial proteins
1.6.1 Introduction
The eukaryotic cell is organised by a variety of membranes ; the 
plasma membrane which encloses the cell and various intracellular 
membranes which determine cell compartmentation and delimit organelles. 
These organelles perform specialised functions and this is reflected
in their characteristic polypeptide compositions. This organised 
distribution of polypeptides is necessary because, with only few 
exceptions, the proteins of the various organelles and their membranes 
are not synthesised in the same compartments in which they perform 
their functions. Most of them are translated on cytoplasmic ribosomes 
and have to be selectively translocated across these diverse membranes. 
Organelle membranes must not only have devices for the specific recog­
nition of proteins which are destined for the compartments they enclose, 
but also have mechanisms to translocate these proteins across the lipid 
bilayer; this is quite remarkable, as many proteins are very large and 
hydrophilic.
1.6.2 Mechanisms of transport of proteins in the eukaryotic cell
According to our present knowledge, there are two basic mechanisms 
for the transfer of proteins across biological membranes. In the co- 
translational mechanism, proteins can be inserted into membranes in a 
synthesis-dependent fashion. This appears to be the case for secretory 
proteins and proteins destined for the plasma membrane and for lysosomes. 
In contrast, import into organelles such as chloroplasts, mitochondria 
and peroxisomes is apparently the result of a post translational process. 
Some proteins of the endoplasmic reticulum, such as cytochrome b^ and 
NADH cytochrome b^ reductase also appear to utilise this latter type 
of transport (Kreibich et al.. 1985).
Many proteins are translated on polysomes tightly-associated 
with the rough endoplasmic reticulum and co-translationally inserted 
into the membranes. This process, often termed 'vectorial 
translocation' is coupled to elongation of the polypeptide chain.
The finished proteins are sequestered on the opposite site of the 
membrane and once released from the ribosomes may either remain as 
integral membrane proteins or be released into the hm.en. A detailed 
mechanism of co-translational transport was first proposed by Blobel &
Dobberstein (1975a; 1975b) in the so called, 'signal hypothesis', which 
has been modified in response to a large number of data (Meyer, 1982). 
The nascent peptides are thought to interact with the appropriate 
membranes through signal peptides, an amino-terminal presequence of 
15-20 amino acids residues. As the signal sequence emerges from the 
ribosome, it binds an oligomeric 'signal recognition particle' (SEP) 
a ribonucleoprotein complex, which arrests further elongation of the 
polypeptide. The SRP-polysome complex then interacts with an SRP 
receptor or 'docking protein' at the membranes of the endoplasmic 
reticulum. This releases the arrest of elongation and the nascent 
polypeptides penetrate the membrane as they grow. The signal sequence 
is cleaved off the polypeptide before elongation is completed. This 
is accomplished by a 'signal peptidase' an integral membrane protein, 
which is probably located on the luminal side of the membranes of the 
endoplasmic reticulum.
The SRP thus sorts proteins by performing the dual functions of 
preventing inappropriate synthesis in the cytoplasm and by assuring 
that synthesis of signal-bearing proteins occurs only on ribosomes 
attached to the endoplasmic reticulum. The pathway taken for proteins 
within the Golgi en route to secretory granules, plasma membrane and 
lysosomes is becoming clearer as the role of the various types of Golgi 
cisternae is emerging. These proteins reach their final 
locations by transport mechanisms which involve addition of oligo­
saccharides, flow of membrane and shuttling between organelles and 
plasma membrane. The intercompartmental transfer of proteins is 
accompanied by secondary sorting decisions. However, it is not yet 
known how these proteins signal their route or how information is 
encoded in the many kinds of vesicles that are required to carry out 
membrane traffic (Rothman & Lenard, 1984).
The second mechanism of translocation of proteins through 
membranes is a synthesis-independent process. In contrast with the 
co-translational transport mechanism, posttranslationally transferred 
proteins are synthesised essentially on free polysomes and released 
into the cytosol as complete polypeptide chains. The primary trans­
lation products differ in structure and properties from their mature 
counterparts. In particular, precursors to most mitochondrial proteins 
carry pre-sequences. The newly-synthesised proteins enter the cytosolic 
pool of free precursors from which they are rapidly cleared by uptake 
into the appropriate organelles. These precursors interact directly 
with their target membranes, apparently via specific receptors on the 
surface of the organelles. During translocation the precursors are 
processed to the mature protein (Neupert & Schatz, 1981; Hay et al., 1984). 
The most characteristic feature of posttranslational transport is that 
synthesis of the precursors on the polysomes and their translocation 
are two clearly separate events.
1.6.3 Biogenesis of mitochondria
Mitochondria and chloroplasts are organelles which possess their 
own limited genetic systems. The biosynthesis of the proteins for 
these organelles depends on the coordinated interplay between the two 
genetic systems located in the organelle and the nucleus. (De Vries & 
van't Sant, 1983).
It is estimated that mitochondria contain several hundred proteins. 
The mitochondrial genome from various species contains roughly the same 
information for a set of 12 proteins and for the mitochondrial tRNM and 
rRNAs. (Chomyn et al., 1985). An interesting feature is that the products 
of the • mitochondrial genome are mostly hydrophobic components of 
complexes which contain products of both organelle and nuclear genes.
However, it is obvious that the majority of mitochondrial proteins 
(about 95%) are specified by nuclear genes, synthesised on 
cytoplasmic ribosomes and then transported into mitochondria.
Ever since the presence of a mitochondrial biosynthetic system 
was discovered, basic questions were posed: Why are some genes in
the organelle DNA and others in the nucleus?. How do genes in 
organelle and nucleus work together in making mitochondria ?. The 
answers to these and other questions are not known, but considerable 
progress has been achieved in sequencing mitochondrial genes and 
obtaining the transcription maps. By genetic manipulation,it should 
be possible e.g. to transfer mitochondrial genes to the nucleus and to 
test whether mitochondrial genes encode proteins that can be synthesised 
in the active form but cannot be imported into the organelle.
Another interesting aspect of mitochondria is that these 
organelles are surrounded by two differing membranes, whereas only 
single membranes surround most of the other organelles. The two 
mitochondrial membranes divide the mitochondrion into four different 
locations the outer membrane, the inner membrane, the intermembrane 
space, which lies between the two membranes, and the matrix, which is 
enclosed by the inner membrane.
Biogenesis of mitochondria occurs by insertion of individual 
components into pre-existent mitochondria, i.e. mitochondria multiply 
by growth and division. (Yaffe & Schatz,1984b). The transfer of 
hundreds of mitochondrial proteins through the mitochondrial membranes 
to reach their various locations is a complex process. Several aspects 
of the mechanisms involved are known.
It can be divided conceptually into five steps:
i) synthesis of the polypeptide, usually as a larger precursor 
ii) recognition and binding of the precursors at the 
mitochondrial surface
iii) translocation of the precursor across or into one or
both mitochondrial membranes
iv) cleavage and/or other processing modifications of the
polypeptide chain to the mature protein 
v) assembly into functional units 
These steps are schematically shown in Fig. 1.4.
Degradation of mitochondrial proteins is not a well-known process.
The proteolytic systems involved are not yet understood? however, some 
studies indicate that mitochondrial proteins have different half-lives, 
which suggests the existence of mechanisms that regulate their degradation 
(Mori et al., 1981c).
1.6.4 Characteristics of precursor polypeptides
Two different experimental approaches have been used to study 
the synthesis of mitochondrial proteins. The first relies on experiments 
performed in vitro, employing cell-free translation. The second is 
based on experiments performed in vivo. (see also Chapter 8, section 8.1). 
Although precursors are difficult to isolate in appreciable amounts, 
it has been shown by pulse-labelling ofepheroplasts, fibroblasts or 
hepatocytes and subsequent immunoprécipitation, that many of the 
cytoplasmic precursors to mitochondrial proteins are made as larger 
polypeptides. This difference in size is frequently shown by a slow 
migration on SDS/polyacrylamide gel electrophoresis of the precursor 
polypeptide as compared with the mature form. Such larger precursors 
can also be detected in vitro after analysis of the translation products.
mRNA
Nucleus
Mitochondrial 
/  DNA
Other
organelles
Fig. 1.4 Stages on mitochondrial biogenesis
1. Biosynthesis of precursors.
2. Recognition and binding.
3. Translocation.
4. Processing.
5. Assembly Into functional units.
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Cell-free translation is frequently employed to analyse the 
properties of precursors as they are released from the ribosomes. In 
such studies, the mRNA can be obtained from heterologous systems, and 
mitochondria are absent during protein synthesis. This avoids post­
translational modification of the primary translation products which 
is part of their biogenesis. Standardised preparations of lysed 
reticulocytes or extracts of wheat germ are used for most studies 
since efficient translation of mitochondrial proteins is generally 
achieved.
It has become apparent that the majority of mitochondrial proteins 
are formed as precursors, which exhibit 500-10,000 larger than their 
corresponding mature proteins, on the basis of their electrophoretic 
mobility on SDS/polyacrylamide gels.
Cytosolic precursors for many mitochondrial proteins in many 
species have been identified. Table 1.2 summarises the proteins 
discussed in this study. For an extensive list of precursors refer 
to Hay et al. (1984).
There is no apparent correlation between the size of the N- 
terminal extension and the final location of the mature protein within 
the mitochondrion. Furthermore, precursors to subunits of the same 
enzyme complex do not possess 'signal' peptides of identical size 
or amino acid composition. Several imported mitochondrial proteins 
are synthesised with no N-terminal extensions. Among these are porin, 
which appears to be present in all mitochondrial outer membranes so 
far studied and probably forms aqueous channels in the membrane,
(Casser & Schatz, 1983), the adenine nucleotide transporter of Neurospora 
(Zimmermann & Neupert, 1980) and cytochrome c, an intermembrane space 
protein (Zimmermann et al.. 1979).
The amino acid sequence of the amino-terminal extensions of 
several mitochondrial precursors have been elucidated from the nucleo­
tide sequence of the corresponding genes (Reid, 1985). Among these 
are the subunit IX of the Neurospora ATPase and the yeast cytochrome c 
peroxidase (Viebrock et al.. 1982; Kaput et al., 1982). It has been 
suggested that the sequence of 66 amino acids of the precursor to the 
subunit IX of ATPase renders the precursor more basic and more hydrophilic 
than the mature protein.
The observation that precursors,from which the prepiece has been 
removed in vitro by addition of solubilised matrix protease, can no longer 
be imported into mitochondria (Casser et al.. 1982b) supports early 
suggestions (Schatz, 1979) that this sequence contains information for 
targetting the attached protein to its correct intramitochondrial 
location. This has been further demonstrated by DNA recombination 
methods (section 1.6.8). Since some proteins,without transient N- 
terminal extensions,can be imported into mitochondria, it is possible 
that these proteins contain other 'signals' in the polypeptide structure" 
which allow their specific uptake by the organelle. Physicochemical 
and immunological differences have been detected between precursor and 
mature proteins, e.g. between the cytochrome c and its precursor, 
apocytochrorae c (Hennig & Neupert, 1983). Conformational differences 
are also suggested by intermolecular associations between precursor 
molecules e.g. rat liver ornithine transcarbamylase is a trimeric enzyme 
which sediments at 6S; the in vitro synthesised precursor sediments 
at 14S although its is only 3000-4000 larger than the mature protein 
(Miura et al.. 1981 Kalousek et al., 1984). Aggregation of precursors 
has also been reported for other proteins e.g. the adenine nucleotide 
translocator (Zimmermann & Neupert, 1980) and carbamyl phosphate 
synthetase (Miura et al., 1981).
Recent evidence suggests that cytosolic or lysate factors are 
required for import of precursors (Argan et al., 1983; Miura et al.,
1983; Ohta & Schatz, 1984). Such factors could catalyse the formation 
of precursor aggregates, either for their protection in the cytosol 
or for Iheir proper presentation to the mitochondrial surface.
Regarding the subœllular site of synthesis of mitochondrial 
precursors, several lines of evidence indicate that while the membranes 
of the endoplasmic reticulum may be in some case contiguous with the 
mitochondrial outer membrane, there is yet no conclusive evidence that 
this association is related to the biosynthesis of mitochondrial proteins 
(Ades, 1982; Hay et al.. 1984). Answers to this question have been 
obtained by employing cell-free translation systems programmed with 
polysomes (free or membrane-bound) or mRNA extracted from these polysomes. 
The translation products have been analysed by immunoprécipitation 
procedures and the site of synthesis for a number of mitochondrial 
proteins has been found in free polysomes (Raymond & Shore, 1979;
Mihara et al., 1982).
1.6.5 Mitochondrial import receptors
Shortly after synthesis, cytoplasmic precursors tomitochon- . 
drial proteins find their way into the organelle. This step requires 
interaction of precursors with the cytoplasmic face of the outer 
membrane . The interaction may involve specialised receptors, which 
recognise precursors destined for mitochondria.
Alternatively, translocation may not require the presence of 
specific receptors on the outer mitochondrial membrane. The presence 
of extra peptides may introduce features into the precursor which simply 
allow the proteins to diffuse through the mitochondrial membrane(s).
This mode of translocation would accord with the membrane-triggered 
folding model proposed by Wickner (1979).
The existence of the proposed receptors has been tested by 
incubating the precursors, recently-synthesised in vitro, with isolated 
mitochondria. In all cases studied, the precursor can be recognised 
and transported into the organelle. In order to study the interactions 
between precursors and mitochondria, procedures have been employed to 
inhibit translocation. Binding of precursors to mitochondria appears 
to be less dependent on temperature than the translocation or insertion 
into the membrane. Another approach takes advantage of the observation 
that the import of most proteins into mitochondria requires an electo- 
chemical potential across the inner membrane. When the membrane 
potential is dissipated, transfer is halted although precursors remain 
bound to the mitochondrial outer surface. However, under these conditions, 
some precursors bind poorly to mitochondria (Zwizinski et al.. 1984).
From the work of Neupert's group on the biosynthesis and import 
of cytochrome c, evidence for the existence of mitochondrial import 
receptors has been obtained (Hennig & Neupert, 1983). These studies 
exploited the fact that large amounts of the precursor, apocytochrome c, 
can be prepared by chemical means by removing the covalently-bound 
haem group from cytochrome c. Several characteristics of the binding 
of precursors have emerged from these and similar studies;
i) Binding is rapid and reversible. The rate of binding 
is sufficient to account for the rate of transport into 
mitochondria
ii) Binding is specific for precursor molecules. Apocytochrome c 
is tightly-bound but can be released by addition of excess 
unlabelled apocytochrome c, whereas excess cytochrome c 
has no effect.
iii) Binding is specific for the outer membrane or for outer
membrane vesicles and depends on one or more polypeptides 
exposed on the cytoplasmic face of the outer membrane.
Treatment with trypsin (or proteinase K) reduces dramatic­
ally the ability of the particles to bind precursors or 
to import them. (Riezman et al., 1983; Zwizinski et al.,
1984).
iv) Binding is not energy-dependent'nor is it accompanied by proteolytic 
cleavage of the precursor. The precursor to Neurospora 
adenine nucleotide translocator binds to de-energised 
mitochondria and becomes internalised when the membrane 
potential is restored. As precursor does not dissociate 
from the mitochondrial surface before translocation, these 
results suggest also that transport occurs from those sites 
(Zwizinski et al., 1983).
v) Even when the criteria of saturability has not yet been 
met in all cases because of the technical problem of the 
small quantities of precursors that can be synthesised 
in vitro, there is evidence of a limited number of different 
and evnlutionarilyconserved recognition mechanisms.
Transfer in vitro of most proteins studied so far, does not 
exhibit species specificity, i.e. precursors to mitochondrial proteins 
from Neurospora can be transferred into yeast or rat liver mitochondria 
(Schleyer et al.. 1982). Also, precursor proteins from one type of 
cell, e.g. precursor to ornithine transcarbamylase, a urea cycle enzyme 
from rat liver, can be imported into mitochondria from rat kidney and 
heart, which do not contain this protein (Morita et al.. 1982; Cote & 
Boulet, 1985).
At present, the existence of at least 3 mitochondrial receptor 
systems mediating import is suspected on the basis of competition 
experiments: one for import into outer membrane (insensitive to prior
protease treatment) (passer & Schatz, 1983), the apocytochrome c receptor 
(Hennig et al., 1983) and a receptor for intermembrane space and matrix 
proteins (Riezman et al., 1983: Mori et al., 1985).
Evidence for the existence of receptor molecules is very strong. 
The next step must be the isolation of these proteins and detailed 
analysis of their properties and their role in import. Identification 
of receptor-like polypeptides could be achieved in the near future after 
solubilisation and separation of the outer membrane polypeptides which 
contain binding activity. Some progress in this direction has been 
already reported (Riezman et al., 1983; Schmidt & Neupert, 1984; Ono & 
Tuboi, 1985).
1.6.6 Translocation and processing of mitochondrial proteins
Once bound to a receptor site on the mitochondrial surface, 
precursor polypeptides must be transported into or across the mito­
chondrial membranes. This step i.e. translocation into one of the 
mitochondrial compartments, is presumably of considerable complexity.
It is not yet clear how many steps are involved, but it is 
obvious that different pathways exist. It has been repeatedly 
speculated that transport of proteins across the mitochondrial membranes 
takes place in sites where the two mitochondrial membranes come into 
close contact or may even be fused. These 'contact points' have been 
observed by electron microscopy of sectioned mitochondria. However, 
it is not known whether these structures are really related to protein 
transport. An understanding of the precise mechanism of transfer would 
require exact knowledge of the conformation of precursors and their 
changes during interaction with the membrane(s).
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a) Energy requirement for import
Posttranslational import of precursors across the inner mito­
chondrial membrane, unlike import into the outer membrane, is an energy- 
dependent process. Detailed studies have been made by using in vitro 
import systems, in which radiolabelled precursors are incubated with 
isolated mitochondria. After incubation, mitochondria are re-isolated 
from the suspension by centrifugation. Proper processing of the pre­
cursors is assayed by immunoprécipitation and SDS/polyacrylamide gel 
electrophoresis. To confirm that the imported polypeptidesare 
inside the mitochondria, their sensitivity to externally-added 
proteases is examined; internalised polypeptides should be inaccessible 
to the protease because of the physical barrier imposed by the mito­
chondrial membranes.
In elegant experiments, Schleyer et al. (1982) and Casser et al. 
(1982a) demonstrated that,whether supported by substrate respiration 
or ATP hydrolysis, the ability of mitochondria to import proteins 
correlated with experimental conditions where the electrochemical 
potential gradient would be expected to be high, regardless of the 
intramitochondrial ATP concentration. Thus, it appears that import of 
proteins to the mitochondrial matrix or inner membrane depends on an 
electrochemical potential across the inner membrane, contrary to early 
suggestions (Nelson & Schatz, 1979) that ATP was the direct energy source. 
However, it is not known which is the specific role of membrane potential 
in mitochondrial protein import. One possibility is that it provides 
energy for translocation.
It appears that the N-terminal regions of precursors so far 
investigated are predominantly basic in nature; therefore it is possible 
that transport is initiated by movement of a cluster of positively charged 
residues of a precursor polypeptide towards the more electronegative
mitochondrial matrix. Another possibility is that the electrochemical 
potential may induce interactions between the two membranes or favour a 
protein conformation which in turn would allow the polypeptide to cross 
the lipid bilayer, perhaps involving changes in membrane lipid confor­
mation (Schatz & Butow, 1983).
The insertion of mitochondrial proteins into the outer mito­
chondrial membrane seems to be independent of a membrane potential or 
ATP. These features are also shared by cytochrome c. However, unlike 
cytochrome c, the major outer membrane proteins such as ponndo not require 
covalent modification during its insertion in this membrane. (Suissa & 
Schatz, 1982; Freitag et al., 1982, Casser & Schatz, 1983; Pfaller 
et al., 1985).
b) Proteolytic processing of imported precursors
During or shortly after their translocation, many mitochondrial 
precursor proteins undergo some form of covalent modification. The 
most frequent modification is proteolysis. The occurrence of the 
processing protease in the mitochondrial matrix suggests that at least 
part of the precursor molecule must be transferred into the matrix before 
cleavage can take place. For those proteins of the matrix and inner 
membrane which are synthesised as larger precursors, cleavage occurs in 
one step and the resulting species are electrophoretically-indistinguish- 
able from the mature proteins.
The matrix protease has been purified from yeast (McAda & Douglas, 
1982; Bohni et al.. 1983) and detected in rat (Conboy et al.. 1982;
Miura et al., 1982) and Neurospora (Teintze et al., 1982). The yeast 
enzyme is insensitive to serine protease inhibitors, sulphydryl-modifying 
reagents or small peptide protease inhibitors. It is insensitive to 
chelating agents including EDTA, GTP and 1,10-phenanthroline. The 
enzyme exhibits little species specificity.
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Surprisingly, the transport of at least some proteins destined 
for the intermembrane space, which must only cross the outer membrane is 
rather complicated. These proteins are apparently processed by two 
successive proteolytic events, since an intermediate form between the 
original precursor and the mature form is transiently generated. Yeast 
and Neurospora cytochrome c^ (Casser et al.. 1982; Ohashi et al., 1982; 
Teintze et al..1982) and yeast cytochrome bg and cytochrome c peroxidase 
(Daum et al.. 1982b; Reid et al., 1982) have been clearly shown to be 
processed in this fashion. The first cleavage requires the matrix 
protease described above, yielding the intermediate forms, which are 
subsequently cleaved into their mature forms by a second protease which 
is located on the outer face of the inner membrane. A two-step 
processing pathway has been proposed for the rat liver ornithine trans­
carbamylase (Mori et al., 1980; Kolansky et al., 1982). However, the 
conversion of the intermediate form into the mature form has not yet 
been conclusively demonstrated (Morita et al., 1981).
A hypothetical mechanism for the transfer of precursors into 
mitochondria by the various discussed pathways is presented in Fig. 1.5.
1.6.7 Assembly of imported mitochondrial proteins
Once imported into mitochondria, usually after being proteo- 
lytically matured, polypeptides must assume their active conformation. 
Individual monomers must first reach their proper submitochondrial 
compartment, then some of them may bind to ligands such as haem 
groups or FAD to become active. Finally, some proteins require the 
formation ofbomo-ohgomers and/or association with other proteins to 
form hetero-oligomers with either products of the mitochondrial genome 
or with other imported polypeptides. This process is also expected 
to occur in a defined pathway. Assembly of various subunits of these 
complexes must also be a coordinated process since subunits are present
Fig, 1.5 Mechanisms involved in transfer of various precursors 
into mitochondria (Hypothetical sequence of events)
Step 1; Extramitochondrial precursors are recognised by specific
receptors (R) at the mitochondrial surface.
Steps 2 and 3: The outermembrane (OM) and the inner membrane (IM) of
the mitochondria come into contact at certain sites and form "fusion 
sites". The precursor-receptor complex reorients in this area, 
perhaps aided by an lypothetical "translocator" protein (T). Either 
the formation of these fusion sites or the reorientation of the complex 
in the fused areas (or both processes) depend on the electrochemical 
potential across the inner membrane.
Steps 4; A,B and C; Precursors are transiently or permanently inserted 
in the inner membrane, processed and allocated to their final destinations. 
A: the precursor is attacked by a protease contained in the matrix.
After removal of the presequences, the mature protein is discharged in 
the matrix.
B: the precursor is attacked by a protease in the matrix and relocated
into the intermembrane space, a step which may involve a second proteo­
lytic event (two-step processing pathway).
C: the proteolytically-processed precursor occupies its final destination
in the inner membrane.
Polypeptides destined forthe outer membrane and some destined for the 
inner membrane can be inserted without proteolytic processing (e.g. porin 
and the adenine nucleotide translocator) (hot shown).
Modified from Hennig & Neupert (1983).
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in stoicheometric amounts (Hennig & Neupert, 1983).
The techniques for detecting intermediate forms in the assembly 
of mitochondrial complexes have not yet been adequately developed due 
to the experimental difficulties of inhibiting assembly and distinguishing 
between assembled and non assembled polypeptides. In principle, it 
is possible to investigate this process by using yeast mutants in which 
synthesis of a specific subunit of a complex is deficient. It is also 
possible to isolate airains with mutations in components required 
for assembly.
The assembly of the H^-translocating ATPase complex offers one 
interesting model to study the biosynthetic interactions between enzymes 
encoded in the mitochondria and in the nucleus. Using cell-free import 
systems, Lewin & Norman (1983) have shown that at least 3 of the newly- 
imported subunits of this complex are assembled inside the mitochondria 
with sufficient affinity to co-immunoprecipitate.
Evidence chat polypeptides imported in vitro can be transported 
into their correct intramitochondrial locations and assembled into 
functionally-active units has been obtained (Casser et al.. 1982a;
Schleyer & Neupert, 1984). However, further experimentation is necessary 
to find a system capable of importing sufficient precursor to generate 
detectable enzyme activity.
1.6.8 The genetic approach
Many of the questions related to the structural features which 
allow precursor polypeptides to be recognised by mitochondria could be 
answered by a molecular analysis of these proteins. Such studies 
have been hindered by the low abundance of precursors. At the present, 
only the subunit of the yeast F^-ATPase has been purified in relatively 
large amounts (Ohta & Schatz, 1984) by growing rho mutants in the 
presence of CCCP (Reid & Schatz, 1982a).
Recently developed methods for isolating and manipulating 
nuclear genes encoding mitochondrial proteins have provided a new 
tool to elucidate the molecular features of the import process. The 
sequencesof about a dozen cloned genes have been determined. For 
those proteins synthesised as larger polypeptides, the amino acid 
sequenceofthe extra segment in the precursor (if the N-terminal sequence 
of the mature protein is known) can be obtained (Reid, 1985).
Analysis of the N-terminal sequences shoved no obvious homologies, but 
this is not surprising, considering that the N-terminal regions of 
different mitochondrial proteins vary in size, and the proteins 
so far investigated are transported into different submitochondrial 
compartments, so presumably have different addressing signals.
The N-terminal regions examined are predominantly basic. The 
signal sequencesfor secretory proteins are also basic and contain a 
stretch of uncharged amino acids which may form a transmembraneous 
segment during translocation. A similar feature has been found in 
the precursor to cytochrome c peroxidase, which is apparently imported 
in a two-step processing mechanism. The extra peptide of 68 amino 
acids includes a stretch of 23 uncharged amino acids in which 10 
consecutive alanine residues are found. This hydrophobic region is 
assumed to form an a -helix to span the bilayer of the inner membrane 
when the precursor is imported, acting as a stop-transfer signal 
(Blobel, 1980; Kaput et al., 1982). The hydrophobic segment is 
flanked by basic residues, perhaps to anchor the protein in the membrane. 
The basic nature of the extra sequences and the hydrophobic segments 
are not sufficient to explain either intracellular or intramitochondrial 
sorting. In addition, information in the precursors must specify cleavage 
site(s) for processing enzymes. One approach that has been followed to 
delineate the targettingregions in the precursor molecules,which are
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essential for processing or for correct localisation, has been the 
introduction of restricted deletions in different regions of the poly­
peptide chain and following the fate of the mutant protein (Hase et al,, 
1984; Mihara & Sato, 1985).
By combining deletions and gene fusion experiments, it has been 
shown that the sigial regions of mitochondrial proteins (ornithine trans- 
carbamylase, subunit IV. of cytochrome c oxidase) can direct enzymes 
of non mitochondrial origin such as dihydrofolate reductase into mito­
chondria. (Hurt et al., 1984; Horwich et al., 1985). Fusions have 
also been constructed between proteins of the secretory pathway and 
signal sequences for mitochondrial proteins. In most studies, the 
information contained in the amino terminal region can direct the 
hybrid (or chimeric) proteins into the mitochondrion(Hurt et al., 1985).
Studies on molecular cloning of mitochondrial proteins have 
been successful in yeast (S_. cerevisiae). This is due, among other 
reasons, to the possibility of transformation of these cells by plasmid 
vectors and the availability of genetically-well characterised strains. 
Mutants which have defective components in the mitochondrial import 
machinery; receptors, translocating components, proteases and other 
unknown molecules could be obtained. Yaffe and coworkers have character­
ised two of these mutants (Yaffe & Schatz, 1984a; Yaffe et al., 1985).
The import of proteins into chloroplasts shareSmany features 
with mitochondrial protein import (Chua & Schmidt, 1979); however, 
there must be clearly recognisable differences between the precursors 
destined for mitochondria and those for chloroplasts since the two 
import processes are able to coexist in the plant cell.
It is now thought that the selection of nuclear genes and their 
manipulation, in conjunction with well characterised and highly
efficient transcription-translation systems will make it feasible to 
reconstitute the import pathways in vitro. This will permit a more 
detailed analysis of the molecular events involved in the biogenesis 
of mitochondria.
Chapter 2; MATERIALS AND METHODS
2.1 MATERIALS
2.1.1 Chemicals
The following reagents were obtained from Sigma Chemical Co., 
Poole, Dorset, U.K. : substrates and coenzymes for enzymatic assays,
CoA esters, PMSF, TEMED, benzaraidine-HCl, Coomassie Brilliant Blue 
types R250 and G, 1,10-phenanthroline, N-ethylmaleimide, Mops, DNP 
leupeptin, digitonin, deoxycholic acid (sodium salt), Tween 20, EGTA, 
DTNB.
Leuco 2’,7' dichlorofluorescein diacetate was purchased from 
Eastman-Kodak Ltd., Lancs., U.K. Poly(ethylene glycol) 6000 was 
obtained from Serva, Heidelberg, W. Germany. lodogen"^ was from 
Pierce Labs, Rockford, Illinois, U.S.A. FCCP was a generous gift 
from Dr. P.G, Heytler, Du Pont De Nemours & Co., Delaware, U.S.A.
DMSO, DTT, PPO and sucrose were purchased from Koch-Light Laboratories, 
Colnbrook, Berks, U.K. Sodium salicylate was obtained from Aldrich 
Chemical Co., Ltd., Gillingham, U.K.
All other chemicals including reagents for polyacrylamide gel 
electrophoresis were AnalaR grade from BDH Chemicals Ltd., Poole, U.K.
2.1.2 Tissue culture materials
Eagle's medium (Glasgow modification), bovine kidney (NBL-1), 
pig kidney (PK-15) and Buffalo rat liver (BRL) cells lines were 
obtained from Flow Laboratories, Irvine, U.K.
Eagle's medium (minus L-methionine, minus L-glutamine), new 
born calf serum and foetal calf serum were purchased from GIBCO, 
Paisley, U.K.
Penicillin G and streptomycin sulphate were from Sigma Chemical 
Co., Poole, Dorset, U.K.
"Versene" solution (0.6 nM-EDTA, 0.17 M-NaCl, 10 mM-Na2HP0^,
2.4 D1M-KH2P04» 0.002% (w/v) phenol red, pH 7.8) and "Trypsin" solution 
(0.25% (w/v) trypsin,10 mM-NaCl, 1 mM-sodium citrate, 0.002% (w/v) 
phenol red, pH 7.8) were supplied as sterile solutions by the Tissue 
Culture Unit of our Department.
Disposable plasticware was obtained from Sterilin, Teddington,
U.K. Minus methionine medium was prepared by mixing 100 ml Eagle's 
medium (minus L-methionine, minus L-glutamine medium) with 10 ml of 
calf or foetal serum plus 5 ml of non-essential amino acids and 5 ml 
of 0.2 M-glutamine. Before use, this solution was diluted 19:1 with 
normal growth medium (low methionine medium).
2.1.3 Radiochemicals
N-ethyl[2,3-^^C] raaleimide (6 mCi/mmol), L-[^^S]methionine 
(1100-1600 Ci/mmol), [^^C]methylated protein mixture, Na^^^I (carrier 
free), [2-^^C]pyruvate (10.4 Ci/mmol) were obtained from Araersham 
International, Bucks, U.K.
N-[Et-2-%]Ethylmaleimide (50 Ci/mmol) dissolved in pentane and 
Protosol were purchased from New England Nuclear, Ltd., Southampton, U.K.
[Y-32pjATP (100-130 Ci/mmol) was either purchased from Amersham 
International or synthesised according to Maxam & Gilbert (1980) by 
Mr. D.Mease in our Department.
2.1.4 Enzymes and proteins
The following commercial protein preparations were obtained 
from Sigma Chemical Co. : citrate synthase, type II (porcine heart),
actin (rabbit muscle), cytochrome c, type III (horse heart), protein A 
(Staphylococcus aureus. Cowan I strain), hexokinase, fraction II (yeast), 
glucose 6-P dehydrogenase, type VIII (baker's yeast), fumarase (affinity 
purified from porcine heart), bovine serum albumin, immunoglobulin G,
horse-radish peroxidase, TPCK-treated trypsin, TLCK-treated 
a-chymotrypsin and elastase type II (porcine pancreas).
Lipoamide dehydrogenase (diaphorase) from pig heart was from 
Boehringer Corp., (London) Ltd., Sussex, U.K.
Staphylococcus aureus V8 protease was purchased from Miles 
Laboratories, Stoke Poges, Slough, U.K.
Marker proteins for M^ determinations were obtained from 
Bio-Rad Laboratories (low molecular weight kit), Watford, Herts, U.K.
Pyruvate dehydrogenase complex from Escherichia coli was a 
gift from Dr. John Coggins in our Department. Purified pyruvate 
dehydrogenase kinase (bovine kidney) was the generous gift of 
Dr. Lester Reed, University of Texas, Texas, U.S.A.
Subunits of the yeast pyruvate dehydrogenase complex were kindly 
provided by Dr. Hans Bisswanger, Universitat Tubingen, Physiologisch 
Chemisches Institut, W. Germany.
Purified branched-chain 2-oxo-acid dehydrogenase complex and 
antiserum to the E2 subunit of this complex were a gift from 
Mr. G. Clarkson; 2-oxoglutarate dehydrogenase complex and antiserum 
to pig heart fumarase were kindly provided by Miss A. Hunter and 
Mr. G. Gibb, respectively (Department of Biochemistry, University of 
Glasgow).
2.1.5 Chromatographic reagents
Sepharose CL-2B, CL-6B and 4B were the products of Pharmacia, 
London, U.K. Phosphocellulose was obtained from Whatman Biochemicals, 
Kent, U.K. CNBr-activated Sepharose 4B was obtained from Sigma Chemical 
Co., Poole, Dorset, U.K.
The TSK 3000 GSW column for high performance gel chromatography 
was obtained from Toya-Soda Corp., Japan.
2.1.6 Animals
New Zealand white rabbits (approx. 4-months old) and male rats 
(Albino Wistar strain) were obtained from the colony of the Departmental 
Animal House.
Ox hearts were obtained from Paisley Abattoir, Sandyford Rd., 
Paisley or from Glasgow Abattoir, Duke St., Glasgow. The hearts were 
chilled on ice and brought to the laboratory within 2 h of slaughter.
2.1.7 Miscellaneous
Nitrocellulose paper (0.45 ym pore size) was obtained from 
Schleicher and Schüll, Dassel, W. Germany.
Standardised Staphylococcus aureus cell suspension (Pansorbin) 
and Aquacide II (Mj. 500,000) were obtained from Calbiochem-Behring 
Corp., Bishops Stortford, Herts, U.K.
Nalgene filters (0.2 ^ m pore size) were purchased from Nalge 
Co., Rochester, N.Y. U.S.A.
Freund's adjuyants were obtained from Difco, West Molesey,
Sussex, U.K.
Normal rabbit serum was from the Scottish Antibody Production 
Unit (S.A.P.U) Lanarkshire, U.K.
"Lightning Plus" intensifying screens were purchased from Du 
Pont Cronex, Stirling, U.K.
2.2 METHODS
2.2.1 Measurement of protein concentration
The concentration of protein was routinely determined by the 
method of Lowry et al. (1951) as modified by Markwell et al. (1976).
The dye binding method of Bradford (1976), as modified by Spector (1978), 
was utilised when the samples contained reagents which interfered 
with the method of Lowry e.g. urea, 2-mercaptoethanol.
The method of Bradford is based in the quantitative binding of 
protein to Coomassie Brilliant Blue. The reagent was prepared as 
follows: 100 mg of Coomassie Brilliant Blue G 250 were dissolved in
50 ml of 95% (v/v) ethanol, then 100 ml of 85% (w/v) phosphoric acid 
were slowly added. The solution was diluted to a final volume of 
1 litre with glass distilled water and filtered through Whatman No.l 
filter paper. The reagent was stored at room temperature.
Aliquots of the protein solution,containing up to 40 ^g of 
protein in 100 )il, were mixed with 2.5 ml of the reagent and the 
absorbance was measured at 595 nm in a spectrophotometer using 
disposable plastic cuvettes.
Standard curves were constructed with each set of assays using 
bovine serum albumin as a standard. The concentration of the BSA 
solution was calculated using A^|q 6.6.
Protein was also determined by scanning the Coomassie Brilliant 
Blue-stained bands of proteins resolved.by SDS/polyacrylamide gel 
electrophoresis. Various amounts (1 to 10 jig) of BSA were 
electrophoresed in the same gel. The values of the integrated area 
under each peak (arbitrary units) were used to establish a standard 
curve.
2.2.2 Dialysis
Dialysis was carried out using Visking Tubing (Scientific 
Instrument Centre Pic., London, U.K.),which has been immersed in 
boiling 0.5-1% (w/v) EDTA for 15 min and washed thoroughly with 
distilled water to remove impurities.
2.2.3 Concentration of protein samples
Protein solutions were concentrated by freeze-drying or by 
treatment with poly(ethylene glycol) or Aquacide (trade name for 
carboxymethyl cellulose). For this procedure, samples were placed 
in small diameter dialysis bags prepared as described in section 2.2.2 
and layed on a flat surface. The bags were sprinkled with dry 
Aquacide or poly(ethylene glycol)to cover themcompletely and left at 
4°C until the sample had concentrated to the required volume.
Frequently, samples for SDS/polyacrylamide gel electrophoresis 
were previously concentrated by addition of 4-6 vol. acetone and 
stored at -20°C for several hours.
Alternatively, to remove salts or other reagents which interfered • 
with electrophoretic migration, samples were concentrated by adding 
enough 100% , (w/v) TCA to a final concentration of 10% and storage at 
40C for several hours. The pellets were washed with acetone to remove 
traces of TCA, air-dried and redissolved in an appropriate volume of 
Laemmli sample buffer.
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2.2.4 Determination of radioactivity 
1 I was counted in a LKB Wallac 1275 mini Gamma counter.
The isotopes were counted in a Beckman IS
6800 scintillation counter. Aqueous samples (200-500yUl) were mixed 
with 5 ml scintillation fluid containing 35% (v/v) Triton X-100 and 
5 g/1 PPO in toluene.
2.2.5 Measurement of the incorporation of radioactivity into proteins
a) Filter paper discs method
To estimate the incorporation of radioactivity into protein- 
aceous samples, aliquots (10-25yil) were spotted onto Whatman No.l 
filter paper discs (2.5 cm diara.) and dropped into ice-cold 10% (w/v) 
TCA (approx, 10 ml/disc). After 30 min at 4°C, the TCA solution was 
discarded. Filters were washed twice with a similar volume of 10%
(w/v) TCA and once with absolute ethanol. Each wash was carried out 
at 4®C with constant stirring for 30 min. Finally, the discs were 
air-dried for several hours or dried under an infra red lamp, 
transferred to scintillation vials and counted with 5 ml of 
scintillation fluid. Background radioactivity was estimated using 
blank discs that were mixed with the sample discs during the first wash.
b) Determination of radioactivity incorporated into gel slices 
Samples of radioactive proteins were separated by SDS/poly­
acrylamide gel electrophoresis. The gels were stained with Coomassie
Blue (section 2.2.6 d). After destaining, the gel was
dried under vacuum on Whatman No. 3 MM filter paper and the protein 
bands of interest were cut with scissors. The slices were dropped 
into glass scintillation vials and reswollen in 0.5 ml of water.
After 10 rain, the pieces of filter paper were removed as well as the 
remaining liquid and the slices were incubated overnight at 37°C 
with 1 ml of 90% (v/v) Protosol in capped scintillation vials.
The samples were then used for radioactivity measurement after adding 
9 ml of scintillation fluid.
Pieces of gel of similar dimensions were cut from blank tracks 
and used to estimate background radioactivity.
2.2.6 Electrophoretic separation of proteins in SDS/polyacrylamide gels
a) Preparation of samples for electrophoresis
Protein solutions for analysis by SDS/polyacrylamide gel electro­
phoresis were mixed 1:1 (v/v) with Laemmli sample buffer and boiled for 
3-5 min before electrophoresis.
Laemmli sample buffer contained 62.5 mM-Tris/HCl buffer, pH 6.8, 
2% (w/v) SDS, 10% (w/v) sucrose or glycerol (v/v) and Pyronin Y as 
tracking dye. The solution was kept at room temperature. Before 
use, 2-mercaptoethanol or DTT were added to a final concentration of 
5% (v/v) or 10 mM, respectively.
b) Analytical SDS/polyacrylamide gel electrophoresis
For analytical purposes, electrophoresis of proteins in poly­
acrylamide gels was carried out in the discontinuous Tris-glycine- 
buffered system of Laemmli (1970).
Gels were cast using our own equipment in slabs of 19 cm x 9.5 
cm X  1.5 mm. Separating gels were polymerized from solutions that 
contained 0.375 M-Tris/HCl buffer pH 8.8, 0.1% (w/v) SDS, 0.03% (v/v) 
TEMED, 0.075% (w/v) ammonium persulphate and acrylamide to 10% (w/v).
The ratio of acrylamide to NN' methylene(bis)acrylamide was 30:0.8.
The stacking gel solution contained 0.12 M-Tris/HCl buffer, pH 6.8,
0.1% (w/v) SDS, 0.03% (v/v) TEMED, 0.2% (w/v) ammonium persulphate,
5% (w/v) acrylamide and 0.133% (w/v) NN' methylene(bis)acrylamide.
On occasions, 10% (w/v) polyacrylamide gel rods (12 cm x 0.5 cm) 
were polymerised in siliconised tubes using the Laemmli system or the 
phosphate-buffered system as described by Weber & Osborn (1969).
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The electrophoresis buffer contained 0.024 M-Tris, 0.192 M- 
glycine, 0.1% (w/v) SDS (Laemmli system) or 0.05 M-sodium phosphate 
buffer, pH 7.0, 0.1% (w/v) SDS (phosphate-buffered system).
Electrophoresis was performed at constant current at 40-60 
raA/slab gel and 6-8 mA/rod gel.
c) Preparative SDS/polyacrylamide eel electrophoresis 
Preparative gels were polymerised as a large scale version of
the analytical procedure described above by increasing the gel thickness 
to 3 mm. This permitted application of up to 3 mg protein, while 
maintaining most of the high resolution power obtained with the 
analytical system.
d) Staining and scanning of gels
Protein bands were visualised by immersing the gels in a 
solution containing 0.04% (w/v) Coomassie Brilliant Blue R in 25%
(v/v) isopropanol, 10% (v/v) acetic acid for 8-12 h, and destaining 
in 10% (v/v) acetic acid.
Slab gels were scanned with a LKB 2202 Ultroscan Laser 
Densitometer (LKB, Uppsala, Sweden). Rod gels were subjected to 
densitometric analysis at 595 nm in a Gilford 2410-S spectrophotometer 
with a scanning attachment.
e) Fluorography
Gels to be fluorographed were preyiously stained or directly 
fixed overnight by immersing in 25% (v/v) isopropanol, 10% (v/v) 
acetic acid.
Fluorography was performed according to the procedure described 
by Bonner & Laskey (1974) with DMSO-PPO or by following the method 
described by Chamberlain (1979) employing sodium salicylate as fluor.
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Slab gels were dried under vacuum and subjected to fluorography 
with Kodak X-Omat S or XAR-5 film at -80°C for a suitable length of 
time.
f) Autoradiography
Gels were stained or fixed as described above. Before drying, 
gels were soaked for 30 min in a solution containing 20% (v/v) methanol, 
10% (v/v) acetic acid and 0.5% (v/v) glycerol to reduce the risk of 
cracking during drying.
g) Determination of Mr- by SDS/polyacrylamide gel electrophoresis
Mj. of the polypeptides resolved by SDS/polyacrylamide gel
electrophoresis was determined by calibrating 10% (w/v) slab gels with 
a set of standard proteins. They included: phosphorylase b (Mj.
92,000); BSA (Mj. 68,000); ovalbumin (Mj. 63,000); carbonic anhydrase 
(Mj. 31,000); soybean trypsin inhibitor (M^ 20,100) and lysozyme 
(Mj. 14,000).
Relative mobility (m) was calculated as the ratio:
A plot of m against log (Mj.) of the standards yielded a 
curved line that was used for calibration. Standards and PDC samples 
were run on the same gels.
2.2.7 Isolation of mitochondria and submitochondrial fractions
a) Isolation of rat liver mitochondria
Rat liver mitochondria were prepared by differential centri­
fugation as described by Chance & Hagihara (1963).
Isolation medium;
0.225 M-mannitol, 0,075 M-sucrose, 500yd^-EGTA, 2 mM-Mops.
The solution was adjusted to pH 7.2 with NaOH and stirred until the 
EGTA was completely dissolved; then the pH was finally adjusted to 7.4.
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Rats were starved overnight and killed by cervical dislocation.
The livers were removed, blotted, chopped to small pieces with scissors 
and transferred into ice-cold isolation medium.
Livers from 6 rats were homogenised in approx, 30 ml isolation 
medium per liver with a tight-fitting Potter-Elvehjgnhomogenizer 
(0.004-0,006 in clearance, shaft rotation approx. 1000 rev/min).
Between 6 and 10 passes were required for maximal cell disruption.
After sedimentation of the nuclear fraction at 800 g for 7 min in a 
MSE-21 8x50 ml angle rotor at 4°C, mitochondria were sedimented from 
the supernatant fluid by centrifugation at 6500 g for 15 min. Pellets 
were washed by manual resuspension in the same buffer and centrifugation 
at 6500 g for 15 min. To remove residual contamination from nuclei, 
red blood cells and unbroken cells, mitochondrial pellets were resuspen­
ded in one-half the initial volume of isolation medium and centrifuged 
at 800 g for 7 min. The pellets were discarded and the supernatant 
fractions were carefully combined and centrifuged at 6500 g for 15 min. 
The final pellets contained mitochondria which were kept frozen at -20°C 
until required.
For most purposes, the mitochondrial preparation described above 
was found to be satisfactory. On occasions, however, as for the 
preparation of sub-mitochondrial fractions, it was convenient to further 
purify the organelles. This was accomplished after a sucrose-density 
gradient centrifugation as described by D' Souza & Lindsay (1981).
The purified mitochondria were found in the interface between the 45% 
(w/w) and the 39% (w/w) sucrose solutions (density 1.19 g/ml). Approx. 
60% of the protein of the crude mitochondrial preparation was recovered 
in this band. The purified mitochondria were pelleted by centrifugation 
at 6500 g for 15 min after diluting by slow addition of 3 vol. isolation 
medium.
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Mitochondria were washed once with 20 mM-Mops buffer, pH 7.2,
0.12 M-KCl, in order to remove any proteins which were adventitiously 
bound to the outer membrane.
b) Preparation of submitochondrial fractions from rat liver 
Highly-purified mitochondria were subfractionated by a
modification of the procedure described by Sottocasa et al. (1967).
Separation was achieved by osmotically swelling the mitochondria ^  
followed by shrinking the inner membrane compartment,which led to 
partial release of the outer membrane.
Fractions were collected with the aid of a shortened Pasteur 
pipette. The "outer membrane" and "heavy" fractions,collected from 
the gradients,contained a mixed population of vesicles derived from 
the outer and inner mitochondrial membranes? hence these fractions 
were pooled in a mixed membrane fraction (M).
Membrane fractions were washed in 10 ml of 20 mM-Mops, 0.12M- 
KCl, adjusted to pH 7.2 with NaOH, by manual homogenisation followed 
by centrifugation at 105,000 g for 1 h to remove soluble proteins.
The soluble fraction was centrifuged twice at 105,000 g for 1 h to 
remove any particulate material.
Activities of the enzymes used as markers for the submitochon- 
drial compartments (monoamine oxidase, adenylate kinase, fumarase 
and cytochrome c oxidase) were determined in the freshly-prepared 
fractions. The remaining material was stored at -20°C until required.
c) Preparation of ox heart mitochondria and submitochondrial 
fractions
Ox heart mitochondria were isolated as described by Smith (1967). 
Approx. 1.5-1.8 g of mitochondrial protein were obtained from 300 g 
tissue. Mitochondrial pellets were stored at -80°C until use.
Under these conditions PDC activity was stable for less than one month.
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The fractions of ox heart mitochondria utilised in this study were 
prepared by Miss A, Phelps in our laboratory.
For the fractionation of mitochondria, samples containing 
approx. 200 mg protein were manually resuspended in 5 ml of 20 mM- 
potassium phosphate buffer, pH 7.5, 0.1 mM-EDTA and subjected to sonic 
oscillation at 4°C for three 20 s intervals using the maximum setting 
ofai MSE sonicator. Sonicated mitochondria were diluted to 10 ml 
with the same buffer before centrifugation at 105,000 g for 1 h in a 
Beckman Ti 50 rotor. The clear supernatant or 'soluble' fraction 
contained most of the mitochondrial matrix and intermembrane space 
proteins. The dark-brown pellets consisted principally of sub- 
mitochondrial particles (Lee, 1979). The membraneous fraction was 
washed twice by manual homogenisation in 5 ml of 20 mM-potassium 
phosphate buffer, pH 6.5, 0.05 M-NaCI, followed by centrifugation 
at 30,000 g for 30 min at 4°C. The procedure was repeated once more.
Both soluble and washing fractions were concentrated by 
osmotic treatment with Aquacide,as described in section 2.2.3^ 
prior to dialysis against 2x500 ml vol. 20 mM-Tris/HCl buffer, pH 7.4, 
0.01% (w/v) NaNg at 40C.
d) Preparation of cell extracts and subcellular fractions from
cultured mammalian cells
Cell extracts for immunoblotting analysis were prepared under 
conditions which minimised proteolysis. Cells were grown in large 
roller bottles (burlers) until they reached confluence. Monolayers 
were washed twice with ice-cold phosphate-buffered saline (20 mM- 
sodium phosphate buffer, pH 7.4, 0.15 M-NaCI). Cells were harvested 
in a small volume of the same buffer by scraping with a rubber policeman. 
Portions of the suspension were immediately dissociated by boiling in 
Laemmli sample buffer for 5 min. Any insoluble material was removed
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by centrifugation. The remaining extract was fractionated by the 
method described by Attardi & Ching (1979) to obtain nuclear and 
mitochondrial fractions.
To obtain particulate and cytosolic fractions, cells were 
fractionated by the method of Zuurendonk & Tager (1976) as modified 
by Mori et al. (1981a). Aliquots (1 ml) of the cell suspensions 
(5x10^ cells) were mixed at 0°C with an isomotic digitonin solution 
at final concentrations of 0.25 to 5 mg/ml. After standing at 0°C 
for 2 min, the samples were centrifuged for 1 min at 16,000 g in an 
MSE Micro-Centaur centrifuge. The supernatant (cytosolic) fractions 
were assayed for citrate synthase and fumarase, sections. 2.2.8 d and
2.2.8 f, respectively, to establish the degree of mitochondrial 
disruption. Samples were then kept frozen at -20*C until required.
2.2.8 Enzymatic assays
a) 2-oxo-acid dehydrogenase complexes
The overall activity of pyruvate dehydrogenase complex 
(EC 1.2.6.1, EC 2.3.1.12 and EC 1.8.1.6.) was determined by measuring 
NADH formation at 360 nm at 25*C with a recording spectrophotometer 
according to Brown & Perham (1976). Assays were carried out in a 
final volume of 1 ml in 50 mM-potassium phosphate buffer, pH 8.0 
containing 2 mM-TPP, 1 mM-MgCl2» 2.5 mM-NAD+, 0.13 mM-CoA, 2.6 mM 
cysteine-Hd and 2 mM-sodium pyruvate. The activity of 2-oxo-glutarate 
dehydrogenase complex (EC 1.2.6.2, EC 2.3.1.6 and EC 1.8.1.6) was 
measured in a similar reaction mixture containing 2 mM-sodium oxo- 
glutarate instead of pyruvate.
A unit of activity (Kat) was defined as that amount of enzyme 
which produced 1 mol of NADH/sat 25*C under the conditions of assay.
68
b) Pyruvate dehydrogenase kinase» (EC 2.7.1.99) was assayed as
described by Hucho et al. (1972) by measuring the rate of inactivation 
of the complex in the presence of 0.2 mM-ATP at 30°C or by estimation 
of the rate of incorporation of ^^P-labelled phosphoryl groups from
[Y -^^P]ATP into PDC according to Stepp et al. (1983). Incubation 
mixtures contained 20 mM-potassium phosphate buffer, pH 7.5, 1 n^-MgCl^, 
0,1 mM-EDTA, 2 mM-DTT and 20-50 yjg of PDC in 200 yul of assay mix.
After equilibration at 30°C for 1 min, the reaction was initiated 
by addition of 0.02 ml of 2.5 mM [ Y-^^P]ATP (approx. 13,000 d.p.m./ 
nmol). At the indicated times, aliquots (20 yul) were applied to 
filter paper discs. The discs were immediately dropped into 10% (w/v) 
TCA, washed, dried and utilised for radioactivity counting as described 
in section 2.2.5.a.
c) Pyruvate dehydrogenase phosphate phosphatase (EC 3.1.3.43) was 
assayed by the procedure of Hucho et al. (1972).
32p-labelled PDC was used as a substrate. The phosphorylated 
enzyme was prepared by incubation of PDC (1 mg) at 30°C in the 
presence of [ y -^^P]ATP (0.2 mM; 110,000 d.p.m./nmol) as described 
above. After 30 min, aliquots (10yil) were withdrawn to 
estimate protein-bound radioactivity. The remaining sample was 
diluted with 10 ml of 20 mM-potassium phosphate buffer, pH 7.0 
containing 0.1 mM-DTT, 0.01% (w/v)NaN3 and concentrated by 
centrifugation at 144,000 g for 2 h in a Beckman Ti 50 rotor. The 
pellet was dissolved in 500 yil of 20 mM-Tris/HCl buffer, pH 7.5,
10 mM-MgCl2i 0.5 mM-CaCl2, and used for determination of phosphatase 
activity as described in the legend to Fig. 3.5.
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d.) Citrate synthase. Citrate-oxalacetate-lyase (EC 4.1.3.7.) 
activity was measured as described by Srere (1969) by following the 
deacetylation of AcSCoA at 412 nm. The production of CoA was 
detected by the formation of a mercaptide with DTNB (Ellman's 
reagent)vhxch exhibits strong absorbance at 412 nm (e 
The assay mix contained,in a final volume of 1 ml, 200yil, 0.5 M-Tris/
HCl buffer pH 8,0, 200yil, 0,5 mM-DTNB (prepared fresh), 100yul of 
3 mM-AcSCoA, and variable amounts of enzyme and water to 0.9 ml.
The absorption was followed for 1-2 min to measure any endogenous 
levels of thiol or deacylase activity before initiating the reaction 
by the addition of 100yil of 5 mM-oxalacetate (prepared fresh and 
neutralized with diluted KOH).
Enzyme units were expressed as the amount of enzyme that 
produced 1 yimol of CoA/min at 25°C.
e) Monoamine oxidase (Monoamine: oxygen oxidoreductase,
deaminating; EC 1.4.3.4.) activity was measured as described by 
Kochli & Wartburg (1978) by following the oxidation of leuco 2'7’ 
dichlorofluorescein to 2'7' dichlorofluorescein at 502 nm coupled 
to the monoamine oxidase-dependent production of H2O2 in the presence 
of benzamidine. Each cuvette contained in a final volume of 3 ml;
600yil of 0.25 mM-leuco 2’7' dichlorofluorescein diacetate (freshly 
prepared in 10 mM-NaOH), 1.8 ml of horse-radish peroxidase, prepared 
by dissolving 0.83 mg in 10 ml of 0.1 M-sodium phosphate buffer, pH 7.15 
and variable amounts of enzyme and water to a final volume of 2.95 ml.
The absorbance at 502 nm was monitored for 2-3 min until a base line 
was obtained. Reactions were started by the addition of 50yil of 
0.1 M-benzamidine. One unit was defined as the amount of enzyme that 
produced 1 yimol of 2'7' dichlorofluorescein/min at 25°C using *^ 502 ^2,000.
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Crude extracts can lead to slow oxidation of the reagent in the absence 
of amines. Reaction rates were corrected with these blanks.
f) Fumarase. (EC 4.2.1.4.) activity was measured spectrophoto- 
metrically by recording the increase in absorbance at 240 nm following 
the formation of fumarate from malate as described by Hill & Bradshaw 
(1969). Each cuvette contained in a final volume of 1 ml, 0.97 ml of 
ai L-ma]ate solution prepared by dissolving 336 mg L-malic acid in
50 ml 0.1 M-potassium phosphate. The solution was adjusted to pH 7.6 
with 2 M-NaOH. Reactions were initiated by the addition of the enzyme 
solution (0.01-03 ml).
Enzyme units were expressed as the amount of enzyme which 
produced 1 yimol fumarate/min at 25°C ( ^ 240 2,440).
g) Adenylate kinase. (ATP:AMP phosphotransferase; EC 2.7.4.11) 
activity was determined spectrophotometrically by monitoring the 
reduction of NAD"^  at 340 nm in a reaction mixture of 1 ml containing 
50 mM-Tris/HCl buffer, pH 7.5, 5 mM-ADP, 10 mM-glucose, 10 units of 
hexokinase, 10 units of glucose 6-P dehydrogenase, 5 mM-MgSO^ and 
0.2 mM-NADP'*’ at 25°C. (Sottocasa et al., 1967).
Units of enzyme activity were expressed as the amount of enzyme 
which produced 1 yimol of NADPH/min at 25°C(e 340 6,220).
h) Cytochrome c oxidase. (EC 1.9.3.1) activity was monitored 
by following the decrease in absorbance of cytochrome ( a band) at 
550 nm coupled to the oxidation of cytochrome c as described by 
Cooperstein & Lazarow (1951). Each cuvette contained in a final 
volume of 3 ml; 2.98 ml of reduced cytochrome c solution prepared by 
dissolving 1 mg of cytochrome c in 30 ml of 30 mM-sodium phosphate 
buffer, pH 7.4 and adding 100yul of 1.2 M-sodium dithionite.
71
The solution was shaken vigorously for 2 min to remove excess 
dithionite before starting the reaction by the addition of the 
enzyme solution.
Enzyme units were expressed as the amount of enzyme that 
oxidised 1 yimol of cytochrome c/min at 25°C. ( 6550 28,500).
2.2.9 Purification of pyruvate dehydrogenase complex from ox heart
Pyruvate dehydrogenase complex was purified from ox heart 
basically as described by Stanley & Perham (1980) with the modifications 
stated below.
All operations were carried outat 4°C, starting with 250 or 
500 g of fresh ox heart. The tissue cubes were blended and extracted 
twice in a 50 mM-Mops buffer containing 2.7 mM-EDTA, 3% (v/v) Triton 
X-100 and 0.1 mM-DTT, adjusted to pH 7.0 with NaOH. The residual 
material was discarded. The pooled extracts contained assayable 
amounts of 2-oxoglutarate dehydrogenase activity. However, the 
presence of lactate dehydrogenase interfered with the estimation of 
the pyruvate dehydrogenase complex activity at the early stages of 
purification.
The complexes were precipitated by the addition of 0.12 vol. 
of à 35% (w/v) poly(ethylene glycol) solution at pH 6.45. Pellets 
were resuspended in Mops buffer supplemented with 1% (v/v) Triton X-100, 
2.7 mM-EDTA, 0.1 mM-DTT, 1.5yuM-leupeptin and 0.5% (v/v) rat serum^ 
adjusted to pH 6.8 with NaOH,by homogenisation with a loose-fitting 
glass-teflon homogenizer, followed by sonication three times for 30 s 
each with a Dawes Sonicator (3A, setting 6). This extract was adjusted 
to 13 mM-MgCl2 and 50 mM-sodium phosphate before the addition of 
poly(ethylene glycol) for the second precipitation. The activation 
step at 30°C outlined in the original procedure was omitted.
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The 2-oxo-acid dehydrogenase complexes were separated by 
differential precipitation with poly(ethylene glycol). Usually 
0.04-0.06 vol. 35% (w/v) poly(ethylene glycol) was required to 
precipitate 90% of the 2-oxoglutarate dehydrogenase activity.
The resultant fraction contained approx. 90-95% of the PDC activity.
This complex was concentrated by centrifugation for 2 h at 176,000 g
in a Beckman Ti 60 rotor or by addition of 0.15 vol. of 35% (w/v)
poly(ethylene glycol) followed by centrifugation at 30,000 g for 10 min.
Pellets containing the 2-oxoglutarate dehydrogenase and 
pyruvate dehydrogenase activities were dissolved and purified 
separately by gel filtration chromatography on a Sepharose CL-2B 
column (106 cm x 3.5 cm) at 4°C. The Sepharose CL-2B column was 
equilibrated and developed with 50 mM-sodium phosphate buffer, pH 7.0 
containing 1% (v/v) Triton X-lOO, 2.7 mM-EDTA at a flow rate of 24 ml/h. 
Fractions of 12 ml were collected and assayed for pyruvate dehydrogenase 
and 2-oxoglutarate dehydrogenase activities. Fractions were pooled 
in 4-5 portions which were concentrated by centrifugation at 176,000 g
in a Beckman Ti 60 rotor for 2.5 h at 4°C.
The yellow pellets were resuspended by standing overnight in a 
small volume of 50 mM-Mops buffer containing 2.7 mM-EDTA, 1% (v/v)
Triton X-100, 0.01% (w/v)NaN^, 0.15yuM-leupeptin adjusted to pH 6.8 
with NaOH. Solubilization was completed by manual homogenisation in 
the same buffer before storing the enzyme at 4-6 mg/ml at 4°C.
2.2.10 Resolutinn of the ox heart pyruvate dehydrogenase complex
a) Dissociation of the complex and resolution by eel filtration 
chromatography
Pyruvate dehydrogenase complex (25-50 mg) was dissociated under 
conditions of high salt and high pH, essentially as described by 
Linn et al. (1972). Before dissociation, the complex was concentrated
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by centrifugation in a Beckman Ti 50 rotor for 2.5 h at 144,000 g. 
Pellets were resuspended in a small volume of 50 mM-sodium phosphate 
buffer, pH 7.5 containing 1 mM-DTT, 0.1 mM-EDTA. To this solution, 
sufficient 1 M-DTT, solid NaCl and 1 M-glycine buffer adjusted to 
pH 9.0 with NaOH were added to make the final concentration 1 M-NaCl,
10 mM-DTT and 0.1 M-glycine. The final pH was 9.0 and the protein 
concentration about 15 mg/ml.
The sample was allowed to stand for 30 min at room temperature
before applying to a Sepharose CL-6B (or 4B) column (80 cm x 1.5 cm).
This column was equilibrated and developed in 0.1 M-glycine buffer
containing 1 M-NaCI, 2 mM-DTT, 1 mM-MgCl^, 0.01 mM-EDTA, adjusted
to pH 9.0 with NaOH. The flow rate was 8 ml/h. Fractions of 2 ml
were collected and the A___ was measured. Protein was determined in
zoU
the peak fractions by the method of Bradford (1976) as described in 
section 2.2.1.
Analysis of the polypeptide composition of the fractions was 
performed by SDS/polyacrylamide gel electrophoresis on 10% (w/v) slab 
gels. Samples containing approx. 15yig protein were precipitated in 
10% (w/v) TCA before electrophoresis as described in section 2.2.3.
PDC was also dissociated in 0.25M-MgCl2 described by Kresze &
Steher (1979). Samples were concentrated and redissolved as outlined 
above. Solid MgCl^ was added to a final concentration of 0.25 M and 
the sample was dialysed overnight against 250 ml of 0.1 M-Tris/HCl 
buffer, pH 7.0, 0.25 M-MgCl^.
To facilitate dissociation of the complex, the dialysed solution 
was frozen at -80°C for 16 h and thawed once; then it was left to stand
at room temperature for 30 min before chromatography.
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b) High performance gel filtration chromatography
PDC was dissociated with 0.25 M-MgCl2 as described above.
Aliquots of the solution containing the dissociated complex (1 mg) 
were injected onto a TSK 3000 GSW column (600 mm x 7.5 mm). Chromato­
graphy was perforned at room temperature using a Gilson Model 303 high 
performance gel chromatography system. The flow rate was 0.5 ral/min 
and fractions of 0.5 ml were collected. A215 was monitored continuously 
with a Microm M3000 u.v. detector.
The polypeptide composition of the fractions was analysed by 
SDS/polyacrylamide gel electrophoresis. Protein was precipitated by 
addition of 2 ml of acetone and stored at -20*C for 16 h. Pellets 
were redissolved by boiling in 25yil of Laemmli sample buffer before 
electrophoresis.
c) Fractionation of the dihydrolipoyl acetyltransferase-component
X-kinase subcomplex
Peaks I and II, obtained after resolution of the PDC by gel 
filtration chromatography (see Fig. 3.6), were further resolved in 
order to isolate the individual constituents of the complex.
Peak I (called hereafter subcomplex I) contained the E2 subunit 
transacetylase component), which forms the core of the complex and 
component X. Variable amounts of El and E3 remained associated with 
the core. PDC kinase can be purified from this fraction (Linn et al., 
1972) after treatment with p-hydroxymercuriphenyl sulphonic acid.
Further dissociation of subcomplex I was attempted by following 
the procedure of Linn et al. (1972) as modified by Stepp et al. (1983)
Pooled fractions from this subcomplex were concentrated by 
treatment with Aquacide (section 2.2.3) to 5 mg protein/ml and dialysed 
for 24 h against 2x500 ml volume of 0.1 M-glycine containing 1 M-NaCI,
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1 mM-MgCl2, 2 mM-DTT, 0.01 mM-EDTA, adjusted to pH 9.0 with NaOH, 
Attempts to concentrate the samples by freeze-drying resulted in 
aggregation of the protein.
The dialysed solution was treated for 16 h at 0°C with 
p-hydroxymercuriphenyl sulphonic acid. This treatment caused 
reductive aggregation of the core, which was recovered after 
centrifugation at 150,000 g in a Beckman SW 60 rotor (acetyltransferase 
fraction). The transparent pellet was redissolved in a small volume 
of 50 mM-potassium phosphate buffer, pH 7.5 containing 30 mM-DTT,
0.1 mM-MgCl2 0.01 mM-EDTA and was stored at -20°C. The supernatant 
fluid was clarified twice by similar centrifugation steps to remove 
traces of the acetyltransferase. Finally, it was concentrated by 
treatment with Aquacide, dialysed overnight against 50 mM-potassium 
phosphate buffer, pH 7.5 containing 2 mM-DTT, 0.1 mM-MgCl2» 0.01 mM-EDTA 
and stored at -20°C (kinase fraction),
d) Ammonium sulphate fractionation of Peak II
The second peak,emerging from the gel filtration chromatography 
columns of the dissociated complex,was subfractionated as follows: 
pyruvate dehydrogenase component (El) was separated from the lipoamide 
dehydrogenase component (E3) by selective precipitation with ammonium 
sulphate as described by Linn et al. (1972). The El component was 
precipitated after the addition of solid ammonium sulphate to 30% (w/v) 
saturation at 0°C. The pellet was recovered by centrifugation at 
8,000 g for 30 min. The supernatant fluid contained most of the 
E3 component.
Purified El was redissolved in a small volume of 50 mM-potassium 
phosphate buffer, pH 7.5 containing 1 mM-DTT, 0.1 mM-MgCl2, 0.01 mM- 
EDTA before dialysis against 2x500 ml vol. of the same buffer.
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Refractionation by ammonium sulphate precipitation was often found 
to be necessary to remove contaminating lipoamide dehydrogenase.
e) Separation of o and 6 chains of pyruvate dehydrogenase (El)
El a and El B subunits were separated as described by
Barrera et al. (1972). Approx. 5 mg protein were dissociated by 
dialysis at room temperature for 2 h against 200 ml 20 mM-imidazole 
containing 8 M-urea, 50 mM-2-mercaptoethanol, adjusted to pH 6.0 with 
HCl.
Phosphocellulose chromatography was carried out in a (10 cm x 
0.9 cm) column equilibrated in the same buffer. After application 
of the sample, the column was washed with 10 ml buffer before the 
bound protein was eluted by increasing the concentration of LiCl in 
a stepwise manner up to 1 M.
Purified a and 6 subunits were subjected to SDS/polyacryl­
amide gel electrophoresis after measuring the protein concentration 
(Bradford, 1976). Fractions were dialysed against 50 mM-potassium 
phosphate buffer, pH 7.5 containing 0.1% (w/v) SDS and concentrated 
by treatment with Aquacide before storing at -20°C.
f) Elution of PDC subunits from polyacrylamide gels
Purified subunits of PDC were recovered from SDS/polyacrylamide 
gels basically as described by Tolan et al. (1980) with some modifications.
PDC (3 mg protein) was electrophoresed in 10% (w/v).preparative 
polyacrylamide gels (see section 2.2.6 c). Gels were stained for 
4 h and destained with several changes of 10% (v/v) acetic acid, 20%
(v/v) methanol. Stained protein bands were cut out of the gel and 
rinsed with distilled water for about 30 rain. After extruding gel 
strips through the barrels of 2-ml disposable syringes to fragment the 
gels ,pieces were transferred into glass scintillation vials and dried 
in a vacuum dessicator over NaOH pellets to remove the acid from
the destaining solution and to facilitate extraction. Dried gel 
pieces were swollen in a minimal volume (2-3 ml) of 50 mM-triethano- 
1amine, 1% (w/v) SDS, 1 mM-DTT,adjusted to pH 8.0 with HCl (extraction 
buffer). The suspensions were heated for 5 rain at 65-70°C and the 
gel slurry extracted by continuous stirring at room temperature for 
16-20 h. Fragments of gel were removed by centrifugation at 1,000 g 
for 5 min to yield a clear blue-coloured extract. The gel slurry was 
extracted once more in a similar manner before pooling the extracts 
and concentrating them by freeze-drying.
Samples were redissolved in a very small volume of water and 
clarified by a brief centrifugation as before to remove any residual 
fragments of gel. Proteins were precipitated by addition of A vol. 
of acetone and stored at -20°C, a procedure which also partially 
removed the dye. Pellets were redissolved by boiling in a small 
volume of 1% (w/v) SDS and stored at -20^C until required.
It was convenient to repeat the acetone precipitation step 
when large white precipitates of SDS were obtained after the first 
acetone precipitation.
The presence of SDS interfered with the estimation of proteins 
by the method of Bradford (1976), while traces of the dye interfered 
with the method of Lowry et al. (1951). The concentration of proteins 
was determined by quantitative scanning of Coomassie Blue stained bands 
of protein after resolution on polyacrylamide gels by comparison with 
BSA used as a standard (see Methods section 2.2.1).
As a convenient precaution against proteases,extraction buffer 
was either prepared fresh each time or kept frozen at -20°C. Before 
use, the solution was filtered through Nalgene filters.
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2.2.11 Tissue culture methods
a) Growth conditions
All cell lines were maintained routinely as monolayers in glass 
or plastic Roux flasks. Eagle's medium (Glasgow modification) was 
used in all cultures. Penicillin (1000 U/ml), streptomycin (lOOyig/ml) 
and non-essential amino acids were included in the standard media.
Buffalo rat liver cells (ERL) were maintained in the standard 
medium supplemented with 10% (v/v) calf serum. Bovine kidney 
(NBL-1) and pig kidney (PK-15) cells were cultured in the same medium 
supplemented withlO% or 5% (v/v) foetal calf serum, respectively.
b) Cell harvesting and counting
Cells were harvested in log phase and detached from their 
substrate by washing the monolayers with a solution of EDTA ("Versene" 
solution) followed by incubation for 5-10 min with a "Trypsin" solution 
(see section 2.12). Tryptic activity was inhibited by addition of 
25 ml growth medium and cells were resuspended thoroughly by pipetting 
several times. The concentration of cells was determined by light 
microscopy using a haemocytometer.
Cells were subcultured by transferring one-fifth of this 
suspension into another Roux flask and adding approx. 50 ml of growth 
medium.
c) Incorporation of [^^S1 methionine into cultured cells 
Cells were harvested from log phase cultures and resuspended
in medium at a concentration of 2-4 x 10^ cells/ml. Portions 
containing 2-3 x 10^ cells were transferred into plastic Petri dishes 
(10 cm diam.). Normal growth medium was added to a total volume of 
10 ml and the cells were incubated in a 37°C incubator (Vindon 
Scientific Ltd), equilibrated with 5% (v/v) CO2 and 95% (v/v) air.
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Confluent monolayers were generally observed after 24-48 h.
On removal of normal medium, the monolayers were rinsed and 
then incubated with 4'ml low methionine medium (section 2.1.2) for 
1-2 h to reduce endogenous levels of methionine.
Radiolabelling was initiated by the addition of [ ^ %] methionine 
to 100-200yuCi/dish. For short-term labelling, cells were incubated 
generally for 4 h, whereas for long-term labelling, cells were incubated 
for 16-20 h at 37°C in medium supplemented with 50-100yiCi of isotope/dish.
For accumulation of mitochondrial precursors, monolayers were 
incubated in low methionine medium for 1-2 h before adding either DNP
or FCCP to final concentrations of 1-2 mM or 5-10yiM, respectively.
Stock solutions of DNP (100 mM) and FCCP (1 mM) in ethanol, were 
prepared fresh on each occasion. After the addition of uncoupler, 
dishes were returned to the 37°C incubator for another 5-10 min before 
adding [^^S] methionine (200 yuCi/dish),
d) Pulse-chase experiments
Monolayers were labelled as described in section 2.2.11 c,in the 
presence of uncouplers for 4 h at 37°C. The radioactive medium was 
removed and substituted by 10 ml of normal growth medium (warmed at 
37°C) with or without uncoupler as required. Cells were harvested 
as described below after the indicated chase periods.
e) Preparation of cell lysates for immunoprécipitation 
Solutions required:
PBS: 20 mM-potassium phosphate buffer, pH 7.4, 0.15 M-NaCI
Triton-TKM buffer: 0.1 M-Tris/HCl buffer, pH 8.2, 1% (v/v) Triton
X-100, 0.1 M-KCl, 5 mM-MgCl^.
3-D lysis buffer: 0.1 M-Tris/HCl buffer, pH 8.2,1% (v/v) Triton
X-100, 1% (w/v) SDS, 2% (w/v) sodium deoxycholate, 0.1 M-KCl,
5 mM-MgClg,
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Solutions were sterilized by filtration through Nalgene filters 
(0.22yim pore size) type S (115 ml) and kept at room temperature.
The method of Mosmannet al. (1979) as described by Cushley 
(1981) was used to prepare the cell extracts used for the specific 
immunoprécipitation of radiolabelled polypeptides.
After the labelling or chase periods, medium was removed and 
monolayers were rapidly rinsed 3-4 times with ice-cold PBS. One ml of 
cold Triton-TKM buffer containing 4 mM-l,10-phenanthroline, 0.4 mM- 
PMSF and 0.3yuM-leupeptin was added to each dish. Cells were scraped 
into the solution with the aid of a small rubber stopper and the 
resulting lysate was transferred into a conical centrifuge tube. 
Unbroken cells and nuclei were removed by centrifugation at 1100 g 
for 5 min at 4°C, in a Beckman Model TJ 6 bench centrifuge. The 
concentration of deoxycholate was adjusted to 1% (w/v) and SDS to 
0.5% (w/v) by mixing the samples with an equal volume of 3-D lysis 
buffer.
Any insoluble material or aggregates were removed by centrifug­
ation at 30,000 g for 30 min at 4°C. The clarified extracts were 
used immediately for immunoprécipitation or stored at -80°C until 
required.
2.2.12 Immunological methods
a) Preparation of antibodies to native PDC
Production of high titre, monospecific, polyclonal antibodies 
against ox heart PDC required highly-purified preparation of antigen. 
Samples of PDC (20-30yug) were electrophoresed in 10% (w/v) SDS/ 
polyacrylamide gels and their purity was estimated after densitometric 
scanning of the Coomassie Brilliant Blue-stained bands. Samples from 
the Sepharose C1-2B column were screened and those fractions found to
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contain between 96-98% pure PDC, as judged by this criterion, 
were used to raise antibodies against the whole complex.
PDC (1 mg protein), dissolved in 50 raM-Mops buffer containing 
2 mM-EDTA, 0.1 mM-DTT adjusted to pH 7.0 with NaOH was mixed with an 
equal volume of Freund's complete adjuvant and injected subcutaneously 
at multiple sites in the neck and back of a 4-months old New Zealand 
white rabbit. Similar amounts of enzyme were administered at 2-3 
week intervals thereafter. Ten to fourteen days after the fourth 
injection, blood was obtained from a marginal ear vein. Additional 
booster injections were administered at approx. one-month intervals 
with 0.5 mg of protein mixed with incomplete Freund's adjuvant.
Blood (approximately 40 ml) was collected in Universal 
bottles and left to clot at 4°C for 24 h. The serum was collected, 
clarified by centrifugation and stored frozen in 1.0 ml aliquots 
at -20°C.
b) Preparation of antibodies to PDC subunits
For the production of subunit-specific antisera, samples of PDC 
(approx. 2.5 mg) were resolved on preparative slab gels as described 
in section 2.2.6.C. After staining with Coomassie Blue, protein bands 
were excised from the gels with a scalpel, diced and rinsed twice with 
distilled water to remove solvents. The pieces were ground finely 
in a mortar and pestle whilst kept frozen by adding small amounts of 
liquid nitrogen. The frozen powder was weighed and stored at 
-20°C until use. This technique yielded between 100-300yug protein
per gram of gel (Mihara & Blobel, 1980).
Before injection into rabbits, 1 g gel was homogenized with
0.5 ml 0.9% (w/v) NaCl with a tight-fitting glass teflon homogenizer.
The gel slurry was mixed with an equal volume of Freund's complete 
adjuvant and injected subcutaneously into a rabbit. The rest of the
ÜZ
protocol followed was similar to that described above for the 
production of antiserum to native PDC.
Antisera to subunit E3 and citrate synthase were obtained after 
injecting commercially purified pig heart lipoamide dehydrogenase and 
citrate synthase. Protocols for immunisation were similar to 
that for native PDC (section 2.2.12.a).
c) Studies on the effects of several antisera on PDC activity
Samples of PDC (approx. 20yig protein) were incubated with
varying amounts of antisera (O-lOOyil) in a final volume of 250yul in 
0.1 M-sodium phosphate buffer, pH 7.0, 0.15 M-NaCl. After incubation 
at room temperature for 90 min, aliquots of lO-lOOyil were assayed in 
duplicate for overall PDC activity as indicated in section 2.2.8.a. 
Control experiments showed that PDC activity was stable in this 
buffer for at least 90 min.
d) Studies on the effects of several antisera on pyruvate
dehydrogenase kinase activity
The effects of several antisera on PDC kinase were studied 
by either measuring the rate of inactivation of PDC in the presence 
of 0.2 mM-ATP or the rate of incorporation of [Y -^^P] ATP into 
TCA-precipitable material. For the former experiments, samples of 
PDC (66yug) were incubated for 30 min at room temperature (20°C) 
with 100yul of the indicated antiserum. The incubation mixtures 
contained in a final volume of 200y:l, 20 mM-potassium phosphate 
buffer, pH 7.5, 2 mM-MgCl2. 0.01 mM-EDTA, 1 mM-DTT. Inactivation 
of PDC was followed at 30°C after the addition of ATP to a final 
concentration of 0.2 mM. Aliquots of lO-lOOypl were withdrawn at 
the times stated in the Figure legends for measurement of PDC activity.
For the latter experiments, samples of PDC (50yjg) were 
incubated as described above with 100yil antiserum. Phosphorylation 
was started at 30°C by adding 25yil of a mix containing 3yuCi [ y-^^P] 
ATP, 50 nmol ATP and 2 nmol MgCl2« Aliquots of 20yil were removed 
after various times and spotted onto Whatman No.l filter paper discs 
to estimate protein-bound radioactivity (see section 2.2.5.a),
e) Analysis of antibody specificity by immunoblotting techniques
Relevant information on the specificity and relative titre of 
the antibodies raised against native PDC and its constituent poly­
peptides was obtained by immunoblotting techniques.
Proteins were resolved on SDS/polyacrylamide gels prior to 
electrophoretic transfer onto nitrocellulose sheets. After incubation 
with specific antisera, formation of immunocomplexes was detected by 
the binding of ^^^I-labelled protein A.
One dimensional SDS/polyacrylamide gel electrophoresis was 
performed in slab gels until the tracking dye had moved to 1-2 cm from 
the bottom of the resolving gel. Usually, samples of purified PDC 
and ^^^I-labelled Mj- standards (approx. 30,000 c.p.m.) were included 
to facilitate identification of the indiddual proteins by their 
characteristic electrophoretic mobility.
Electrophoretic transfer of proteins onto nitrocellulose sheets 
was performed essentially as described by Towbin et al. (1979), except 
that 0.02% (w/v) SDS was included in the transfer buffer.
Pyronin Y binds tightly to nitrocellulose and can therefore 
serve as a readily visible indicator of transfer. It also allows the 
identification of individual tracks on the transfers (blots) so they 
can be excised and treated separately.
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The blots were subjected to incubation with gentle shaking at
room temperature in blotting buffer (20 mM-Tris/HCl buffer, pH 7.2
containing 0.15 M-NaCl, 0.5% (v/v) Tween 20) for at least 1 h and
then with the particular antiserum diluted 1:50-1:200 in blotting
buffer for 90 min. Inactivated horse or goat serum (5% (v/v)) was
included as carrier at this stage. Excess antiserum was removed by
washing with 5 changes of blotting buffer (approx. 50 ml each) over
125
a period of 30 min. Incubation with I-labelled protein A (approx.
0.8-1.0 X 10^  c.p.m/ml) in blotting buffer for 1 h, was followed by 
another 5 washes (5-10 min each) with blotting buffer, to remove 
excess unbound radiolabel. Finally, the blots were air-dried and 
exposed for 24-48 h to Kodak X-Omat S film with intensifying screens 
at -80°C.
The inclusion of Tween 20 to 0.5% (v/v) in all steps as suggested
by Batteiger et_al.(1982) was found to reduce substantially the
background due to non-specific binding.
To identify unambiguously some immunoreactive proteins or to
assess the quality of the transfer, nitrocellulose sheets were stained
for 5 rain with 0.1% (w/v) Amido Black 10-B dissolved in 45% (v/v)
methanol, 10% (v/v) acetic acid for 2-5 min and destained with 50%
(v/v) methanol, 10% (v/v) acetic acid for another 5 min.
Immunoblots can be sequentially treated with another different
antiserum without the removal of the preceding antibodies.
125
I-labelled protein A and standards were prepared by the 
lodogen method as described in section 2.2.14.a.
Immunoprécipitation methodology
This method permits the isolation and identification of small
amounts of a particular protein in a complex mixture by means of its
specific interaction with an antibody. Immunoprécipitation of antigens 
is usually performed in two stages. First, specific antibody is
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added to a detergent cell lysate containing the radiolabelled antigen. 
Next, the immune complexes are bound to a second agent that provides 
sufficient mass to facilitate precipitation. This second agent can 
be an immunoglobulin directed against the first antibody (double 
antibody precipitation system) or chemically-fixed protein A-bearing 
strains of Staphyloccus aureus bacteria. The isolated antigen is 
resolved by SDS/polyacrylamide gel electrophoresis and detected 
by fluorography.
The procedure was applied to purified PDC labelled with 
N-[%]ethylmaleimide (section 2.2.13) and to [^%]methionine-labelled 
cellular extracts (section 2.2.11.e). Immune complexes were precipitated 
by binding to formalinised S. aureus bacteria (Pansorbin). 
Immunoprécipitation of %-labelled PDC 
Immunoprécipitations were carried out in a final volume of 
lOOyil containing 1 yjg (approx. 140,000 c.p.m.) of tritiated complex 
in Triton-buffer (0.01 M-Tris/HCl buffer, pH 7.4, 1% (v/v) Triton 
X-100, 0.3 M-NaCl, 5 mM-EDTA) or in 3-D TKM buffer (0.1 M-Tris/HCl 
buffer, pH 8.2, O.lM-KCl, 1% (v/v) Triton X-100, 1% (v/v) sodium 
deoxycholate, 0.5% (w/v) SDS, 5 mM-MgCl2*
PDC was immunoprecipitated by adding 10-50yil of antiserum. 
Appropriate controls were included by replacing the specific antiserum 
with similar amounts of preimmune serum.
After incubation with the antiserum for 1 h at room temperature, 
samples were incubated overnight (16-20 h) at 4“C. Immunocomplexes 
were precipitated by addition of 4 0 - 5 0 of a 10% (w/v) suspension of 
standardized S. aureus cells (Cowan I strain) previously washed and 
resuspended in immunoprécipitation buffer. Incubations were extended 
for another hour at room temperature with occasional mixing.
Pellets were collected by centrifugation at 14,000 g for 5 min 
inai MSB Micro-Centaur centrifuge, washed 3 x with 1 ml of immuno­
précipitation buffer and finally with 1 ml of 20 mM-Tris/HCl buffer, 
pH 7.4 in order to remove detergents. Immunocomplexes were dissoc­
iated by boiling with 40-50yul of Laemmli sample buffer. Aliquots 
of 5yul were counted and the remaining sample was loaded onto 
polyacrylamide slab gels. Immunoprecipitated proteins were detected 
after fluorography (section 2.2.6.e).
Immunoprécipitation of cellular extracts
Aliquots of cell lysates containing 10-20 x 10^ c.p.m. ^^S- 
label were incubated with 10-20yil of antisera prior to adsorption on 
S. aureus cells. Sterile 3-D TKM buffer was employed for the washing 
steps. Immunoprécipitation was carried out essentially as described 
above for the %-labelled antigen.
g) Immune-mapping techniques
This procedure premits the characterisation of antigens 
by immunoblotting of proteolytic fragments of these proteins resolved 
by SDS/polyacrylamide gel electrophoresis.
Pyruvate dehydrogenase complex (1 mg) was incubated with 
elastase (4.5yug/ral) or trypsin (13.5yug/ml) in 0.1 M-potassium phosphate 
buffer, pH 7.0 at 25*C. Aliquots (30yul) were withdrawn at appropriate 
time intervals (0-60 min). Reactions were terminated by boiling for 
5 min with 30yil of Laemmli sample buffer. Samples were loaded onto 
polyacrylamide gels that were either stained with Coomassie Brilliant 
Blue or used for immunoblotting analysis as described in section 2.2.12.e.
h) Immunoadsorption
Immunoadsorption was utilised to remove unwanted antibody 
activity (anti-E2) from the antiserum raised against El S subunit of PDC.
Highly-purified subunit E2 (100yug) isolated from polyacryl­
amide gel slices (section 2.2.10.f) was coupled to 1 ml of CNBr- 
activated Sepharose 4B according to the manufacturer's instructions.
Beads were washed with 30 ml PBS (20 mM-potassium phosphate buffer, 
pH 7.4 containing 0.15 M-NaCl, 0.01% (w/v) NaNg) and dispensed into 
three 1.5 ml Eppendorf tubes. The beadswere sedimented by centri­
fugation and the supernatant fluid was discarded. One ml of antiserum 
to El 8 was placed into one of the tubes and incubated for 30 min at 
37°C in an end-over-end mixer. The serum was separated from the beads 
and the immunoadsorption repeated twice with the beads contained in the 
second and third tubes.
This procedure was found to be more efficient than using a 
column and also minimized dilution of the antiserum with PBS. Efficiency 
of immunoadsorption was checked by immunoblotting using PDC as antigen.
The used beads were regenerated by washing with 3 ml 3 M-KSCN in 
0.5 M-NH4OH followed by washing with 30 ml PBS. The beads were stored 
at 4"C in PBS until required,
i) Preparation of affinity-purified IgG
Affinity chromatography on protein A-Sepharose columns was used 
to obtain small amounts of highly-purified IgG from rabbit serum.
Protein A-Sepharose columns were prepared by coupling 2 mg
protein A to 3 ml of swollen CNBr-activated Sepharose 4B, following the 
manufacturer's instructions. One ml columns were packed in the barrels 
of 2 ml disposable syringes,plugged with glass wool and washed with PBS
(20 ml)^  followed by 3 ml of 3 M-KSCN and 30 ml PBS. One ml serum was
applied to each column at approximately 6 ml/h at room temperature.
The eluant was recirculated for 2 h. The non-bound material was 
discarded and the columns were washed with PBS until the A^go was 
<0.02. Then, the IgG bound was eluted with 3 ml of 3 M-KSCN.
Fig. 2.1 Affinity-purified IgG fractions
Immunoglobulins were purified by affinity chromatography on 
protein A- Sepharose columns as described in section 2.2.12.i.
Samples of each fraction were mixed with Laemmli sample buffer 
and boiled for 5 min, before electrophoresis on a 10% (w/v) SDS/ 
polyacrylamide gel. Protein bands were visualized after staining 
with Coomassie Blue.
Lane 1, standards; lane 2, anti-X IgG fraction, 12yag protein; 
lane 3, IgG control, 14yjg; lane 4, commercially purified IgG, 10yig.
10 5 X M
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Fractions of 1 ml were collected and the A28O measured. Peaks of
u.v. absorbing material were pooled and dialysed against 4 x 250 ml'
of PBS for 48 h. The yield of IgG was determined from the A28O assuming
1%
that it was mostly IgG (A28O (Fig. 2.1).
j) Sucrose-density gradient centrifugation of PDC incubated with 
purified IgG
Anti-X and control IgG were purified from rabbit serum (section 
2.2.l2.i) and radioiodinated with lodogen method as indicated
in section 2.2.14.b.
Native PDC (1.9 mg*, 100 nKat/mg)dissolved in 200y:l of 20 mM- 
potassium phosphate buffer, pH 7.2, 20yiM-TPP, 1 mM-MgCl2, 0.1 M-KCl,
0.15yiM leupeptin was incubated with anti-X or control ^^^I-labelled 
IgG (2 X 10^ c.p.m. each). After 1 h at room temperature, samples 
were loaded on the top of linear 10-30% (w/v) sucrose-density gradients 
formed in tubes of the Spinco SW 27 rotor. Sucrose solutions were 
prepared in the same buffer. A cushion of 2 ml 50% (w/v) sucrose 
was placed on the bottom of the tubes. Centrifugation was performed 
at 96,300 g at 4®C for 4 h.
Fractions of 1 ml were collected manually with the aid of a 
peristaltic pump. Aliquots of 200yil were used to estimate the 
distribution of 125j the gradients with a Gamma counter. PDC 
activity was assayed spectrophotometrically as described in section 
2.2.8.a.
2.2.13 Preparation of native and denatured N-I^lethylmaleimide- 
labelled PDC
Thiol groups of dissociated PDC were labelled with N-[%] 
ethylmaleimide as follows: a 100yal portion of sample containing
100yig protein was precipitated with 80% (v/v) acetone by storing
at -20“C for several hours. The pellets were air-dried and re- 
dissolved in 200yil of 20 mM Tris/HCl buffer, pH 7.4, 2% (w/v) SDS 
before incubation with 50yiCi N-[%]ethylmaleimide at room temperature 
for 30 min. Reactions were terminated by addition of lOyil 2-mercapto- 
ethanol and 4 vol. acetone. Pellets were collected as before, washed 
once more with acetone and dissolved by boiling in the same buffer. 
Before use, samples were diluted 5-fold with Triton buffer (see section 
2.2.12.f).
Incorporation of radioactivity into protein was determined as
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described in section 2.2.5.a. Approx. 140,000 c.p.m. H were incorpor­
ated peryjg protein. %  labelled denatured PDC is the standard used in Ch.8, 
Native PDC (200yig) was labelled with 50yiCi N-[^H]ethylmaleimide 
after incubation at room temperature for 30 min in 200^1 of 20 mM- 
potassium phosphate buffer, pH 7.2,0.5 mM-MgCl2» 0.25 mM-EDTA in the 
absence of pyruvate. Reactions were terminated by the addition of DTT 
to 10 mM and the samples were dialysed extensively against 4 x 500 ml 
of 20 mM-Tris/HCl buffer, pH 7.4, 0.1 mM-DTT, 0.01% (w/v) NaNs.
Approx. 56,000 c.p.m. were incorporated/pg protein and 96% of the 
counts were TCA-precipitable.
2.2.14 Radioiodination of proteins by the lodogen method
lodogen is a mild solid-phase reagent that efficiently reacts 
with aqueous mixtures of I and proteins to produce iodinated proteins 
(Fraker & Speck, 1978).
a) Radioiodination of protein A and Mr standards
lodogen ( 1 mg) was dissolved in 1 ml chloroform. The solvent
was removed subsequently with a gentle air stream by rotating the 
reaction container until a thin film of lodogen was formed on the bottom.
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Proteins for icdination (1 mg protein A or 578 yig low value
standards) were dissolved in 0.5 ml 0.1 M-Tris/HCl buffer pH 7.2,
0.15 M-NaCl and transferred into the container with the lodogen.
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After addition of 200-400yiCi [ I] Nal, incubations were carried out 
for 15 min at room temperature with occasional mixing. Reactions were 
terminated by removing the samples from the containers and applying 
to Sephadex G-25 or G-50 columns packed in 10-ml disposable syringes 
and equilibrated with the same buffer. Fractions (1 ml) were collected 
in disposable plastic tubes. The iodinated protein was generally 
found in fractions 4-7; this was confirmed with a gamma counter.
The peak fractions were pooled and stored at -20°C. Protein A for 
immunoblotting analysis was dispensed in 0.05-0.1 ml aliquots containing 
approx. 3 x 10^ c.p.m. each.
b) Radiolabelling of IgG
Samples containing IgG (approx. 20 ug) were iodinated with 
I 125
200yiCi of [ I] Nal in test tubes (13 cm x 1.0 cm) containing 25yig 
lodogen. Incubations were performed for 15 min at room temperature 
in 50yil of 0.25 M-potassium phosphate buffer, pH 7.5. Proteins were 
applied to 5 ml columns of Sephadex G-50, previously washed with 10 mg 
of BSA and equilibrated with PBS. The rest of the procedure was 
similar to that described for radiolabelling of protein A.
c) Radioiodination of subunits E2 and X Isolated from SDS/ 
polyacrylamide gels
Purified acetyltransferase subunit (E2) and component X, obtained 
as described in section 2.2.10.f, were iodinated in (7.5 cm x 1 cm) test 
tubes containing 50yjg of lodogen essentially as described by Tolan 
et al. (1980).
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Samples containing 16yig of E2 protein and 18yig of component X
in 50yil of 1% (w/v) SDS were mixed with 20yil of 100 mM-Tris/HCl
buffer, pH 7.4 at 0°C. Reactions were started by addition of 20yil
5 mM-KI containing 100yjCi and allowed to proceed at 0°C for 15 min,
with occasional mixing. Mixtures were transferred into Eppendorf
tubes containing 10yil 2-mercaptoethanol before precipitation of
protein with 4 vol. acetone and lOOyig PDC, which was used as a carrier.
Pellets were recovered after storage at -20°C for 16 h, washed 3x with
125
1 ml acetone to remove free I, air-dried and dissolved by boiling 
in 500yjl 125 mM-Tris/HCl buffer, pH 6.8, 0.5% (w/v) SDS and 10% (v/v) 
glycerol.
Aliquots of 5 ul were withdrawn to estimate radioactivity in a
5 125
gamma counter. Approx. 1 x 10 c.p.m. I were incorporated/lOyil sample.
2.2.15 Modification of enzyme-bound lipoyl groups in pyruvate
dehydrogenase complex
a) Acétylation assay
The acétylation of covalently-associated lipoyl groups in PDC
14 14
was assayed by measuring the incorporation of C from [2- C] pyruvate 
into TCA-precipitable material as described by Cate & Roche (1979).
Standard mixtures (200yil) contained 50 mM-potassium phosphate 
buffer, pH 7.2, 0.2 mM-TPP, 0.5 mM-MgClg, 0.25 mM-EDTA and 200yig PDC. 
Catalysis was initiated after a 1 min preincubation at 30°C by addition 
of 0.10 mM-[2-14c] pyruvate (10.4 mCi/mmol).
Samples (lOyil) were withdrawn at the indicated times, spotted 
onto Whatman No.l filter paper discs and processed for measurement of 
TCA-insoluble radioactivity (section 2.2.5.a).
In some experiments NEM was added to a final concentration of 
0.5 mM before preincubation. Stock 10 mM-NEM solution was prepared 
fresh each time.
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b) Pretreatment of PDC with NEM
PDC (1 mg) was preincubated at 0“C or at room temperature 
for 30 rain in the presence of 0.5 mM-NEM in 20mM-potassium phosphate 
buffer, pH 7.5. The sample was then diluted with 5 ml of the same 
buffer and concentrated by centrifugation at 144,000 g for 2.5 h in 
a Beckman SW 60 rotor. The pellet of PDC was resuspended in a small 
volume of the same buffer. Protein concentration was determined by 
the procedure of Markwell et al. (1976) and aliquots containing 200yig 
protein were included in the standard acétylation assay described in 
section 2.2.15.a.
c) Pretreatment of PDC with pyruvate
PDC (1 mg) was acetylated in the presence of 2 mM-pyruvate after 
incubation with 20 mM-potassium phosphate buffer, pH 7.2 containing 
0.2 mM-TPP, 0.5 mM-MgCl^, 0.25 mM-EDTA as described above.
Samples were concentrated by centrifugation at 144,000 g for 
2.5 h in a Beckman SW 60 rotor, essentially as described for pre­
treatment with NEM. Acetylated PDC was used as control in the 
acétylation experiments.
d) Acétylation of phosphorylated PDC
PDC (500yig) was incubated for 30 min at 30°C in the presence 
of 0.2 mM-ATP (see section 2.2.8.b). Under these conditions, 
the activity of the complex declined to less than 5% of its original 
value after a 35 min incubation. Aliquots (200yig) were used for 
standard acétylation assays. Control samples incubated as above in 
the absence of ATP were also included.
e) Deacetylation assay
PDC was incubated as described in section 2.2.15.a for 30-40 min 
to allow the complete acétylation of the complex. CoA was added to a 
final concentration of 1 mM and the deacetylation reaction was followed
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at 30*C by removing 10yul aliquots of reaction mixtures, spotting
onto filter paper discs and counting the TCA-insoluble radioactivity.
The effects of several compounds on the deacetylation reaction
were tested in similar fashion. The following compounds were
included with CoA at the indicated final concentration: NADH (1 mM),
+
NAD (0.5 mM).
The following compounds were added instead of CoA at a final 
concentration of 1 mM: AcSoA, malonyl CoA, propionyl CoA, acetoacetate,
acetoacetyl CoA, n-butyryl CoA, palmitoyl CoA, carnitine.
To study the effects of NEM on the deacetylation reaction,
NEM (0.5 mM) was added at the indicated times.
f) Estimation of moles of acetyl group incorporated/mol complex
14
The concentration of the [2- C] pyruvate solution was estimated
using the NAD"*” reduction assay for PDC (section 2.2.8.a). The
concentration of stock solution was found to be 3.86 mM. Its specific
activity was assumed to be identical to the value given by the manufacturer.
14
Efficiency of counting for C by the filter paper discs was 
estimated as 56% using ^^C-labelled proteins as a standard. Samples 
of the stock solution of ^^C-labelled proteins (5yiCi/ml) were mixed 
with 50yug BSA and spotted into Whatman No.l filter paper discs.
The filters were washed and counted as done with samples of PDC for 
the acétylation assays.
M^ for the ox heart PDC was assumed to be 8.5 x 10^. (Reed & 
Pettit, 1981)
2.2.16 Limited proteolysis and peptide mapping of subunits E2 and X
a) Radioiodinated proteins
Peptide analysis of proteins was performed as described by 
Cleveland et al. (1977) in 15% (w/v) SDS/polyacrylamide gels with
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purified subunits E2 and X extracted from gel strips and radioiodinated 
as described in sections 2.2.l0.f and 2.2.14.C.
19c
Aliquots of 20yil containing approx. 200,000 c.p.m. I- 
labelled protein were mixed with 20yil of distilled water and 50yil 
125mM~Tris/HCl buffer, pH 7.4, 1% (v/v) Triton X—100, reducing the SDS 
concentration to 0.1% (w/v). Proteolysis was started by the addition 
of 10yil of the protease solution. Samples were incubated at 35°C for 
0-60 min. After the indicated times, 10yil aliquots were removed with 
10yil Laemmli sample buffer and boiled for 5 min. Samples were 
loaded on a 15% (w/v) polyacrylamide slab gel and run under standard 
conditions. The gels were dried under vacuum and autoradiographed 
for 14 days at room temperature.
Protease solutions were prepared as follows:
Elastase: Stock solution of 50yig/ml was prepared in 0.1 M-potassium
phosphate buffer pH 7.0 and stored at -20°C in small aliquots. Before 
use, the enzyme was diluted in 0.1 M-Tris/HCl buffer, pH 7.4 to a final 
concentration of 3 yjg/ml.
Chymotrvpsin: A solution (6yig/ml) was prepared fresh each time in
0.1 M-Tris/HCl buffer, pH 7.4. Samples of TLCK-treated a -chymotrypsin 
were weighed on a Mettler ME22 microbalance.
Protease V8, S. aureus: Stock solution (1 mg/ml) was prepared in
0.01 M-ammonium bicarbonate and stored at -20°C in small aliquots 
(for up to one month). Before use, the enzyme stock was diluted to 
15yig/ml in 0.1 M-Tris/HCl buffer, pH 7.4.
The final ratiosprotease: protein (w/w) were estimated as: 0.75%
for elastase, 1.5% for chymotrypsin and 3.75% for protease VS. These 
ratios were selected after preliminary studies designed to determine 
the optimal values and most suitable incubation times to produce high- 
quality maps.
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b) C-labelled proteins
Peptide maps using ^^C-labelled subunits E2 and X were carried 
out as follows: Native PDC (2 mg) was incubated for 30 min with 0.1 mM-
[2-^^C] pyruvate under standard conditions (see section 2.2.15a). The 
complex was concentrated by precipitation in the presence of 5% (w/v) 
poly(ethylene glycol) and 10 mM-MgCl2 at 0°C for 1 h. The yellow 
pellet was recovered after centrifugation in a microfuge at 14,000 g 
for 5 min. The acetylated enzyme was dissociated in SDS by re- 
suspending the pellet in 2% (w/v) SDS by manual homogenisation 
followed by incubation at 4°C for 16 h.
Attempts to concentrate the enzyme by freeze-drying or by 
extraction from gels using the procedure described in section 2.2.10.f 
resulted in heavy losses of radioactivity and/or protein. Boiling 
in SDS was also avoided owing to the instability of the S-acetyl 
dihydrolipoamide. Recovery of radioactivity at this stage was 90% 
as estimated by the filter paper discs method. The sample was 
resolved on a 10% (w/v) SDS/polyacrylamide preparative gel slab and 
the bands of protein were visualized after staining with Coomassie 
Blue. Gel strips containing the subunits E2 and X were washed 
with distilled water and cut into smaller pieces with a scalpel to 
fit into the wells of a second polyacrylamide gel. Gel slices 
were equilibrated by washing in SDS-containing buffer as 
described by Cleveland et al. (1977). Slices were placed on the 
second gel and overlayed with various amounts of elastase.
Digestions were allowed to proceed directly in a 4.5 cm long stacking 
gel made up with 4% (w/v) polyacrylamide in a Bethesda Res. Lab.
Model V-16 Slab Apparatus (16 cm x 17 cm).
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Electrophoresis was carried out at 20 mA until the tracking
dye (Pyronin Y) reached the bottom of the stacking gel. The current
was turned off and the digestions were allowed to take place for
30 min. Then,electrophoresis was resumed until the tracking dye
reached 1 cm from the bottom of the 15% (w/v) SDS/polyacrylamide
resolving gel. Slabs were stained with Coomassie Brilliant Blue
and subjected to fliorography as described in section 2,2.6.e.
Peptide maps were also obtained with the SDS-denatured subunits 
14
E2 and X labelled with C as described below.
PDC (6 mg), dissolved in 600yil 50 mM-potassium phosphate
buffer, pH 7.5, 0.25% (v/v) Triton X-lOO, 1 mM-NAD"^, 5 mM-MgClg,
2 mM-TPP, 0.5 mM-NEM, was incubated for 24 h at 4°C. Unreacted 
reagents were removed by gel filtration in 1 ml columns of Sephadex 
G-25-F equilibrated in 50 mM-potassium phosphate buffer, pH 7.5, 1% 
(v/v) Triton X-100, 1 mM-NAD'*’, 5 mM-MgClg, 2 mM-TPP according to 
Penefsky (1977). This procedure blocked all NEM-sensitive sites 
available in the complex in the absence of pyruvate (J>A. Hodgson, 
unpublished results).
To this sample, 5yiCi of N-ethyl[2, 3-^^C] maleimide in 
n-pentane were added to a final concentration of 1.44 mM. After 
removal of the solvent by a gentle stream of N^, 5yiCi [2-^^C] pyruvate 
were added immediately, to a final concentration of 0.8 mM. After 
15 min incubation at room temperature, the reaction was terminated 
by the addition of 2-mercaptoethanol to 17.5 mM. Approx. 130 c.p.m. 
^^C-label were incorporated^g protein.
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The C-labelled complex was mixed with the same volume of 
Laemmli sample buffer (no sulphydryl reagents added) and the sample 
was loaded onto two 10% (w/v) SDS/polyacrylamide preparative slab 
gels. Gel slices corresponding to subunits E2 and X were extracted 
as described in section 2.2.10.f. Samples containing approx.
6,000 c.p.m. of each protein were incubated with elastase as described 
in the legend to Fig. 7.10, before SDS/polyacrylamide gel electro­
phoresis. Proteolytic fragments were detected by Coomassie Blue 
staining followed by fluorography.
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RESULTS AND DISCUSSION
Chapter 3: PURIFICATION. CHARACTERISATION AND RESOLUTION OF THE
PYRUVATE DEHYDROGENASE COMPLEX FROM OX HEART
3.1 Purification of PDC from ox heart
The mammalian pyruvate dehydrogenase complex has been purified 
from a variety of tissues: bovine kidney and heart (Linn et al., 1972)
porcine liver (Roche & Cate, 1977), porcine heart (Hayakawa et al., 1969) 
pigeon breast muscle (Severin & Glemza, 1964) and rat heart (Matuda 
et al., 1983). Electron microscopy and sedimentation equilibrium 
analysis indicate that the complexes isolated from these sources are 
similar in size and appearance (icosahedral design) and have 
values in the range 7-8.5 x 10^.
Most procedures for the purification of the complex rely on an 
initial large scale isolation of mitochondria. Conventional 
preparations of liver and kidney mitochondria tend to contain 
lysosomes and PDC is particularly sensitive to proteolytic cleavage 
by lysosomal proteases. Wieland (1975) has shown that extracts from 
rat liver mitochondria are capable of inactivating PDC owing to the 
presence of a thiol protease or "inactivase", which has been partially 
purified and characterised (Lynen et al., 1978). Proteolytic attack 
leads to dissociation of the complex, accompanied by loss of activity 
(Kresze & Steber, 1979). Mitochondrial extracts from ox heart and 
kidney contain at least 5 times more PDC activity than extracts from 
liver. On this basis, ox heart seems to be the most suitable source 
of mammalian PDC.
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More recently, a procedure which allows the purification of 
the ox heart 2-oxo-acid dehydrogenase complexes from whole tissue 
by homogenisation in the presence of Triton X-100 has been described 
(Stanley & Perham, 1980). This method eliminates the tedious 
procedures involved in the purification of mitochondria and the 
freeze-thaw treatment required for efficient release of the multienzyme 
complexes. In addition, it employs relatively few steps in producing 
purified complexes in good yields.
Most schemes for purification of 2-oxo-acid dehydrogenase 
complexes are centred on selective precipitation with poly(ethylene 
glycol), originally described by Linn et al. (1972). Poly(ethylene 
glycol) precipitation is a relatively mild procedure not detrimental 
to enzymatic activity. Quantitative precipitation occurs at very 
low concentrations (around 5% w/v) of the polymer (M^ 6000) at pH 
values near the isoelectric points of the complexes.
The purification scheme developed by Stanley & Perham was 
utilised with some minor modifications, introduced after experiencing 
difficulties in purifying the 2-oxoglutarate dehydrogenase complex.
Inclusion of leupeptin (0.15yuM) and rat serum (0.5% (v/v))in 
all buffered solutions after the first precipitation with poly(ethylene 
glycol) stabilised the activity of the 2-oxoglutarate dehydrogenase 
complex. These compounds are potent inhibitors of the lysosomal 
protease which specifically inactivates 2-oxo-acid dehydrogenase 
multienzyme complexes (Lynen et al., 1978). Alternatively, it is 
possible that the components of this complex are more susceptible to 
dissociation or proteolysis than the pyruvate dehydrogenase complex.
It was observed that the activation step described in the original 
procedure did not cause any appreciable increase in PDC activity
Fig. 3.1 Purification of ox heart PDC by gel filtration 
chromatography on Sepharose CL-2B
Partially purified PDC (approx. 100 mg) was chromatographed on 
a column (106 cm x 3.5 cm) of Sepharose CL-2B equilibrated and 
developed in 50 mM-sodium phosphate buffer, pH 7.0, containing 2.7 mM- 
EDTA and 1% (v/v) Triton X-100. Overall PDC activity ( •  )
and 2-oxoglutarate dehydrogenase activity (— ■ ■ □-----) were determined
spectrophotometrically as described in section 2.2.8,a. . Protein
concentration ( O - — ) was determined by the procedure described
by Markwell et al. (1976).
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while the omission of 13 mM-MgCl^ at this stage led to lower yields of 
the complex. Pellets from the second poly(ethylene glycol) precipi­
tation step were usually extracted twice in 50 mM-Mops buffer, pH 6.8 
containing 2.7 mM-EDTA, 0.1 mM-DTT and 1% (v/v) Triton X-100 plus the 
above indicated inhibitors. This was necessary to achieve maximal 
solubilisation of the enzymic activities.
After separation of the 2-oxoglutarate dehydrogenase activity 
by differential precipitation with poly(ethylene glycol), the fraction 
containing partially-purified PDC was loaded onto a Sepharose CL-2B 
column to remove traces of the contaminating 2-oxoglutarate dehydrogenase 
complex. This enzyme was also purified and utilised for a parallel 
study by Miss A. Hunter in our laboratory.
Fig. 3.1 shows a typical separation of the pyruvate dehydrogenase 
and 2-oxoglutarate dehydrogenase complexes by gel filtration chromato­
graphy on Sepharose CL-2B. A large peak of dark-brown material eluting 
after the peak of 2-oxoglutarate dehydrogenase activity was found 
consistently. The nature of this contaminant is not known but it may 
be derived from membranes since it also sedimented after centrifugation 
at 150,000 g for 2 h. Peak fractions of PDC activity were analysed 
separately to establish their specific activity and polypeptide 
composition.
3.2 Characterisation of purified ox heart PDC
Table 3.1 shows how a typical purification of PDC, starting with 
250 g fresh ox heart, gave highly-purified enzyme with specific 
activities 16-fold higher than the initial poly(ethylene glycol) 
precipitate.
The range of specific activities found for 8 different preparations 
was 100-240 nKat/mg. These values compare favourably with those 
reported by Stanley & Perham (1980) using the same procedure and with
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values of 150-280 nKat/mg reported by Linn et al. (1972).
Overall recoveries ranged from 45-65% of the activity observed 
in extracts after the first poly(ethylene glycol) precipitation.
Average yields of PDC were approx. 40yiKat/Kg heart as
compared with 73yjKat/Kg heart reported by Stanley & Perham (1980).
The reasons for this discrepancy are not known, but it may reflect 
losses by proteolysis or dissociation of the complex during purification.
Purified PDC fractions were substantially free of 2-oxoglutarate 
dehydrogenase activity. The degree of cross-contamination was 
estimated as 0.5-1.5% on the basis of activity.
Enzymic activity was found to be stable for up to 3 months at 
4°C in 20 mM-sodium phosphate buffer, pH 7.2 containing 1% (v/v) Triton 
X-100, 2.7 mM-EDTA, 0.1 mM-DTT, 0.01% (w/v) NaN^, 0.15^-leupeptin. 
Freezing in the same buffer or omission of Triton X-100 caused appreciable 
loss of enzymic activity. (approx. 50% in one month at -20°C).
3.2.1 Polypeptide composition
Pooled fractions from the gel filtration step, as well as samples 
from earlier stages of the purification, were analysed by SDS/polyacryl­
amide gel electrophoresis. Fig. 3.2 shows a typical result from one 
of the routine preparations of the complex.
Highly-purified PDC showed a characteristic protein pattern 
similar to that described previously for the ox heart enzyme (Linn et al., 
1972). Four main bands were evident»corresponding to the dihydrolipoyl 
acetyltransferase subunit (E2), the lipoamide dehydrogenase subunit (E3) 
and the a and 6 subunits of the pyruvate dehydrogenase (El). An 
additional band of approx. M 50,000, migrating more rapidly than the 
E3 component, was also observed.
Fig. 3.2 SDS/polyacrylamide gel analysis of samples at successive 
stages in the purification of PDC from ox heart
PDC was purified from ox heart as indicated in section 2.2.9. 
Portions of the samples obtained at different stages of the purification 
(20-50yug protein) were electrophoresed on a 10% (w/v) SDS/polyacrylamide 
slab gel. Protein bands were visualised after staining with Coomassie 
Blue.
Lane a) First poly(ethylene glycol) pellet after sonication.
b) Second poly(ethylene glycol) pellet after sonication.
c) First extract of the second poly(ethylene glycol) pellet.
d) Second extract of the second poly(ethylene glycol) pellet.
e) Pooled extracts.
f) PDC fraction after separation of the 2-oxoglutarate 
dehydrogenase complex.
g)- 1) Peak fractions from the gel filtration chromatography-step,
m) Purified PDC fraction utilised to raise antibodies.
S, standards.
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Additional minor bands of —  100,000 and in the region of
29,000 were detected occasionally. Similar contaminants have been 
described before Oloche & Cate, 1977; Sugden & Randle,1978; Kresze & 
Steber, 1979).
In some instances, a sucrose-density gradient was included as 
a final step in the purification of the complex (section 2.2.12.j).
These contaminant polypeptides were removed by this procedure, as well 
as traces of the brown material eluted from the column, which contained 
a main component with subunit 48,000. In contrast, the polypeptide 
of M 50,000, termed by us component X,was always present in highly- 
purified PDC preparations in reproducible amounts (see also Chapter 6, 
Table 6.1).
M values calculated for the subunits of PDC after resolution on 
r
10% (w/v) SDS/polyacrylamide gels, were similar to those previously 
reported for the ox heart complex (Fig. 3.3). The for component X 
was estimated by this method as 51,000 ± 1,000.
The degree of purity of the various fractions, obtained after 
purification of PDC by gel chromatography, was estimated by densitometric 
scanning of the Coomassie Blue-stained gels from each preparation.
Areas under the peaks corresponding to the five major bands were 
quantitatively evaluated with a densitometer (section 2.2.6.d).
Peak fractions e.g. as shown in Fig. 3.2 (lane m) were apparently 
homogeneous ( i  98% purity). This fraction met the standard requirement 
for use as an immunogen.
The protocols for preparation of antibodies against native PDC 
and for characterisation of the antiserum are discussed in Chapter 4.
Fig. 3.3 Determination of the apparent M of PDC subunits
L '
by SDS/polvacrvlamide eel electrophoresis
A standard curve of relative electrophoretic mobility (m) 
against log subunit was established after scanning a 10% (w/v) 
SDS/polyacrylamide slab gel in which standard proteins and purified 
PDC (15yig) had been co-electrophoresed. Electrophoresis was 
performed in the Laemmli buffer system and the gel was stained with 
Coomassie Brilliant Blue (insert).
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No bands at A7,000-45,000 corresponding to the subunits of 
PDC kinase (Stepp et al., 1983) were detected .suggesting that the 
kinase constituted a minor component of the purified complex. (< 1%). 
However, preparations of PDC used in this study did contain a very 
active kinase.
3.2.2. Presence of pyruvate dehydrogenase kinase and absence of 
phosphatase in the purified PDC
Assays of pyruvate dehydrogenase kinase were performed by
monitoring the initial rate of inactivation of the complex in the
presence of 0.2 mM-ATP (Fig. 3.4) or by measuring the incorporation 
32 32
of P from [ Y - P] ATP into protein-bound radioactivity (Fig. 3.5).
Pyruvate dehydrogenase phosphatase activity was not detected when
assayed as the change (increase) in overall PDC activity following
incubation of ATP-inactivated PDC in a medium containing 10 mM-MgCl^,
0.5 mM-CaClg (Fig. 3.4), or by measuring the difference (decrease)
32
in protein-bound radioactivity from P-labelled PDC after incubation
under similar conditions (Fig. 3.5). Controls in which no MgClg or
CaClg were added, were also included (not shown). Fig. 3.5(B) 
demonstrates that phosphorylation of PDC is confined to the a chain 
of pyruvate dehydrogenase (El).
Similar analysis has been conducted previously to test for the 
presence of pyruvate dehydrogenase phosphatase in purified preparations 
of the complex (Kresze & Steber, 1979). However, it has also been 
reported that inorganic phosphate slightly inhibits phosphatase 
activity (Hucho et al., 1972) in the presence of 10 mN-MgClg» Low levels 
of phosphatase could be masked if pyruvate dehydrogenase kinase was not 
fully inhibited at high Mg^ '*’ concentrations. These results were 
confirmed as depicted in Fig. 3.5. In this case, incubations were
Fig. 3.4 Assay of pyruvate dehydrogenase kinase and phosphatase 
by monitoring changes in the overall activity of the 
complex
PDC (20-50yig) was incubated at 30°C in 20 mM-potassium phosphate 
buffer, pH 7.5 containing 0.5 mM-MgCl^, 2 mM-DTT in the presence
( ----#  ) or absence ( O  ) of 0.2 mM-ATP. Samples were
removed for spectrophotometric assay of PDC activity as described in 
section 2.2.8.a. At the time indicated by the vertical arrow,
MgCl^ and CaCl^ were added to give a final concentration of 10 mM and 
0.5 mM, respectively. Activity measurements were continued for a 
further 60 min. Results are means of duplicate determinations which 
varied by less than ± 5%.
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Fig. 3.5 Assay of pyruvate dehydrogenase kinase and phosphatase by
32
measuring changes in the amount of P-labelled PDC
For the kinase assays, PDC (50yig) was incubated at 30*C in 20mM-
potassium phosphate buffer, pH 7.5 containing 0.5 2 mM-DTT.
32
Reactions were initiated by the addition of [ Y - P] ATP (0.2 mM;
100,000 d.p.m./ nmol). Aliquots of 10^1 were applied to filtçr papers 
to estimate the time course of incorporation into TCA-precipitable 
radioactivity (A).
32
For the phosphatase assays, P-labelled PDC (50yug), prepared 
as described in section 2.2.8.C (approx. 240,000 d.p.m./mg), was 
incubated in 20 mM-Tris/HCl buffer, pH 7.5 containing 10 mM-MgCl^,
0.5 mM-CaClg for 60 min at 30®C in the presence of various amounts of 
native PDC. Aliquots (20yil) were removed to estimate radioactivity. 
The remaining sample was solubilised in Laemmli sample buffer and 
electrophoresed on a 10% (w/v) SDS/polyacrylamide gel. After staining
with Coomassie Blue, the gel was dried and autoradiographed (B).
125 32
Lane 1, I-labelled standards; lane 2, P-labelled PDC
32
before incubation; lane 3, P-labelled PDC incubated with 50yjg
heat-inactivated PDC; lane 4, PDC lOyig, used as a marker; lanes 5,
32
6 and 7 P-labelled PDC incubated with 50^g, 75yig and 120yig PDC, 
respectively.
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32performed in the absence of inorganic phosphate and [ Y - p] aTP. The
32
amount of radioactivity associated with P-labelled PDC remained
constant during the period of incubation. It can be concluded that
no dephosphorylation or proteolysis of El a took place under these
experimental conditions.
It has been previously established that pyruvate dehydrogenase
phosphatase is less tightly-bound to the complex than the kinase and
can be separated from the remaining components of the complex by
ultracentrifugation. (Linn et al.»1972). Pyruvate dehydrogenase
phosphatase becomes associated with the dihydrolipoyl acetyltransferase
core of the complex in a Ca -dependent process (Pettit et al.,1972).
This property has affordeda basis for its purification from bovine
kidney and heart (Pratt et al.,1982; Pettit et al..1982) and from pig
heart mitochondria (Seiss & Wieland, 1972).
In contrast, the other regulatory enzyme of the complex, pyruvate
dehydrogenase kinase, is retained as an integral component of the
complex during purification (Linn et al..1972; Stepp et al..1983).
Whereas phosphatase activity requires a divalent cation (Mg^* or
Ca^ "*") for activity, either ion, if present in sufficient concentration,
2+
will cause inhibition of the kinase activity. In particular, Ca 
inhibits the kinase at very low concentrations, whereas Mg^^ inhibits it 
at higher levels ( > 10 mM) (Wieland et al.,1975).
3.3 Resolution of ox heart PDC
This procedure for the purification of PDC gave relatively large 
amounts (50-60 mg) purified complex from 250 g tissue. One of the 
approaches adopted in this study for production of subunit-specific 
antisera was to achieve resolution . of the complex by standard published 
procedures and employ the individual activities for immunisation.
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Most of the classical procedures for resolution of the 2-oxo-acid 
dehydrogenase complexes were developed initially by Linn et al. (1972) 
and Barrera et al. (1972). These methods allow the isolation of the 
dihydrolipoyl acetyltransferase, lipoamide dehydrogenase and pyruvate 
dehydrogenase components as well as partially-purified pyruvate 
dehydrogenase kinase and phosphatase.
3.3.1 Gel filtration chromatography
PDC was resolved into its constituent enzymes after dissociation 
of the complex at alkaline pH and high salt before chromatography on 
Sepharose CL-6B or Sepharose 4B columns.
Fig. 3.6 shows a typical profile obtained with 50 mg complex. 
Similar patterns were obtained when the chromatographic separation was 
performed in 0.25 M-MgCl^ at neutral pH (Kresze & Steber,1979). Analysis 
of the fractions obtained from the two peaks, showed that Peak I 
contained the dihydrolipoyl acetyltransferase core and component X along 
with smaller amounts of El and traces of E3. Peak II contained most of 
the El and E3 present in the original sample. Owing to the small 
difference in size between the pyruvate dehydrogenase component, M^
154,000 and E3, M 110,000, they were not clearly separated from each 
other.
Attempts to remove the El component from Peak I by prolonged 
incubation of the complex or by repeated freezing and thawing failed 
to increase substantially the degree of dissociation of El from the 
core. This may reflect strong interactions between the components, 
orpartial reassociation of the complex during chromatography, or both.
The profile obtained by high pressure gel permeation chromato­
graphy of the complex in 0.1 M-Tris/HCl pH 7.0, 0.25 M-MgCl^ (Fig. 3.7) 
is very similar to Fig. 3.6, except for the appearance of a third peak 
containing most of the El a subunit. The reasons for this difference
Fig. 3.6 Elution profile of constituent enzymes of ox heart PDC 
on Sepharose CL-6B 
Purified PDC (50 mg) was dissociated in 0.1 M-glycine, 1 M-NaCl,
1 mM-MgCl^, 2 mM-DTT, 0,1 mM-EDTA, adjusted to pH 9.0 with 1 M-NaOH and 
chromatographed on a column of Sepharose CL-6B (80 cm x 1.5 cm) 
equilibrated and developed with the same buffer as described in section
2.2.10.a. ^280 ^  O   ) and protein concentration ( --- □--- )
were measured in the fractions. Samples containing 15yig protein were 
precipitated in 10% (w/v) TCA in order to reduce the salt concentration. 
Pellets were dissolved in Laemmli sample buffer and applied on a 10% (w/v) 
SDS/polyacrylamide slab gel. (A) Elution profile, (B) Coomassie Blue 
stained gel.
A small peak of u.v.absorbing material was consistently observed 
eluting at the total column volume (fractions 53-56).
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are not known, but it is possible that subunit El a was retarded by 
interacting with the matrix of the column. This result is interesting 
since it may provide a mild method for isolating native El o subunit. 
Dissociation of El has so far only been achieved under strong denaturing 
conditions (Barrera et al., 1972).
3.3.2 Separation of pyruvate dehydrogenase (El) a and 5 chains
Peak II from the gel filtration step was further fractionated 
by ammonium sulphate precipitation to yield pyruvate dehydrogenase, 
collected at 30% (w/v) saturation,and a supernatant fraction containing 
most of the E3 polypeptide.
Samples of pyruvate dehydrogenase were dissociated before chromato­
graphy on a phosphocellulose column in the presence of 8 M-urea, 50 mM-2- 
mercaptoethanol at pH 6.0. The elution pattern and the polypeptide 
composition of the fractions obtained are shown in Fig. 3.8 (A) and (B), 
respectively.
Bands were identified from their respective apparent of 36,000
for the 6 subunit and 42,000 for the a subunit (Barrera et al., 1972). 
At very low LiCl concentration, the eluted fraction contained the g chain. 
Subunit o was bound.to the column and was eluted at 0.05 M-LiCl. A 
third peak was obtained when the ionic strength was increased to 0.075M- 
LiCl.
Examination of the polypeptide pattern in the eluted fractions 
revealed that subunit El S was purified to a large extent (approx. 95%), 
whereas subunit El a was contaminated with E3 present in the original 
El sample. (Fig. 3.8, lane 2). Therefore, it is possible to obtain 
highly-purified subunits El a and El g providing that all traces of 
contaminating E3 component are removed from El fractions by repeated 
ammonium sulphate fractionation before chromatography on phosphocellulose 
columns.
Fig. 3.7 Subfractionation of dissociated PDC by high pressure gel 
permeation chromatography
Purified complex (1 mg) was dissociated 0.1 M Tris/HCl, pH 7.0, 
containing 0.25 as described by Kresze & Ronft (1979) and
resolved on a TSK G3000 SW column equilibrated and developed with the 
same buffer.
Absorbance at 215 nm was monitored continuously (A). Samples 
from the peak fractions were subjected to SDS/polyacrylamide gel 
electrophoresis to determine their polypeptide composition,after 
staining the gel with Coomassie Blue (B).
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Fig. 3,8 ChrotoatoRraphic separation of a and 6 chains of ox heart 
pyruvate dehydrogenase (El)
Pyruvate dehydrogenase (approx. 5 mg) was chromatographed on a 
phosphocellulose column (13 cm x 1 cm) equilibrated in 0.02 M-imidazole 
buffer containing 8 M-urea,0.05M-'mercaptoethanol» adjusted to pH 6.0 
with MCI. The column was developed by stepwise increases in the LiCl 
concentration. Flow rate was 26 ml/h and fractions of 2 ml were collected.
Protein was determined in the eluted fractions by the method of 
Bradford (1976). Aliquots containing approx. lOypg protein were applied 
onto a 10% (w/v) SDS/polyacrylamide gel. Protein bands were visualised 
after staining with Coomassie Blue.
(A) Elution profile, (B) SDS/polyacrylamide gel of the pooled 
fractions. Lane 1, standards; lane 2, pyruvate dehydrogenase 
sample before chromatography; lane 3, peak 1; lane 6, peak 2; 
lane 5, peak 3.
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3.3.3 Treatment of subcomplex E2-X with p-chloromercuriphenvl 
sulphonic acid
Attempts to further resolve Peak I from gel filtration chromato­
graphy of the dissociated complex, by treatment with the reagent 
p-chloromercuriphenyl sulphonic acid at pH 9.0, resulted in a dihydro- 
lipoyl acetyltransferase fraction substantially free of El and E3.
However, component X was still associated with the enzyme (see Chapter 
6, Fig. 6.7, lane 2).
It has been shown that p-chloromercuriphenyl sulphonic acid 
treatment induces aggregation and precipitation of the core enzyme and 
promotes the release of pyruvate dehydrogenase kinase (Stepp et al., 1983). 
However, this procedure failed to dissociate the subcomplex E2-X 
(Fig. 6.7, lane 3).
3.3.6 Purification of the constituent polypeptides of PPG 
by extraction from SDS/polyacrylamide gels
At this stage, it became obvious that this approach for isolation 
of PIÆ subunits in a highly-purified state ( > 95% purity), involved 
the preparation of large amounts of purified complex and tedious and 
time-consuming chromatographic procedures,often giving low yields at 
f.90% purity.
To circumvent these difficulties, the complex was dissociated 
with SDS, and resolved on 10% (w/v) SDS/polyacrylamide preparative gels. 
Polypeptides corresponding to the subunits E2, X,E1 o and El g were 
identified by their electrophoretic mobilities and prepared for immunis­
ation as described in section 2.2.12,b. Studies on the characterisation 
of the antisera are discussed in Chapter 6.
Fig. 3.9 illustrates the use of preparative electrophoresis 
to obtain purified SDS-denatured PDC subunits. Proteins were extracted 
from 10% (w/v) SDS/polyacrylamide gels. After concentration and protein
Fig. 3.9 SDS/polyacrylamide gel electrophoresis of PDC components
purified by extraction from preparative SDS/polyacrylamide
gels
PDC (approx. 3 mg) was resolved into its individual components 
in a 10% (w/v) SDS/polyacrylamide slab gel. After brief staining, 
gel strips were extracted in 50 mM-triethanolamine containing 1% (w/v) 
SDS, 1 mM-DTT adjusted to pH 8.0 with HCl, as described in section
2.2.10.f. Portions containing 2-5yig of the extracted proteins 
were loaded onto a 10% (w/v) SDS/polyacrylamide gel.
Gel (A): lanes 1 and 7, PDC 12yig each; lane 2, M markers; 
lanes 3 and 6,acetyltransferase fraction 3yig and 6yig, respectively; 
lanes 5 and 6, component X, 2yig and 3yig. Gel (B): lane 1,PDC 12yig
protein; lane 2, markers; lanes 3 and 6, El a subunit 3yig and 5yig, 
respectively; lanes 5 and 6, El S subunit 3yig and 2yig respectively.
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determination, samples were re-electrophoresed on a 10% (w/v) 
analytical gel.
Preparative gels could be loaded with a maxiumum of 3 mg of 
PDC protein to ensure complete resolution of component X from E3 
subunit. In purifying proteins by the method of Tolan et al. (1980), 
recoveries were improved by concentrating the extracts by freeze- 
drying before acetone precipitation and by omitting precipitation 
with potassium acetate.
Total yields ranged from 45-65% as estimated by the recovery of
32
P-labelled subunit El a . Between 80-90% of the protein extracted 
was recovered in the final samples.
It was also observed that subunit El a was particularly 
sensitive to degradation (Fig. 3.9, gel B). This problem can be 
overcome by performing the extractions in the presence of protease 
inhibitors such as PMSF.
Chapter 4: IMMUNOLOGICAL STUDIES ON THE MAMMALIAN
PYRUVATE DEHYDROGENASE COMPLEX
4.1 Production of antisera to native PDC and its 
individual subunits
Knowledge about the biogenesis of mitochondria and other
organelles has increased considerably during the last ten years. Part
of this success is related to the development of a variety of immuno­
logical techniques with wide applications in this field.
In most studies on biogenesis of mitochondria, radioactively- 
labelled cellular or mitochondrial extracts are employed as the source 
of newly-synthesised mitochondrial proteins. Antibodies are used to 
detect and isolate the protein under study, which is identified after 
electrophoretic analysis of the dissociated immunocomplexes. The 
specificity of the reaction depends largely on the properties of the 
antiserum. Therefore, a prerequisite to ensure the experimental 
value of this methodology is the availability of specific antibodies 
that recognise only a defined protein in the extracts.
The production of specific antibodies requires the availability
of a highly-purified antigen. Some proteins are weak immunogens and 
the presence of small amounts of a more antigenic contaminant leads 
to decreased specificity of the resulting serum which limits its use­
fulness. The protein(s) is generally considered pure enough to be 
used as an antigen if it has at least 95% purity when examined by SDS/ 
polyacrylamide gel electrophoresis. However, this may not always be 
the case and may be necessary to resort to other fractionation 
procedures e.g. isoelectric focusing or two-dimensional gel electro­
phoresis.
Fig. 4.1 Preparative SDS/polyacrylamide gel electrophoresis of PDC
Partially purified PDC (approx. 90% purity; 2.2 mg) was 
resolved into its constituent polypeptides on a 10% (w/v) SDS/poly­
acrylamide preparative slab gel. After staining with Coomassie Blue, 
the protein bands were excised from the gel and employed for the 
production of subunit-specific antisera as outlined in section 
2.2.12.b.
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The approach adopted in this study for obtaining samples of 
the individual components of the complex, free of cross-contamination 
for the production of subunit-specific antisera, has been to employ 
preparative SDS/polyacrylamide gel electrophoresis. As shown in 
Fig. 4.1, PDC was resolved into its constituent polypeptides which were 
later identified by their characteristic electrophoretic mobilities.
Bands corresponding to the subunits E2, X, El a and El S 
were excised from the gels and the protein-polyacrylamide mixtures 
were used for immunisation of rabbits as described in section 2.2.12.b.
In this way it has been possible tb.obtain monospecific antisera 
to these components without the necessity for isolating the individual 
enzymes (Chapter 3, section 3.3). In dealing with limited amounts of 
valuable proteins, techniques which enhance the immune response should 
be used. The best responses are elicited with the proper use of 
adjuvants. Adjuvants increase the persistence of antigen in the host 
and protect the antigen from degradation by proteolytic enzymes allowing 
more antibody-producing cells to be exposed to the antigen. Commonly 
used adjuvants are inorganic suspensions of alumina cream and aluminium 
sulphate. Particulate materials such as charcoal and polyacrylamide 
gels are very immunogenic and when mixed with the protein elicit an 
enhanced immune response.
The most popular and successful adjuvants are the water/light 
mineral oil emulsions developed by Freund. These reagents are 
emulsified with either solutions or suspensions of the immunogen 
(incomplete Freund's adjuvant). The addition of heat-killed mycobacteria 
(Mycobacterium butyricum. Mycobacterium tuberculosis) in small amounts 
to the suspension (complete Freund’s adjuvant) leads to further 
enhancement of the immune response. This has been attributed to the 
increased local inflammatory response.
For priming immunisation, complete Freund's adjuvant is most 
suitable. If the subcutaneous (intradermal or intramuscular) route 
is chosen, multiple injections in various sites are better than a single 
large injection. Further booster (secondary) immunisations are usually 
given in complete Freund's adjuvant, since further immune responses 
against the mycobacteria can be detrimental to the host and lead to 
enhanced inflammatory responses.
In general, high affinity antibodies are produced after immunis­
ation with low doses of antigen and the best sera are obtained 3-5 
months after immunisation.
For this study, rabbits were chosen as they produce a higher titre 
of antibody than guinea pigs and mice. Also, there were animal house 
facilities for these animals and reasonable amounts of blood (approx.
60 ml) could be collected, by bleeding of a marginal ear vein.
Test bleedings were usually made after the fourth injection 
and treatment repeated after approx. 4 week intervals. In most cases 
antisera exhibited low titre after the first two bleedings and it was 
beneficial to apply additional booster injections.
Purification of the antibodies was not required for most 
purposes and unfractionated serum was used throughout.
4.2 Effects of several antisera on PDC activity
It has been recognised for some time that antibodies can inhibit 
enzyme activity. Some enzymes are completely inhibited, others are 
partially inhibited and some are not (for a review, see Cinader, 1977).
To some extent, the inhibitory characteristics of an antibody depends on 
the spatial relation between the antigenic determinants and the catalytic 
site. Inhibition may result from steric hindrance of substrate or ligand 
sites owing to binding of antibody near the active site. On the other
hand, there are differences between the antisera raised to native or
denatured protein antigens. Dénaturation of proteins often exposes 
new antigenic determinants which may be inaccessible in the native 
structure. Dénaturation of protein antigens has been extensively 
investigated, and decreased imrounogenicity is often observed in 
comparison with the native form. Studies on native and chemically- 
modified human BSA (Jacobsen et al.. 1972) as well as many similar 
studies have led to the conclusion that protein antigens may contain 
two types of antigenic determinants, namely, sequential and confor­
mational. Sequential determinants are those occurring in a linear 
sequence as in the unfolded form of an SDS/denatured protein. 
Conformational determinants are those that are recognised by their 
homologous antibodies when they occur in a particular conformation.
This latter case includes determinants formed from amino acids that 
are located at distant points in the peptide chain, but are in close 
proximity in the native molecule. It seems also likely that proteins 
displaying quaternary structure have unique conformational determinants.
Other factors which may also be important in contributing to 
differences in the immune response to native and denatured antigens are 
the accessibility of determinants and the value and/or state of 
aggregation of the protein. In general, the greater the the 
greater the response that can be expected.
In summary, there are many variables implicated in influencing 
the multifaceted and complex sequence of events of the immune response, 
beginning with the particular species and the physiological state of 
the animal, the presentation of the antigen and the physicochemical 
characteristics of the protein in question (Maurer & Callahan, 1980).
Antisera against the whole complex and the individual subunits 
were characterised regarding their ability to inhibit the overall 
activity of the complex.
Fig. 4.2 shows that antisera to PDC and subunit E3 were capable 
of inhibiting totally or partially the activity of the complex, respect­
ively, whereas antisera to subunits E2, X, El a and El g did not inhibit 
at all. Antieerum to PDC exhibits a very high titre and approx. lyil 
serum was capable of inactivating 0.02-0.04 units of enzymic activity 
(nKat) or approx. 0.2yig protein.
Effects of several antisera on pyruvate dehydrogenase kinase 
activity were also determined (Chapter 6, section 6.5,Fig. 6.5 and 6.6).
Analysis of the effects of antisera on enzymic activity provides 
information which has little relevance for studies on biogenesis. Most 
studies involve exposure of proteins to detergents before immunological 
reaction. These detergents are often strong dénaturants e.g. SDS and 
deoxycholate. Detergent treatment may cause more less pronounced 
conformational changes in the. protein that may affect the binding of 
antibodies. Hence, before using the antisera, relevant information 
on their specificity and titre must be obtained.
Binding of antigen and antibody can be detected by allowing 
the proteins to diffuse through agar or agarose gels (immunodiffusion) 
or electrophoreticaily driving the antigen against the antibody 
(Immunoelectrophoresis). A precipitate will form at the point at 
which they reach an optimal ratio (equivalence point). These are 
the simplest methods to detect precipitating antibodies and can be made 
quantitative. Many modifications of the immunoelectrophoresis technique 
had been developed (Johnston & Thorpe,1982). The limitations of these 
methods are basically imposed by their low sensitivity and poor electro­
phoretic resolution of complex antigenic mixtures on agarose gels as 
compared with polyacrylamide gels. Other difficulties arise in 
connection with performing immunological analysis in the presence of 
detergents e.g. SDS.
Fig. 4.2 Effects of various antisera on the activity of PDC
PDC (16.8yug) was incubated with varying amounts of antiserum 
in 0.1 M-sodium phosphate buffer, pH 7.0, 0.15 M-NaCl. The incubations 
were carried out at room temperature for 90 min. Aliquots of 5-100^1
were assayed for PDC activity. Results are means of two determinations, 
differing by less than ± 5%.
( .0— .) anti-PDC serum; (  >ût ) anti-E3 serum; ( — )
control serum; ( — o---) anti-E2 serum; (— * _ _ ) anti-El a serum;
( A  ) anti-El 6 serum; ( v  ) anti-X serum.
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Recently, a simple but powerful immunological technique has 
been developed by Towbin et al. (1979) which allows the detection of 
antibodies even in sera of low titre. The technique offers several 
advantages as compared with other immunoassay methods, in particular 
it gives information about the capacity of antibodies to bind SDS- 
denatured antigens.
4.3 Characterization of antisera by immunoblotting technique
The immunoblotting (immunoreplica) technique has provided a 
simple but extremely sensitive experimental tool to assess both the 
specificity and titre of an antiserum. The combination of SDS/poly­
acrylamide gel electrophoresis and radioimmunoassay is the basis for 
its sensitivity which enables the detection of very small amounts of 
individual proteins in complex mixtures. The method depends on the 
electrophoretic transfer of proteins and their immobilisation in such 
a way that a faithful replica of the original polyacrylamide gel 
pattern is generated on nitrocellulose sheets.
The only prerequisite is that the protein is not altered during 
the adsorption process and the binding sites remain accessible to the 
antibody. The technique is applicable to the study of other types of 
interactions e.g. hormone-receptor and protein-nucleic acid.
Several recent review articles deal with the parameters affecting 
the efficiency of transference of proteins from SDS/polyacrylamide gels 
to nitrocellulose paper. (Gershoni & Palade, 1983). Basically, 
transfer efficiencies depend on the elution rate of the individual 
proteins from the gel and their ability to adsorb onto nitrocellulose.
For most.proteins the rate of transfer is inversely related to their 
value. Some membrane proteins are transferred very slowly because 
of their hydrophobicity. However, virtually all proteins are transferred
116
if 0.02% (w/v) SDS is added to the transfer buffer. This modification 
does not interfere with adsorption or with immunodetection.
The immunoblotting technique has the advantage over alternative 
immunological methods that the values of all polypeptides reacting 
with the antiserum are clearly indicated. Information on the titre 
can be obtained with fixed amounts of antigen by testing various 
dilutions of the antiserum. Monospecificity of an antiserum is best 
demonstrated by showing that it reacts only with a single component 
when challenged with a cell extract.
4.4. Characterization of anti-PDC serum by immunoblotting analysis
In this study, cell extracts from various cultured cell lines 
were tested with the various antisera to assess the specificity and 
reactivity of the antibodies with the individual components of the 
complex. These cell lines were later used for studies on the 
biosynthesis of PDC (Chapter 8).
Information concerning the specificity and relative reactivities 
of the antiserum raised to the whole complex against the individual 
components was initially,obtained by immunoblotting analysis of samples 
of purified PDC.
As shown in Fig. 4.3, anti-PDC serum exhibits high reactivity 
against all the components of the complex except the lipoamide 
dehydrogenase (E3). When low amounts of PDC were loaded on the gel 
(lanes 1 and 2), no reaction with E3 subunit could be detected whereas 
the bands for the other components were clearly visible. It was 
determined that the minimal amount of complex required to detect the 
E3 component was about 0.75-1.0yug protein, whereas the other components 
were seen when 0.01-0.03yig protein were present. This indicated that 
the levels required to detect E3 were about 20-50 times higher than 
those for detection of the remaining components of the complex.
Fig. 4.3 Reactivity of antiserum to ox heart PDC with the 
constituent polypeptides of the complex
Varying amounts of purified PDC were subjected to electro­
phoresis on 10% (w/v) SDS/polyacrylamide slab gels. Half of the gel 
was used for transferring the resolved proteins onto nitrocellulose 
paper (lanes 1-4); the duplicate half was stained with Coomassie Blue
(lanes 5-8). After incubation with the antiserum, the immune complexes
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were "decorated" with I-labelled protein A before autoradiography 
(see details in section 2.2.12.e.).
Lanes 1-4, 0.3yig,0.75yig, 1.5yig and 3 protein, respectively. 
Lanes 5-8 contained 3.3 times more enzyme (1 yug,2^,5yig, and lOyig) 
than their counterparts in lanes 1-4 to facilitate direct visible 
staining with Coomassie Blue. Lane 9, markers.
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In an analogous way, antiserum raised against the 2-oxoglutarate 
dehydrogenase complex was not capable of reaction with the E3 subunit 
whereas it detected small amounts of the El and E2 components of this 
complex (De Marcucci et al., 1985a).
Lipoamide dehydrogenase is the only component common to the 
three types of 2-oxo-acid dehydrogenase complex. The poor immuno­
logical response elicited by this polypeptide relative to the other 
components of the complex cannot be explained on the basis of this 
component not being exposed on the surface of the assembly, perhaps 
rendering it inaccessible to the immune system. Current ideas on 
the structure of 2-oxo-acid dehydrogenase complexes indicate that 
E3 is located on the surface of the complexes since it can be 
released without disrupting the organisation of the core (Bleile et al.,
1981). Moreover, it is not possible to attribute these results to
a low content of E3 in the preparation of PDC used as antigen. The 
proportion of E3 estimated by densitometric analysis of PDC after 
SDS/polyacrylamide gel electrophoresis was approx. 10%, whereas the 
percentage of component X was approx. 6% (Chapter 6, table 6.1).
However, the titre for component X was at least 20 times higher than
that for the lipoamide dehydrogenase. •
Fig. 4.4 shows that anti-PDC serum was capable of detecting the 
components of the complex present in various cell extracts with high 
specificity and sensitivity. The antigenic proteins were detectable 
in SDS-extracts of cultured rat liver (BRL) or bovine kidney cells 
(NBL-1). The antiserum did not detect the components of the complex 
in the nuclear fraction but exclusively in mitochondria (Fig. 4.4, 
lane 7). In this immune replica analysis there were several interesting 
features. The most obvious was the absence of the E3 subunit. The
Fig, 4.4 Immunodetection of PDC polypeptides in whole cell extracts 
and cellular subfractions
Samples of purified PDC and various cell extracts were electro- 
phoresed on 10% (w/v) SDS/polyacrylamide gels. Half of the slab gel 
was employed for transference of the polypeptides onto nitrocellulose 
paper and subsequent immunoblotting analysis (A); the other half was 
stained with Coomassie Blue (B).
(A and B) Lane 1, PDC, 0.4yug and 10yig protein, respectively; 
lane 2, SDS-extract of BRL cells, 80yig; lane 3 and 4, post-nuclear 
supernatant fraction, 20yug and 40yig; lane 5, BRL nuclei, SOyig; 
lane 6, SDS-extract of NBL-1 cells, 100yig; lane 7, BRL mitochondria, 
40yjg; lane 8, markers.
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sizes of the transacetylase components of bovine and rat tissues were 
quite clearly different. values for the E2 subunit have been
estimated as 70,000-74,000 for the bovine heart and kidney complex but 
only 68,000 for the rat heart enzyme (Matuda et al., 1983). A further 
important finding was that component X was located in the mitochondrial 
fraction. This location argued against the possibility that the protein 
became adventitiously bound to the complex during its isolation.
(see also Chapter 6, section 6.4).
Immunological studies using antiserum to native PDC have been 
employed previously. Matuda et al. (1983) produced antiserum to rat 
heart PDC and component enzymes. The antisera were characterized by 
immunodiffusion and immunoprécipitation techniques. The immunoprécipit­
ation patterns were difficult to analyse because the heavy chain of IgG 
(M^ 50,000) interfered with the detection of E3 and X components in the 
Coomassie Blue-stained gels.
Sheu & Kim (1984) have examined PDC from rat and bovine brain 
using antibodies raised against the bovine kidney enzyme. In a later 
report, Sheu et al. (1985) have characterfeed this antiserum by immuno­
blotting and immunoprécipitation. Immunoblotting patterns reported 
by these authors showed only three bands, identified as the E2, E3 and 
El o subunits. Subunits El g and X, although present in the antigen 
preparation, were not detectable on immunological analysis.
The striking differences between these results and the ones 
described in this study may be attributable to the various factors that 
affect the immune response (see section 4.2).
As shown in Fig. 4.5, anti-PDC serum does not cross-react with 
components El and E2 of the 2-oxoglutarate and branched-chain 2-oxo-acid 
dehydrogenase complexes.
Fig. 4.5 Cross-reactivity of antiserum to ox heart PDC with the bovine 
2-oxoglutarate dehydroaenase and branched-chain 2-oxo-acid 
dehydrogenase complexes
Varying amounts of purified pyruvate dehydrogenase, 2-oxoglutarate
dehydrogenase and branched-chain 2-oxo-acid dehydrogenase complexes were
electrophoresed onto 10% (w/v) polyacrylamide slab gels and employed for
immunological analysis with anti-PDC serum (A). A similar gel was
stained with Coomassie Blue (B).
(A) Lanes 1 and 2, PDC 0.25yig and 0.4yig, respectively; lanes
3, 4 and 5, 2-oxoglutarate complex, 5yig, 10yig and 20yug; lanes 6, 7
and 8, branched-chain 2-oxo-acid dehydrogenase complex, 5yig, 10 ug
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and 20yig, respectively; lane S, I-labelled M markers. In (B) hne 1, 
PDC, 15yig; lane 2, 2-oxoglutarate dehydrogenase complex, 12yig; 
lane 3, branched-chain 2-oxo-acid dehydrogenase complex, 15yjg.
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When relatively high amounts of 2-oxoglutarate dehydrogenase 
complex were present in the immune replica (lane A), bands corresponding 
to the components of PDC were clearly detected as well as the cross­
reacting component E3. At higher levels of protein (lane 5) a weak 
cross-reaction with the 2-oxoglutarate decarboxylase component (El) was 
observed. The lipoyl succinyltransferase component (E2), the structural 
core of the 2-oxoglutarate dehydrogenase complex (E2) was not detectable. 
Also, no cross-reaction was observed with the components of the bovine 
kidney branched-chain 2-oxo-acid dehydrogenase complex under these 
conditions.
It is currently accepted that component E3 is common to the 
branched-chain, pyruvate and 2-oxoglutarate dehydrogenase complexes 
(Guest, 1978). E3 is only loosely-associated with the branched-chain 
2-oxo-acid dehydrogenase complex (Pettit et al.,1978) and is absent in 
most purified preparations of this complex (Fig. A.5 (B), lane 3).
The detection of small contaminating amounts of PDC in the 
2-oxoglutarate dehydrogenase complex preparation reveals the high 
sensitivity of the immunoblotting technique. Cross-contamination 
with pyruvate dehydrogenase complex was estimated as approx. 1.5% , 
very close to the value of 1%.obtained from activity measurements.
Matuda et al.(1983) arrived at similar conclusions regarding 
the specificity of anti-PDC serum raised against the rat heart enzyme.
They observed no immunological cross-reactions between the three 
2-oxo-acid dehydrogenase complexes when examining the effects of anti-PDC 
serum on the enzymic activities of the complexes present in rat 
mitochondrial extracts.
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4.5 Characterisation of subunit-specific antisera
by immunoblotting analysis
Immunological detection of the dihydrolipoyl acetyltransferase 
subunit of PDC by using its subunit-specific antisera is shown in 
Fig. 4.6.
The antiserum showed a high specificity for subunit E2 and 
cross-reacted with the enzyme present in various tissues. It was 
also apparent that the rat enzyme exhibited a lower M value in 
comparison with the enzymes from bovine and porcine tissues. The 
variability in the value for subunit E2 was previously observed 
with the antiserum to PDC (Fig. 4.4).
The antiserum showed a very high titre since only 10 ng of 
the complex were sufficient to detect the E2 component with 1:200 
dilutions of the antiserum, under standard conditions.
No other protein in the cell extracts was recognised by these 
antibodies, which demonstrated the monospecificity of the antiserum 
to subunit E2. A similar analysis was performed by immunoblotting 
with the antiserum to subunit Elo . The protein band detected in all 
the mammalian cells tested had an M value corresponding to the El a 
subunit. (Fig. 4.7). It was also observed that the antiserum appeared 
to react more strongly with the ElK subunit from rat cells than with 
the bovine cell line. Similar results were also obtained after immuno­
précipitation of cell extracts from these cell lines (Chapter 8).
Fig. 4.8 (B) and (C) reveals chat antisera to subunits El 6 and 
E3 possess high titre and specificity. The specificity for subunit El 0 
was greatly increased after pre-adsorption of the antiserum to CNBr- 
activated Sepharose 4B to which subunit E2 had been bound covalently.
The reasons for the presence of contaminating anti-E2 antibodies in
Fig. 4.6 Immunoblotting analysis of dihydrolipoyl acetyltransferase (E2)
in various cell extracts
Purified PDC and various cell extracts were resolved by electro­
phoresis on a 10% (w/v) SDS/polyacrylamide slab gel. The gel was used 
for immunoblotting analysis with antiserum raised against subunit E2 (A).
A parallel gel was stained to Coomassie Blue (B).
Lanes 1 and. 5> PDG 0.1 yug protein in (a ) and 12;ug protein in (B);
( A and B)' lane 2, SDS-extract of BRL cells, 80yig and 60yig; 
lane 3, BRL mitochondria, 40^g; lane 4, rat liver mitochondria, 40^g; 
lane 6, ox heart mitochondria, 15^pg and 50yig; lane 7, SDS-extract of 
NBL-1 cells, 80yig and 50yug; lane 8, SDS-extract of PK-15 cells,
80 ug and 50 ug; lane 9, PK-15 mitochondria, 20 ug; lane 10, PK-15
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cytosol, 60yjg; lane 11, I-labelled markers.
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Fig. 4.7 Immunological detection of pyruvate dehydrogenase (El)
subunit g in various cell extracts
Samples of purified PDC and various cell extracts were electro- 
phoresed on 10% (w/v) SDS/polyacrylamide slab gels. One half was utilized 
for the transfer of polypeptides onto nitrocellulose paper and subsequent 
immunoblotting analysis using antiserum raised against the subunit 
El a (A). The other half was stained with Coomassie Blue (B).
Lanes 1 and 9, PDC 1/ig protein in (a) and 12/ig In (B)^ (a and B), 
lane 2, partially purified subunit E] a , 0.2yig and 3yig; lane 3, ox 
heart mitochondria,40^g; lane 4, rat liver mitochondria, 80yug and 
50yig; lane 5, SDS-extract of NBL-1 cells, 90yig and 70yig; lane 6,
BRL cells, 80yjg each; lane 7, BRL mitochondria, 60yig; lane 8,
yig and 80 yig;
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this antiserum could only be explained by the presence of small amounts 
of an E2 fragment in the SDS-denatured antigen. As discussed by 
Suissa & Reid (1983), the use of gel electrophoresis for purifying 
antigenic proteins has some disadvantages. Although a single band 
is observed after electrophoresis on polyacrylamide gels, a serum 
raised against this preparation may react with a higher M protein.
This can result from the presence of fragments derived from the larger 
polypeptide which co-migrate with the band of protein of interest.
Studies on the structure of bovine heart dihydrolipoyl acetyl­
transferase indicated that the enzyme can be cleaved by trypsin-like 
proteases into fragments of apparent M 36,000 and 26,000. The former 
fragments contains the lipoyl domain and the latter, the subunit-binding 
domain. The lipoyl domain is acidic and contains an unusually high 
proportion of prolyl residues (Kresze & Ronft, 1980; Bleile et al.,
1981). This peptide co-migrates with the El 3 subunit and, as discussed 
in Chapter 7 (section 7.6) seems very immunogenic. Therefore, it is 
probable that small amounts of a fragment of similar value to the El 3
subunit derived from the E2 polypeptide were present in the preparation 
used for immunisation against the El 3 subunit. This contamination 
would explain the presence of unwanted anti-E2 specificity in the antiserum. 
In spite of this difficulty the application of the immunoadsorptlon 
technique helped to remove the contaminating anti-E2 antibodies and 
rendered the antiserum monospecific for subunit El 3 . Experimental 
details are provided in section 2.2.12.h.
Fig. 4.8 (B) shows that only a single band was detected in the 
cell extracts from various cell types by immunoblotting analysis with 
the antiserum to ElB , with a M value identical to subunit El 3 in 
all cells. In Fig. 4.8 (C), it is clear that small differences in 
exist between the E3 subunit from various mammalian cells. However,
Fig. 4.8 Immunological detection of PDC subunits El 6 and E3 
in various cell extracts
Samples of purified PDC and cell extracts from cultured cells 
were subjected to electrophoresis on a 10% (w/v) SDS/polyacrylamide gel. 
Proteins resolved were transferred onto nitrocellulose paper and employed 
for immunoblotting analysis with antisera to the El g subunit (B) or 
to the E3 subunit (C). A similar gel was stained with Coomassie 
Blue (A).
(A,B and C) Lane 1, PDC, 12 yig, 0.25yug and 1 yjg protein,
respectively; lane 2, SDS-extract of NBL-1 cells, 60yug, 40yig and 4^g;
lane 3, NBL-1 mitochondria, 50yug, 40yug and 40yig; lane 4, SDS-extract
of BRL cells, 60yig each; lane 5, BRL mitochondria, 50yig each; lane 6,
SDS-extract of PK-15 cells, 60yug each; lane 7, PK-15 mitochondria,
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SOyig each; lane 8, I-labelled M standards.
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there was no evidence for the existence of multiple forms of this 
enzyme. Sakuraiet al. (1970) suggested that the multiple forms of 
lipoamide dehydrogenase detected by some authors on DEAE-cellulose 
chromatography could be explained as a result of proteolytic modification 
of the enzyme and not as physiological isoenzymes. Alternatively,
it is also possible that the antiserum cross-reacted with only one
form of the enzyme (see also Chapter 1, section 1,3.6).
4.6. Cross-reactivity of antisera to ox heart PDC
with the complex from yeast (S. cerevisiae).
PDC has been purified from the yeasts Saccharomyces cerevisiae 
(Kresze & Ronft, 1981a, 1981b) and S. carlbergensis (Keha et al., 1982).
The baker's yeast complex is similar in size, S2Q^77S, to the 
mammalian enzyme (pig heart 67.5S, Koike & Koike, 1976; bovine heart 
90S, Linn et al., 1972). This indicates an of 7-8x10^ (Kresze & 
Ronft, 1981b). The complex possess®icosahedral symmetry suggesting a 
core structure of 60 subunits as in the mammalian complex. The yeast 
complex has been purified to homogeneity and the polypeptide pattern 
examined after SDS/polyacrylamide gel electrophoresis. values
have been assigned as: 58,000 (E2), 53,000 (E3), 45,000 (El a ) and 
35,000 (El 6 ). A minor band, 50,000, was also found. This 
polypeptide behaved in a analogous manner to the minor component (X) 
detected in purified PDC from mammalian tissues (Kresze & Ronft, 1981b).
The yeast complex differs from the complexes from gram-negative 
bacteria such as Escherichia coli, which contain one large El chain 
instead of two subunits and resembles gram-positive bacteria such as 
Bacillus stearothermophilus and B. subtilis (Henderson & Perham, 1980). 
However, there is no evidence for regulation by covalent modification 
(phosphorylation) of the El a subunit as occurs in the mammalian and 
N. crassa enzymes (Kresze & Ronft, 1981a).
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Fig. 4.9 illustrates the peptide pattern of the isolated yeast 
PDC components, obtained as a gift from Dr. H. Bisswanger (Universitat 
Tubingen, W. Germany). E2 showed a main band at 58,000 as well as 
many fragments of smaller size, presumably resulting from proteolysis 
of the protein during isolation or transit to the U.K., since most of 
them cross-react with the anti-PDC serum (lanes 2 and 3). Subunit E3 
was similar in size to the mammalian enzyme (lane 10), although it also 
reacted poorly with this antiserum (lanes 4 and 5). Component El 
showed extensive degradation of the El a subunit, since an approx. 1:1 
ratio between the a and 6 chains should be expected in the Coomassie 
Blue pattern. A strong cross-reaction was found with the El 0 subunit. 
No cross-reaction with the El a subunit was detected, even when 
relatively large amounts of protein were present in the immune replica 
(lane 7).
The low cross reactivity between the El a subunit from yeast and 
mammalian complex was confirmed by loading up to 10yug of El protein on 
the gels and carrying out the immunoblotting analysis with anti-El a 
serum (results not shown).
Fig. 4.10 (A) lane E indicates that only subunits E2 and El 
were detected in whole yeast cell extracts. Since the titre against 
subunit E3 in the anti-PDC serum was very low (this Chapter, section 
4.2), the cross-reactivity of the E3 polypeptide was also evaluated 
by immunoblotting analysis using the subunit-specific antiserum.
The immunoblots indicated strong cross-reaction with the purified 
lipoamide dehydrogenase from yeast and with the enzyme present in yeast 
mitochondria (results not shown).
Fig. 4.9 Immunological cross-reaction of antiserum to ox heart PDC 
with the isolated components of the yeast complex
Samples of purified ox PDC and components of the S. cerevisiae
complex were electrophoresed onto 10% (w/v) SDS/polyacrylamide slab gels.
One half was employed for immunological detection with anti-PDC serum ^ ).
Bound antibodes were detected by autoradiography after incubation with 
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I-labelled protein A as described in section 2.2.12.e.. The 
parallel gel was stained with Coomassie Blue (B).
Lanes 1 and 8, ox heart PDC 0.2yug and 12yig, respectively, 
lanes 2, 3 and 9, yeast dihydrolipoyl acetyltransferase component (E2),
1 yug, 2yjg and 3yug, respectively; lanes 4, 5 and 10,yeast lipoamide 
dehydrogenase (E3), 1 yug, 2yug and 2.5yug, respectively; lanes 6, 7 
and 11, yeast pyruvate dehydrogenase component (El), 2yug, 4yug and 5yug, 
respectively; lane S,Mj. standards; lane E, yeast total cell extract, 
100 yug.
E2, E3, El o and El g , refer to the component polypeptides 
of the yeast PDC.
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In summary, by immunoblotting analysis with various antisera 
it has been shown that there is strong immunological cross-reactivity 
between the yeast and the mammalian PDC, particularly for the subunits 
E2, E3 and El 6 . These findings suggest that the complexes from 
lower and higher eukaryotes share many structural features and present 
similar antigenic determinants which have been highly-conserved during 
evolution.
The lack of reactivity of the antisera to PDC and El a against 
the El o subunit of the yeast enzyme is an interesting observation.
The yeast polypeptide is only slightly larger than its mammalian 
counterpart, however, is not subjected to regulation by phosphorylation/ 
dephosphorylation. It is possible to speculate that this protein has 
evolved considerably from the lower to higher eukaryotes to become 
part of a system responsible for regulation of the complex which 
involves interactions with additional enzymes.
4.7 Cross-reactivity of anti-PDC serum with E. coli complex
Bacterial PDC are also composed of three constituent enzymes, 
but there are considerable differences in the molecular organisation 
of the complexes from various sources. In gram-negative bacteria as 
in E. coli and Azotobacter vinelandil (Reed, 1974; Bosma et al., 1984), 
the complex consists of three polypeptide chains; the largest, M
89.000-110.000 contains the pyruvate dehydrogenase activity, whereas 
the other two contain the acetyltransferase activity (subunit M
65.000-66,000)' and the lipoamide dehydrogenase activity (subunit M 
56,000) respectively. In contrast, complexes from mammals, birds, 
yeast and gram-positive bacteria possess El components composed of two 
subunits ( a and g ).
Fig. 4.10 Reactivity of antiserum to ox heart PDC with the E. coli complex
Samples of purified PDC from ox heart and E. coli were electro­
phoresed on 10% (w/v) SDS/polyacrylamide slab gels. Half of the gel 
was employed for immunoblotting analysis with anti-PDC serum (A), the 
other half was stained with Coomassie Blue (B). Lanes 1 and 6, E. coli 
PDC, 1 yüg protein each; lanes 2 and 7, E. coli PDC, 5yug; lanes 3 and 
8, E. coli PDC, 10yug; lanes 4 and 5, ox heart PDC, 0.2yig and 12y^g 
protein respectively. S, markers.
El refers to the component enzyme of the E. coli PDC.
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It seemed interesting to explore whether there was immunological 
cross-reaction between the mammalian complex and the enzymes from a 
gram-negative bacterium. Samples of E. coli PDC were obtained as a 
gift from Dr. J. Coggins in this Department.
Fig. 4.10 (B) shows the polypeptide pattern of the sample when 
examined by SDS/polyacrylamide gel electrophoresis. The complex 
was degraded and a number of fragments were observed in the M
56,000-95,000 region, which made it impossible to identify conclusively 
the components E2 and E3. However, immunoblotting analysis with anti- 
PDC serum showed strong cross-reaction of the El component. As little 
as 1 yjg of the E. coli PDC protein could be detected with a 1:100 
dilution of the antiserum.
Samples of the yeast components and E. coli PDC were immunoblotted 
against the antiserum to subunit El S . Fig. 4.11 shows that subunit 
El B can be detected in rat liver, ox heart and yeast mitochondria as 
a band of identical M^. In the E. coli enzyme, the antiserum cross- 
reacts with a bands of 95,000 and another at M 50,000, probably 
corresponding to a fragment of El. This result seems to indicate that 
most of the strong cross-reaction observed on the E. coli PDC with the 
anti-PDC serum (Fig. 4.10) is indeed due to the El 6 component. 
Conclusive data must await the availability of a highly-purified and 
undegraded E. coli PDC.
Fig. 4.11 Cross-reactivity of yeast and E. coli El components vith 
antiserum to ox heart subunit El g
Purified samples of E. coli PDC, ox heart PDC and subunit El g 
and yeast El component were electrophoresed on 10% (w/v) SDS/poly­
acrylamide slab gels. Half of the gel was employed for transferring 
resolved proteins onto nitrocellulose paper and subsequent immuno­
blotting analysis with antiserum to El 6 subunit (A). The parallel 
gel was stained with Coomassie Blue (B).
(A and B) Lane 1, PDC, 0.25yUg and 10yug protein, respectively; 
lane 2, ox heart El component, 0.1 yjg and 6yjg; lane 3, ox heart El g 
subunit, 0.01 yjg and 3yug; lane 4, ox heart mitochondria, 10yig and 
40yjg; lane 5, rat liver mitochondria, 25yig and 40yug; lane 6, 
yeast El component, 2.5yjg and 6yig; lane 7, yeast mitochondria,
1 5 and 35yug; lane 8, E. coli PDC, 5yig and 15yig; lane 9,
I-labelled M markers, 
r
Track .8 was exposed for a shorter length of time as compared 
with the other lanes.
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Chapter 5; STUDIES ON THE SUBMITOCHONDRIAL LOCALISATION OF PYRUVATE 
DEHYDROGENASE COMPLEX BY USING IMMUNOLOGICAL TECHNIQUES
5.1 Introduction
In addition to the well-known multienzyme aggregates that 
catalyse the oxidation of 2-oxo-acids and fatty acids, many studies 
indicate that other weak reversible associations exist between 
metabolically-related enzymes. These transient complexes include 
the ’soluble' enzymes of the glycolytic pathway and the citric acid 
cycle enzymes as well as enzymes from other metabolic routes. The 
existence of these associations were initially based on predictions 
that closer spatial relationship between the enzymes of a metabolic 
sequence allowed metabolic "chanelling", resulting in higher 
efficiencies in the oxidation of substrates.
In recent years, many metabolically significant interactions 
have been demonstrated between enzymes and between proteins and 
specific membranes(reviewed by Srere, 1984).
The high protein concentration of the mitochondrial matrix 
(over 50%) can markedly affect these weak protein interactions, which 
may have important consequences for the regulation of energy metabolism 
and in the biogenesis of mitochondria. Srere (1982) has presented 
a scheme for the hypothetical distribution of proteins in the inner 
membrane-raatrix compartment of rat heart mitochondria, in which most 
matrix proteins would be adjacent (or perhaps also bound) to the inner 
membrane. Experimental evidence supporting this model can be summarised 
as follows:
1) Studies with immobilised enzymes, where several (2-3) metabolically- 
related enzymes acting consecutively are trapped within the pores of
Sepharose or polyacrylamide matrices (Srere et al., 1973) or cross- 
linked with glutaraldehyde (Koch-Schmidt et al.. 1977),indicated that 
such systems exhibited catalytic efficiencies several fold higher than 
that measured with the same amounts of enzymes acting free in solution.
These results have been interpreted in terms of the closer 
proximity of the enzymes participating in the reaction and/or to the 
increase of concentration of intermediate around the enzymes resulting 
from restricted diffusion out of the gel phase (microenvironmental 
compartmentation).
2) Histochemical and electron microscopic studies of several matrix 
enzymes e.g. citrate synthase (Srere, 1980) and PDC (Nestorescu et al., 
1973) indicated that these enzymes are preferentially associated with 
the inner face of the inner mitochondrial membrane.
3) The existence of physical interactions between consecutive enzymes 
of the citric acid cycle and malate-aspartate shuttle have been reported 
(Srere et al., 1973; Beeckmans & Kanarek, 1981).
4) Recent reports from the laboratory of Srere have shown that enzymes , 
of the g -oxidation pathway, fumarase (mitochondrial), malate dehydro­
genase (mitochondrial) and citrate synthase can bind to inverted inner 
membrane vesicles in a specific manner. The 'receptor' or binding sites 
seem to be located on the matrix side of the inner mitochondrial membranes. 
(D' Souza & Srere, 1983; Sumegi & Srere, 1984a).
5.2 Aims of study
The mitochondrial localisation of mammalian PDC has been long 
established, since the complex can be purified from disrupted mitochondria. 
(Linn et al., 1972; Cooper et al., 1974), but the difficulty of solubilis­
ing the heart complex suggested that it may be bound to the inner membrane 
(Addink et al., 1972; Pettit & Reed, 1982). Complete solubilisation of
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the complex and higher yields were achieved by the inclusion of Triton 
X-100 in the extraction buffer. This result is consistent with the 
idea that most PDC activity is bound to the inner mitochondrial 
membranes (Stanley & Perham, 1980).
Nestorescu et al. (1973) have presented evidence by histochemical 
methods that PDC activity is associated with the inner membrane of rat 
heart mitochondria.
By using a variety of procedures for extraction of PDC from pig 
heart mitochondria, Kenney et al.(1972) concluded that the heart complex 
appeared to be either in close proximity to the inner membrane or became 
strongly associated with it on breaking the mitochondria. At present, 
conclusive evidence on the localisation of PDC within the mitochondrial 
compartment and its mode of interaction with the inner membrane has not 
yet been established unequivocally.
It was the aim of these studies to gain additional information 
on this topic by using immunoblotting as an analytical tool, which permits 
the detection of small amounts of several mitochondrial proteins present • 
in the various submitochondrial compartments by means of monospecific 
antisera. The distribution of PDC was compared with that of two 'typical' 
matrix enzymes: fumarase (mitochondrial) and citrate synthase.
A reasonable hypothesis was that PDC could be associated specific­
ally with the inner mitochondrial membrane to allow "channelling" of NADH 
directly into the electron transport chain. There was also the question 
of whether the 50,000 polypeptide (component X) was an integral protein 
involved in specific binding of PDC to the inner membrane which was 
released with the complex during its purification.
5.3 Studies on the submitochondrial localization of PDC in rat liver
Preliminary studies showed that PDC components could be detected 
in both matrix and inner membrane fractions isolated from rat liver 
mitochondria. These studies were extended in order to verify that this 
result was not caused by cross-contamination between the fractions.
Rat liver mitochondria were purified and fractionated into 
matrix or soluble, inner membrane, intermembrane space and outer membrane 
fractions, and a fraction containing mixed membranes by following the 
procedures described in sections 2.2.7.a and 2.2.7.b.
The distribution of marker enzymes in the subfractions obtained 
is presented in Fig. 5.1. Recoveries of enzymic activity ranged from 
80-101% for each marker. Most of the adenylate kinase activity was 
recovered in the intermembrane space fraction, which was also contaminated 
with matrix as shown by the distribution of fumarase activity.
The pattern of distribution of marker enzymes is very similar 
to that reported previously by Sottocasa et al. (1967) using the same 
procedure. The small cross-contamination observed between membrane 
fractions may be explained at least partially, by the existence of 
"membrane junctions" which have been detected as contact points between 
the outer and inner mitochondrial membranes in many types of mitochondria. 
Contamination of inner membranes with matrix may be attributed to entrap­
ment of matrix material into membrane vesicles formed during fractionation 
or possibly to the existence of matrix polypeptides interacting strongly 
with the inner face of the inner membrane. Attempts to reduce the 
contamination of matrix in the intermembrane space fraction by increasing 
the tonicity of the medium used for swelling the mitochondria helped to 
reduce the matrix contamination but also led to lower recoveries of 
adenylate kinase activity.
Fig. 5,1 Distribution of some marker enzymic activities in rat
liver submitochondrial fractions
Rat liver mitochondria were fractionated by differential 
centrifugation into an outer membrane fraction (OM), and intermembrane 
space fraction (IS) and a pellet containing mitoplasts and unbroken 
mitochondria. This pellet was sonicated and separated by sucrose- 
denisty gradient centrifugation into a scM>le fraction (S), a membrane 
fraction (M) containing mixed outer and inner membrane vesicles and an 
inner membrane fraction (IM) (see .section 2,2.7). Enzymic 
activities were assayed as indicated in section 2.2,8. The 
ordinates represent relative specific activities of monoamine oxidase, 
adenylate kinase, fumarase and cytochrome c reductase on a protein 
basis. The specific activities of the purified mitochondria 
(sonicated prior to assay) were taken as 1. The abscissas indicate 
the percentages of total mitochondrial protein recovered in each fraction.
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Although some contamination between the mitochondrial compart­
ments was unavoidable, the distribution of marker enzymes showed that 
these fractions were appropriate for studies on the submitochondrial 
location of PDC in rat liver.
The polypeptide composition of the purified fractions is shown 
in Fig. 5.2 (B). The distribution of ’typical’ matrix markers was 
checked after electrophoresis and imraunoblotting analysis of the 
fractions. Fig. 5.2 shows the results obtained after immunoblotting 
with anti-fumarase serum (lA) and anti-citrate synthase serum (2A).
Bands corresponding to the for the subunits of these proteins 
were detectable in the mitochondrial matrix and more weakly in the 
intermembrane space fraction (lanes 3 and 5) as well as in the whole 
mitochondrial fraction (lane 2). Similar bands were not detected in 
the inner or outer membrane fractions (lanes 4 and 6).
Immunoblots with the anti-fumarase serum also showed a band at 
lower values. This protein was also present in the commercially-
purified pig heart fumarase preparation utilised as antigen. The protein 
can be detected in Coomassie Blue-stained gels when ^  5yug protein 
are loaded.
Anti-citrate synthase serum also showed the presence of a cross­
reacting protein at higher values (approx. 55,000). In this case, 
no bands of similar electrophoretic mobility could be detected in the 
purified sample utilised for immunisation when 10yug protein were loaded 
on a gel. It also seems unlikely that this reaction is due to lack of 
specificity of the antiserum because the extra band was not detected by 
immunoblotting analysis in bovine kidney cell extracts (Fig. 5.6,lanes 
8, 9 and 10). However, it was found in extracts from cultured rat 
liver cells (not shown). The enzyme from rat liver is a dimer of 
two identical subunits 48,000 (Moriyama & Srere, 1971) and no
Fig. 5.2 Immunological detection of fuitarase and citrate synthase
in rat liver submitochondrial fractions
Fumarase and citrate synthase were electrophoresed with rat liver 
mitochondria subfractions on 10% (w/v) SDS/polyacrylamide slab gels. 
Proteins were transferred onto nitrocellulose paper for the immuno­
logical detection with anti-fumarase (lA) or anti-citrate synthase (2A) 
sera. Coomassie Blue pattern of the gels are also shown (IB and 2B, 
respectively).
(lA and IB) Lane 1, fumarase, 0.2yug and 4yug protein, respectively; 
(2A and 28) lane 1, citrate synthase, 0.2yug and 3yug; (lA, IB, 2A and
2B) lanes 2, 3, 4, 5 and 6 contain 50^ of each, rat liver mitochondria,
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and fractions S. IM, IS and CM, respectively; S, I-labelled M markers.
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isoenzymes had been described in this tissue. At present, there is no 
satisfactory explanation for these results.
When similar amounts of protein from the various fractions 
obtained were loaded on a gel and analysed by immunoblotting with anti-PDC 
serum, (Fig. 5.3, A), components E2, X, El a and El g were detected in 
both matrix and inner membrane fractions (lanes 3 and A). Small amounts 
of the subunits El o and ElB were also seen in the intermembrane space 
fraction. This can be attributed to matrix contamination in the inter­
membrane space fraction as discussed previously.
No reaction was detected with the outer membrane fraction (lane 6). 
A closer inspection of the immunoblot shown in Fig. 5.3 (A) revealed 
differences in the relative intensities of the individual subunits of 
matrix and membrane-bound PDC. A higher proportion of components E2 
and X as compared to El a and El S were observed in the membrane-bound 
PDC. This result may reflect a higher content of components E2 and X 
in the membrane bound PDC or to a preferential degradation of these 
subunits in the soluble form. It was mentioned previously (Chapter 3, 
section 3.1) that rat liver mitochondria contain a lysosomal protease or 
"inactivase" that selectively cleaves the transacetylase core of the 
complex.
Another possibility was that sonication promoted the preferential 
release of subunits EL and E3 from the core enzyme.
The amounts of PDC that can be detected in the soluble and inner 
membrane fractions seemed to be similar in terras of yig PDC^g protein 
in each fraction. However, the amount of protein present in the soluble 
fraction is about 3 times higher than the amount that corresponds to the 
inner membrane (Sottocasa et al.. 1967). Hence, in rat liver, the 
distribution of PDC seems to predominantly in the soluble fraction and 
only 30% of the enzyme may be bound to the inner membrane under these
Fig. 5.3 Immunological detection of PDC polypeptides in rat liver
submitochondrial fractions
Samples of purified PDC and submitochondrial fractions from rat 
liver were electrophoresed in duplicate on 10% (w/v) polyacrylamide 
gels. Part of the gel was utilized for the detection of antigen proteins 
with anti-PDC serum (A). The other half was stained with Coomassie 
Blue (B).
(A and B) Lane 1, PDC 0.5yjg and 14yug protein, respectively;
lane 2, rat liver mitochondria, 50ypg each; lanes 3, 4, 5 and 6 contain
50 ug protein from fractions S, IM, IS and ON, respectively; lane 8,
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conditions. A similar study was carried out in ox heart mitochondria.
5.4. Studies on the submitochondrial location of PDC in ox heart
For these experiments ox heart mitochondria were purified as 
described by Smith (1967). After sonication, mitochondria were fraction­
ated into membrane and soluble fractions. The membrane pellets were 
extensively washed as described in section 2.2.7.C. and the washings 
reserved for analysis.
As shown in Fig. 5.4, samples from the membrane, soluble and washing 
steps fractions were analysed by SDS/polyacrylamide gel electrophoresis.
The polypeptide patterns obtained (Fig. 5.4.A) from soluble and membrane 
fractions were different. The first washing showed essentially the same 
polypeptide pattern as the soluble fraction, but the second washing 
contained very few components and showed a main band at M 55,000.
(Fig. 5.4 B, lane 6).
Samples containing equal amounts of protein from each fraction 
(except from the last washing step) were analysed by immunoblotting 
with anti-PDC serum (Fi& 5.4 %  All five components of PDC were detected 
in both soluble and membrane fractions. The band of 55,000 present 
in the last washing seems to correspond to subunit E3. This could be 
attributed to partial release of this component during the washing procedure.
Although the immunoblots were not rigorously quantitated, the 
relative amounts of the individual components of the complex were similar 
in soluble and membrane-bound PDC (lanes 3 and 4), with the exception 
of subunit E3 which was less abundant in the membrane fraction. It has 
been estimated on the basis of protein recovered in each fraction that 
the amount of PDC that remained associated to the membrane of ox heart 
mitochondria was about 65-70% (w/w) of the total. These results suggest 
that a large proportion of PDC is bound to the inner mitochondrial membrane
Fig. 5.4 Immunological detection of PDC polypeptides in ox heart
submitochondrial fractions
Ox heart mitochondria were sonicated and fractionated into
a membrane and a soluble fraction as indicated in section 2.2.7.C.
The membrane fraction was washed 2X with 20 mM-potassium phosphate
buffer, pH 6.5, 0.05 M-NaCl and 1% (v/v) rabbit serum. Samples were
boiled in Laemmli buffer and loaded on a 10% (w/v) SDS/polyacrylamide
slab gel. After transferring onto nitrocellulose paper, the samples
were analysed by immunoblotting with anti-PDC (B) or anti-X (C) sera.
Protein profiles are shown in (A).
(A, B and C) Lane 1, PDC 8yug, 0.4yug and 0.5yug protein,
respectively; lane 2, ox heart mitochondria, 50yug, lOyig and 15yig;
lane 3, membrane fraction, 35yig, 10yig and 10yug; lanes 4 and 5,
soluble and first washing fractions, 35 ug, 10 ug and 10 ug; lane 6,
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second washing fraction, 10yug protein each; S, I-labelled mixture 
of standard proteins.
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and the association is resistant to the extensive washing treatment.
Subunit E3 dissociated from the complex and was recovered in the 
washing solution.
Fig. 5.4. C shows that there is no preferential distribution of 
component X in the membrane fraction as compared with the soluble fraction 
(lanes 3 and 4). This result does not exclude the possibility that 
X may be involved in interactions with the inner membrane.
Immunoblotting analysis of the submitochondrial fractions obtained 
from ox heart were also performed with anti-fumarase serum (Fig.5.5) 
and anti-citrate synthase serum (Fig. 5.6).
Fumarase was detected in the matrix or soluble fraction and in 
the first washing, but was not seen in the membrane fraction (lane 3).
Small amounts of a cross-reacting antigen of lower were detected in 
the soluble fraction.
The distribution of citrate synthase is similar to fumarase, but 
traces of the enzyme were detected in the membrane fraction (Fig. 5.6 
lane 4). Also, in this immune replica, cellular fractions from bovine 
kidney cells (NBL-1) were analysed to demonstrate the specificity of 
the antiserum to citrate synthase. Immunoprécipitation studies (not 
shown) confirmed that this antiserum is capable of specifically immuno- 
precipitating citrate synthase from NBL-1 cells whereas immunoprecipitates 
from rat liver cell extracts showed two protein bands of similar M 
to those shown in Fig. 5.2 (2A).
PDC activity was detectable in the initial sonicated mitochondria 
and in the soluble and first washing fractions. However, activity was 
not detectable in the final membrane fraction. This result can be 
explained by loss of component E3 from the membrane-bound complex during 
the washing steps (Fig. 5.4). Enzymic activity was not restored by 
adding 5 units of pig heart lipoamide dehydrogenase or by adding antimycin A
Fig. 5.5 Immunoblotting analysis of ox heart submitochondrial fractions 
with anti-fumarase serum
Ox heart submitochondrial fractions obtained as described in 
section 2.2.7.C. and purified fumarase were electrophoresed in 
duplicate on 10% (w/v) SDS/polyacrylamide slab gels. Polypeptides 
were transferred onto nitrocellulose and subsequently analysed with 
anti-fumarase serum (A) by immunoblotting technique. A replica of 
the gel was stained with Coomassie Blue (B).
(A and B), Lane 1, fumarase 1.5yig each; lane 2, ox heart 
mitochondria 15yig and 35yug; lane 3, membrane fraction lOyig and 
35yig; lane 4 and 5, fractions soluble and first washing 10yug and 
35yig each, respectively.
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Fig. 5.6 Immunological detection of citrate synthase in ox heart 
submitochondrial fractions and subcellular extracts from 
NBL-1 cells
NBL-1 cell extracts and ox heart submitochondrial fractions were
analysed by immunoblotting technique with anti-citrate synthase serum
essentially as described in legend to Fig. 5.5. (A) Immunoblot.
(B) Coomassie Blue pattern.
(A and B) Lane 1, citrate synthase, 0.2yug and 3yug protein,
respectively; lane 2, ox heart mitochondria, 15yug and 35yjg; lane 3,
soluble fraction 10yig and 35yjg; lane 4, membrane fraction, lOyig and 
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35yig; lane 5, I-labelled standards; lane 6, PDC, 5yjg and 15yig; 
lane 7, citrate synthase, 0.2yig and 3yig; lanes 8, 9 and 10,NBL-l-cells, 
NBL-1 mitochondria and NBL-1 cytosol 40yig and 60yug protein each, 
respectively.
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to inhibit NADH oxidase activity which could interfere with the assay. 
However, it is possible that correct assembly of the externally-added 
E3 component did not take place under the conditions tested owing to 
steric hindrance or because of a slow reassocdaion process. These 
preliminary findings deserve further investigation.
5.5. Discussion
Evidence presented in this Chapter suggests that PDC is largely 
bound to the ox heart inner mitochondrial membranes. It seems also 
probable that a fraction of the enzyme has a similar distribution in 
rat liver mitochondria.
This interaction between PDC and the inner mitochondrial membrane 
is significatively higher than that of two other mitochondrial proteins, 
fumarase and citrate synthase, which bind weakly or not at all to the 
inner membranes in both rat liver and ox heart mitochondria.
The ox heart system seems to be more suitable for these types of 
study than the rat liver, partly owing to the fact that ox heart 
mitochondria have a heavily invaginated inner membrane comprising about 
50% (w/w) of the total mitochondrial protein, whereas in the rat liver 
is only about 20%. In addition, obvious limitations are imposed by the 
procedures available for fractionating rat liver mitochondria to obtain 
preparations with low levels of cross-contamination between adjacent 
compartments.
Moreover, the rat liver system has the additional disadvantage 
of containing lower amounts of the complex than ox heart and that 
selective proteolytic degradation of PDC may occur to an unknown extent 
during fractionation of the rat liver mitochondria stemming from the 
presence on this tissue of an "inactivase" of lysosomal origin 
(Wieland, 1975).
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No evidence for degradation of PDC was found in the ox heart 
fractions.
Results from ox heart mitochondria agree with those obtained 
after sonication of pig heart mitochondria or treatment with phospho- 
lipase followed by subsequent exposure to high ionic strength (Kenney 
et al., 1972) which resulted in only 20-30% solubilization of PDC 
activity; 70% of the complex was recovered in the inner membrane 
fraction. It remains to be established whether the observed 
distribution of PDC between soluble and membrane-bound fractions is 
artifactual or reflects functional/structural differences between two 
dissimilar populations of macromolecules.
The apparent distribution of component X between the soluble and 
membrane-bound fractions of ox heart mitochondria is similar to that of 
the other constituents of the complex (Fig. 5.4). This result suggests 
that component X is an integral component of PDC rather than a mitochon­
drial protein involved in binding of the complex to the inner membranes.
Lipoamide dehydrogenase seemed to be released from the membrane- 
bound enzyme during the washing steps (Fig. 5.4). Massey (1966) has 
suggested that E3 is quite easily dissociated from the complexes.
Even when the enzyme is carefully prepared, free uncomplexed flavo- 
protein is found in the cytosol (Matuda & Saheki, 1982). This could 
result from the protein being functionally interchangeable with respect 
to the various 2-oxo-acid dehydrogenase complexes (Sakurai et al.. 1970).
Sümegi & Srere (1984b) had recently presented evidence on binding 
of PDC to pig heart inner mitochondrial membranes. .They have also 
shown that PDC and two other dehydrogenases: 2-oxoglutarate dehydrogenase
complex and malate dehydrogenase were able to bind NADH-ubiquinone 
oxidoreductase (Complex I) under certain in vitro conditions.
These results are very interesting since the binding of these 
dehydrogenases to Complex I, the integral membrane NADH-ubiquinone 
oxidoreductase complex could result in a functionally-linked organisation 
where the NADH-producing enzymes (dehydrogenases) would be associated 
with the NADH-oxidising system in a highly efficient manner. However, 
at present, functional evidence for the existence of a coupled system 
between these complexes has still to be produced.
Many of the quantitative parameters of the interaction of PDC 
with inner membrane have yet to be determined, as well as the nature of 
the interaction and the components of the complex involved. Moreover, 
it will be most important to establish if the inner membrane protein(s) 
involved in binding are components of Complex I which contains about 26 
polypeptides, most of unknown function (Heron et al.. 1979).
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Chapter 6; STUDIES ON COMPONENT X: AN IMMUNOLOGICALLY DISTINCT
POLYPEPTIDE ASSOCIATED WITH MAMMALIAN PYRUVATE 
DEHYDROGENASE COMPLEX
6.1 Introduction
Ox heart PDC is a large macromolecular assembly, M^ 8.5 x 10^ 
containing multiple copies of its three constituent enzymes: pyruvate
dehydrogenase (El), dihydrolipoyl acetyltransferase (E2) and lipoamide 
dehydrogenase (E3).
When the polypeptide composition of the bovine enzyme is examined 
after SDS/polyacrylamide gel electrophoresis, four main components are 
detectable at M values of 42,000 ( a chain of El), 36,000 ( 6 chain of 
El), 70,000-74,000 (E2) and 55,000 (E3), Linn et al. (1972).
On occasions, an additional polypeptide, M^ 51,000±1,000 has been 
detected in highly-purified PDC or dihydrolipoyl acetyltransferase 
preparations isolated from bovine tissues using different procedures 
(Kresze & Steber, 1979; Machicao & Wieland,1980; Stanley & Perham,
1980; Bleile et al., 1981; Pettit & Reed, 1982) and porcine heart 
(Roche & Cate, 1977).
This polypeptide, termed in this study, component X, has been 
regarded as a proteolytic fragment of E2 (or E3) or possibly the intrinsic 
pyruvate dehydrogenase kinase of the complex. In the majority of earlier 
studies (Barrera et al., 1972) this component remained undetected since 
it does not readily separate from the E3 component on SDS^hosphate gels 
(Stanley & Perham, 1980).
Fig. 6.1 compares the resolution of the constituent polypeptides 
of ox heart PDC in two differing SDS/polyacrylamide gel systems. It is 
clearly shown that separation of component X from the E3 subunit was 
only achieved in the Tris-glycine buffered system of Laemmli (1970)
Fig. 6.1 The subunit composition of ox heart PDC as revealed on 
differing SDS/polyacrylamide gel systems
Purified PDC (15yig) was electrophoresed on 10% (w/v) SDS/poly­
acrylamide cylindrical gels (12 cmx 0.5 cm) prepared in phosphate 
buffer (A) or Tris-glycine buffer (B). Electrophoresis was carried 
out at 7.5 mA/gel until the tracking dye had migrated to 0.5 cm from 
the bottom. The gels were stained with Coomassie Blue. Densitometric 
traces of the protein bands resolved on each gel system are also shown.
For experimental details refer to section 2.2.6.b.
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(Fig. 6.IB) and not in the phosphate-buffered system (Weber & Osborn,
1969) (Fig.e.lA).
Co-migration of components E3 and X in the latter gel system was 
confirmed after quantitation of densitometric scans of the Coomassie 
Blue-stained gels. Table 6.1 shows that this composite peak contributed 
15.2% of the total absorbance, while on Laemmli gels, these proteins 
represented about 9% and 6% of the absorbance, respectively. The 
relative proportions of the other components remained constant in 
both gel systems.
The proportion of E2 as estimated by this method was lower than 
expected from the overall composition of the complex since this poly­
peptide chain has a low colour yield with Coomassie Blue (stain bound 
peryUg protein) (Sugden & Randle, 1978).
In this Chapter, results will be presented which demonstrate the 
investigations carried out on the possible identity of component X.
6.2 Absence of immunological cross-reaction between component X
and the other polypeptides of the complex
Subunit-specific antisera directed against components E2 and X 
were raised in rabbits as described in section 2.2.12.b. In Fig. 6.2, 
the precise reactivities of these antisera against their specific antigens 
were analysed by immunoblotting with varying amounts of PDC resolved by 
SDS/polyacrylamide gel electrophoresis.
In each case, only the parent antigen was detected by its specific 
antiserum and no cross-reaction between these polypeptides was observed. 
This indicated that protein X was not immunologically related to E2 or 
to the other subunits of the complex. Similar results were obtained by 
immunoblotting analysis with antiserum to E3 (not shown).
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Fig. 6.2 Intmune-replica analysis of PDC with subunit-specific 
antisera against the dihydrolipoyl acetyltransferase 
and component X
Varying amounts of PDC were subjected to SDS-polyacrylamide
electrophoresis in a 10% (w/v) slab gel. ' Part of the gel was stained
with Coomassie Blue (A). Another set was transferred onto nitrocellulose
paper for incubation and subsequent immunological detection with anti-E2
(B) or anti-X (C).
Lanes 1-4 contain 2yig, 5yig, 7.5yig and ISyig of protein in (A);
0.05yig, 0.1 yig, 0.25yug, and 0.5yig in (B) and 0.25yig, 0.5yig, 0.75yug
and 1 yig in (C), respectively. In each case, the right hand track
125
contains a standard mixture of I-labelled M markers.
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6.3 Immunological detection of component X in cell extracts
Detection of component X in SDS-extracts of cultured cells was
performed by immunoblotting with antiserum to ox heart PDC. Cell 
extracts were prepared under conditions which were designed to minimise 
proteolytic degradation of the complex (see Chapter 4, Fig. 4.4;
De Marcucci et al.. 1985a). Furthermore, the protein was detected 
exclusively in the mitochondrial fraction along with components E2,
El a and El6 of the complex. The lack of reactivity of anti-PDC serum 
with the E3 component was discussed in Chapter 4, section 4.4. These 
results have been confirmed by similar studies with samples from several 
rat tissues obtained after freezing in liquid and extraction of the 
powdered tissues in hot SDS (not shown).
These results indicate that protein X is a normal cellular 
component in a variety of tissues since no proteolysis is expected under 
these conditions, unless occurring naturally in vivo. It also appears 
that protein X is confined to the mitochondrial compartment.
6.4 Subcellular localisation of component X
The mitochondrial localisation of protein X was further invest­
igated by selective disruption of cells with digitonin for isolation 
of cytosolic and particulate fractions (Zuurendonk & Tager, 1974;
Mori et al.. 1981a). This method exploits the difference in cholesterol 
content between the plasma and inner mitochondrial membrane (Zuurendonk 
et al.,1979). As digitonin interacts selectively with cholesterol, 
conditions can be found in which the plasma membrane is lysed while the 
mitochondrial inner membrane remains intact. At higher levels of 
digitonin, mitochondrial disruption is induced with concomitant, release 
of mitochondrial enzymes into the cytosol.
Fig. 6.3 Immunological detection of PDC polypeptides in extracts from 
pig kidney cells treated with digitonin
Suspensions of PK-15 cells (5 x 10^ cells/ml) in 20 mM-potassium 
Hepes buffer, pH 7.4, 0.25 M-sucrose, 3 mM-EDTA were incubated at 0°C 
with various concentrations of digitonin as indicated in section 2.2.7.d.
After 2 min, cell suspensions were rapidly centrifuged. Samples 
from the supernatant fractions (cytosol) were utilised for assaying
fumarase, ( O  )and citrate synthase,(--- #  ) activities as
described in sections 2.2.8.C and 2.2.8.f. respectively (A). Aliquots 
containing approx. 50yug protein were electrophoresed onto 10% (w/v) 
SDS/polyacrylamide slab gels. The gel was utilised for the immuno­
chemical identification of PDC polypeptide after incubation with anti-PDC 
serum (B). A parallel gel was stained with Coomassie Blue (C).
0  and C) Lane 1, PDC, 0.5yag and 12yjg protein, respectively; 
lane 2, PK-15 mitochondria, 40yig and 50yig; lanes 3, 4, 5 and 6 cytosol
from PK-15 cells treated with 0.25 mg, 0.5 mg, 1.0 mg and 2.0 mg of
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digitonin, respectively (40yig each); lane S, I-labelled standards. 
Part (A) of this Figure was reproduced with permission from Dr. G.Gibb.
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In these experiments, disruption of mitochondria was monitored 
by the appearance of citrate synthase and increase of fumarase 
activities in the cytosolic fractions obtained after treatment of pig 
kidney cells with increasing concentrations of digitonin.
As shown in Fig. 6.3 (A), at concentrations of digitonin 
2l2mg/ml, citrate synthase activity was detected in the cytosol.
Fumarase activity showed a biphasic response. At low levels of 
digitonin, fumarase activity was detectable owing to the presence of a 
cytosolic pool of the enzyme. A two-fold increase in fumarase activity 
was observed when the mitochondrial isoenzyme was released at concen­
trations of digitonin ^ 2mg/ml.
Immunoblotting analysis of the cytosolic fractions with anti-PDC 
serum, (Fig. 6.3,B) showed that the components of the complex were 
detectable in the cytosol only when the concentration of digitonin was 
i  2mg/ml. Under these experimental conditions, this level corresponded 
to the concentration of detergent required for mitochondrial disruption.
A similar study was carried out in Buffalo rat liver cells (BRL). - 
Subcellular fractions were obtained after fractionation by differential 
centrifugation (Attardi & Ching, 1979) and analysed by immunoblotting 
with antiserum to component X. Fig. 6.4 shows that the antiserum cross- 
reacts with an 50,000 polypeptide (lanes 2-5) present in whole cells 
and in the mitochondrial fraction. An additional cross-reacting 
antigen of lower value was also observed in whole cell extracts 
(lane 1) and in postnuclear supernatant fractions (lanes 2 and 3) but 
was absent from mitochondrial fractions (lane 4). The identity of this 
strongly cross-reacting antigen has not yet been established. Results 
with other cell lines confirmed that this protein was a cytosolic 
component.
Fig.6.4 Immunoblotting analysis of subcellular fractions from BRL
cells with antiserum to component X
BRL cells were grown in two large roller bottles (burlers) until 
they reached confluence. Monolayers were washed with PBS, scraped off 
and the resulting cell suspension was subjected to subcellular fraction­
ation following the procedure described by Attardi & Ching (1979). 
Samples of the various fractions obtained were electrophoresed onto 10% 
(w/v) polyacrylamide gels. (A) Immunoreplica obtained after incubation 
with antiserum to component X and (B) Coomassie Blue pattern.
(A) and (B) Lane 1, PDC O.Syug and 12yig protein, respectively; 
lane 2, SDS-extract of whole cells, 80yig and 60yig; lanes 3 and 4,
postnuclear supernatant 50yig and 60yig; lane 5, mitochondrial fraction
125
40yig each; lane 6, nuclear fraction 40yig each; lane 5, 1-labelled
M markers, 
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6.5 Studies on the possible identity of component X with 
pyruvate dehydrogenase kinase
It has been suggested previously that the unassigned M 50,000
polypeptide associated with mammalian PDC could be the pyruvate
dehydrogenase kinase (Sugden & Randle,1978; Stanley & Perham, 1980).
Stepp et al. (1983) reported that subunits of 48,000 and 47,000 have
been observed in highly-purified pyruvate dehydrogenase kinase.
In this study, this possibility was explored initially by
measuring the effects of anti-X serum on the ATP-dependent inactivation
of the complex catalysed by the intrinsic kinase. Fig. 6.5 shows that
anti-X serum did not affect PDC activity but protected the enzyme from
inactivation in the presence of 0.2 mM-ATP. This effect was reflected
in a significant increase in ti for complete (98%) inactivation of the
2
complex from 5 min to 14 rain. Antiserum to subunit El a produced a
similar effect, but the t^ increased to 8 min only.
2
The possibility that component X was related to the kinase was
further examined by direct measurement of the effects of anti-X serum
32
on the initial rate of phosphorylation of PDC in the presence of [V“  P]
ATP. The results of this experiment are shown in Fig. 6.6. Only
antiserum to PDC showed a significant inhibition of the phosphorylation
reaction (approx, 30%) as compared with control serum. Anti-X and
anti-El o slightly decreased phosphorylation, whereas anti-E2 had no
measurable effect. Analysis of the products of phosphorylation by
autoradiography showed that approx. 95% of the radioactive product had a
M identical to subunit El a . 
r
The reasons behind the lack of agreement between these two types 
of experiments are unclear. Phosphorylation at site 1 on the El a 
subunit of PDC is sufficient to cause inactivation of the tetramer
Fig. 6.5 Effects of antiserum against component X on the rate of 
inactivation of PDC in the presence of ATP
PDC (20yUg) was incubated at room temperature in the presence 
of 100yjl of control serum or antiserum to component X essentially as 
described in section 2.2.12,d. After 30 min, the sample was
transferred into a water bath at 30°C and ATP was added to a final 
concentration of 0.2 mM. Aliquots (5-100yil) were withdrawn at the 
indicated times for spectrophotometric assay of PDC activity. Controls 
containing no ATP were also included. Results are means of two 
determinations that differed by less than ± 5%.
(— ^ — ) Control serum (no ATP added); ( — ^ — ) anti-X
serum (no ATP added); ( # --- ) control serum (plus ATP); (---- ^--- )
anti-X serum (plus ATP).
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Fig. 6.6 Effects of various antisera on pyruvate dehydrogenase 
kinase activity
PDC (50yUg) was incubated at room temperature for 30 min with 
100yil of various antisera, as described in section 2.2.12.d.
on
Phosphorylation reactions were initiated by the addition of [Y- P] ATP
(0.2 mM; 132,000 d.p.m./nmol). Pyruvate dehydrogenase kinase was
32
assayed by measuring the initial rate of incorporation of P into 
TCA-precipitable radioactivity by the filter paper discs method.
Results are means of three separate determinations differing by less 
than ±5%.
(- ^ ----) anti-PDC serum;
* --- ) anti-Elo serum;
( A — ■- ) anti-E2 serum;
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•) anti-X serum; 
control serum;
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(Yeaman et al», 1978), whereas the physiological significance of 
phosphorylation at sites 2 and 3 is uncertain. Appreciable phosphory­
lation at sites 2 and 3 accompanies loss of the final 30% of the PDC 
activity. It is possible that binding of antiserum to the complex 
causes a reduction in the rate of phosphorylation at site 1 or prevents 
conformational changes which are involved in the inactivation of the 
complex.
A more definitive answer to the question of the identity of 
component X with the pyruvate dehydrogenase kinase came from studies 
performed with a sample of purified bovine kidney pyruvate dehydrogenase 
kinase, generously provided by Prof. Lester Reed, University of Texas, USA.
The presence of component X and the cross-reactivity with the 
pyruvate dehydrogenase kinase were examined by immunoblotting analysis 
with antiserum to protein X. Fig. 6.7 shows that anti-X serum failed 
to react with subunits o and B of the kinase, which migrated with 
values 47,000 and 46,000, respectively (lane 5). A band corresponding 
to component X was detected in the subcomplex E2-X (Peak I from gel 
filtration of the dissociated complex) and in the acetyltransferase 
fraction obtained after treatment of Peak I with p-chloromercuriphenyl 
sulphonic acid (lanes 2 and 3), (sections 2.2.10.8 and 2.2.10.c).
It was clear that component X remained tightly-associated with 
the core enzyme under conditions in which El and E3 were released. In 
addition protein X was not dissociated after treatment with p-chloro­
mercuriphenyl sulphonic acid, a reagent that promotes dissociation of 
the pyruvate dehydrogenase kinase (Stepp et al.. 1983).
These results provided strong evidence that protein X was not 
related to either subunit of bovine pyruvate dehydrogenase kinase.
Fig. 6.7 Lack of reactivity of antiserum to component X with purified 
pyruvate dehydrogenase kinase from bovine kidney
Subcomplexes of PDC, purified by gel filtration of the dissociated
multienzyme and bovine kidney pyruvate dehydrogenase kinase were analysed
on 10% (w/v) polyacrylamide slab gels, (A) Immunoblotting analysis
after incubation with antiserum to component X and (B) Coomassie Blue profile.
(A and B) Lanes 1 and 6, PDC 0.5yug and 12yug protein, respectively;
lane 2, subcomplex I (E2 plus X) 1 yUg and 5yug; lane 3, subcomplex I
treated with p-hÿdroxymercuriphenyl sulphonate, 4yug each; lane 4, PDC
kinase, 7.5 ug each; lane 5, fraction II (El plus E3) 10 ug each; lane 7, 
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Moreover, the strong association of component X with the core enzyme 
and its mitochondrial localisation argued against the possibility that 
component X is a protein which became adventitiously bound to the complex 
during its isolation.
6.6 Localisation of protein X within the complex
It was apparent from the studies described in section 6.5, that
component X was firmly bound to the core enzyme. However, its location
within the complex has not yet been established.
A reasonable assumption was that if this polypeptide was exposed
on the surface of the complex, it would be possible to detect binding
of antibodies specifically directed against it in the intact assembly.
Since only a small fraction of the total IgG would be expected to bind
to the complex (0.05-1.0%), increased sensitivity was attained by
radioiodination of purified IgG fractions from control and anti-X sera.
The final specific activities of the preparations were 3.2 x 10^
c.p.m.^ug anti-X IgG and 3.9 x 10^ c.p.m.^ug control IgG. lodination
did not alter the immunoreactivity of the IgG as checked by incubation 
125
of the I-labelled anti-X IgG with nitrocellulose blots containing 2yug 
purified protein X followed by autoradiography. Binding of control IgG 
under these conditions was negligible.
125
Native PDC was incubated with approx. 600 ng of each I-labelled
IgG fractions (approx. 2 x 10^ c.p.m.) and loaded onto 10-30% (w/v)
sucrose-density gradients. After centrifugation, fractions were
125
analysed for their content of I and enzymic activity. Fig. 6.8
shows that a small peak of radioactivity co-migrated with the peak of
125
PDC in the sample incubated with I-labelled anti-X IgG. The 
distribution of radioactivity from the sample incubated with the control 
IgG showed a shallow background with no detectable peak at the same 
position of the gradient. This experiment was repeated twice with
Fig. 6.8 Sucrose-density gradient centrifugation of PDC incubated
125,
with I-labelled anti-X IgG
Anti-X and control IgG fractions were purified by affinity
chromatography on protein A-Sepharose columns and radioiodinated with 
125
I as indicated in sections 2.2.12.i and 2.2.I4.b.,
Native PDC (1.9 mg) was incubated for 1 h at room temperature
123 6
in the presence of anti-X and control I-labelled IgG (approx. 2 x 10
c.p.m. each). Samples were centrifuged for 4 h in a linear 10-30% (w/v)
125
sucrose-density gradient. I radioactivity and PDC activity were
determined in the fractions collected.
125
Distribution of I radioactivity in the gradients: PDC
incubated with control IgG: ( q  ); or anti-X IgG;( - #  ■ )
PDC activity in the gradients; sample incubated with control IgG
(  A  ) ; or anti-X IgG: (---^ —  ) .
Additional experimental details in section 2.2.12.j.,
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longer centrifugation times and with the inclusion of 1% (v/v) Triton 
X-100 in the sucrose solutions to reduce non-specific binding. Results 
were essentially the same as shown in Fig. 6.8.
125
Approx. 0.05% of the total radioactivity in the I-labelled 
anti-X IgG was recovered in the peak fractions (after background correction 
from the control value). Hence, these results suggest that antibodies 
to protein X are able to bind to antigenic determinants on the intact 
assembly, indicating that this polypeptide is at least partially exposed 
on the surface of the complex. The precise localisation of this protein 
within the complex would require other types of study, such as recon­
stitution or cross-linking experiments.
6.7 Studies on the possible identity of component X
with a fragment of the E2 subunit
Although earlier data (sections 6.2 and 6.3) suggested that 
component X is not immunologically related to subunit E2, further 
studies were performed to clarify this point. Fig. 6.9 shows the 
characteristic pattern of proteolytic fragments generated by elastase 
digestion after immunodetection with anti-E2 (B) or anti-X (C) sera.
It is apparent that components E2 and X were more susceptible 
to elastase attack than subunits E3, Elo and El S (Fig. 6.9, A).
The main cleavage products of E2 were two strongly immunoreactive 
peptides 65,000 and 62,000 which were largely resistant to further 
degradation under the experimental conditions chosen. A less immuno- 
logically-reactive peptide appeared at 29,000 at longer time intervals.
Fragments of similar size have been observed previously by 
Coomassie Blue staining after digestion of PDC or purified acetyl­
transferase. The 65,000 fragment contains the lipoyl domain whereas
the 29,000 peptide contains the subunit binding domain (Kresze & Ronft,
1980). The pattern of protein X-derived fragments showed two peptides
Fig. 6.9 Immunological detection of peptides derived from E2 and
component X after proteolysis of native PDC with elastase
A sample of PDC (1 rag/ml) was incubated with elastase (4.5yig/ml) 
for the indicated times in 0.1 M-potassium phosphate buffer, pH 7.0 at 
25°C.
Samples containing 15yig protein were resolved by SDS/polyacryl­
amide gel electrophoresis on 10% (w/v) slabs and stained with Coomassie 
Blue (A), Similar gels were loaded with 0.1 pg protein (B) or lyig
protein (C) and subjected to immunoblotting analysis with anti-E2 or
125
anti-X sera, respectively. Lane S corresponds to I-labelled M 
standards.
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of M values 29,000 and 27,000 which were cleaved to smaller peptides
14,000 after 20 min (De Marcucci et al.. 1985b).
As revealed by this immune mapping' technique, there were clear
differences in the pattern of peptides generated from E2 and X after
elastase treatment. To obtain more definitive 'maps’ to compare these
125
proteins, peptide mapping of the I-labelled proteins, purified by 
extraction from polyacrylamide gels, were obtained by the procedure 
devised by Cleveland et al. (1977).
Fig. 6.10 (A) illustrates the haps' obtained after proteolysis 
of subunits E2 and X with elastase. It is apparent that E2 was 
initially cleaved into two fragments of 45,000 and 29,000. At 
longer time intervals, the 45,000 peptide was degraded whereas the 
band at 29,000 increased. Other peptides at values 25,000 and
18.000 appeared at longer incubation times. Component X was relatively 
more resistant to hydrolysis and was cleaved into a 30,000 peptide, 
which appeared to degrade slowly into a smaller fragment of 27,000 
after longer periods of digestion.
Following incubation with VS protease, subunit E2 was fragmented 
into a large peptide 45,000 (indicated with an arrow), whereas 
component X was degraded into several peptides of 40,000-28,000, 
which were not detectable in the maps of the E2 subunit.
Limited proteolysis by a-chymotrypsin (Fig. 6.11) showed that 
component X was cleaved into two principal fragments of values
35.000 and 18,000, which were rather resistant to further proteolysis, 
whereas subunit E2 was fragmented into a number of peptides of 
values in the range 45,000-25,000.
In summary, one-dimensional peptide maps from subunits E2 and X, 
obtained with similar amounts of radioactively-labelled purified proteins, 
indicated no apparent similarities in the patterns generated by various
Fig. 6.10 One-dimensional peptide maps of subunits E2 and X during
limited proteolysis with elastase and V8 protease (S.aureus)
125
I-labelled subunits E2 and X were obtained after resolution
of the dissociated PDC, extraction from SDS-gels and radioiodination 
125
with I by the lodogen method, as described in sections 2.2.10.f and 
2.2.14.C. Samples containing approx. 2 x lO^ c.p.m. of each protein 
were incubated at 35° C with elastase (0.03yug) or V8 protease (0.15yug) 
as outlined in section 2.2.16.a. .
At the indicated times, 10yul aliquots were removed and 
proteolysis stopped after boiling for 5 min with Laemmli sample buffer. 
Samples were subjected to electrophoresis on 15% (w/v) polyacrylamide 
slab gels. Characteristic peptide patterns were observed after 
autoradiography of the dried gels.
(A) Autoradiogram of samples obtained during proteolysis with 
elastase.
(B) Autoradiogram of samples obtained during incubation with V8 
protease.
Lanes E2 and X correspond to the radioactive material before 
125
incubation. S, I-labelled standards.
(A) 10 3xM,
E2
X
(B)
E2 —
E2 0 5 20 60 X 0 5 20 60 S
10 50 90 10 30 90
Time (min)
Fig. 6.11 One-dimensional peptide map of subunits E2 and X during 
limited proteolysis with a-chymotrypsin
125
A time course of proteolysis of I-labelled subunits ,E2
and X with o-chymotrypsin (0.06yig) was performed under similar
conditions as described for elastase and V8 protease in Fig. 6.10.
Samples were electrophoresed on a 15% (w/v) polyacrylamide slab gel.
Peptide bands were detected after autoradiography of the dried gel. 
125
Lane S, I-labelled standards.
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proteases of differing specificities. These results clearly argue 
against the possibility that component X is a large fragment derived 
from the E2 subunit.
In Chapter 7, section 7.5, peptide maps of ^^C-labelled subunits 
E2 and X are presented. Results in these sections provide additional 
support for this conclusion
6.8 Studies on the possible function of component X
On the basis of the main features of protein X, e.g. its M value 
of 51,000± 1,000, subcellular localisation and strong association with 
the core enzyme, studies were carried out to establish its possible 
relationship to known mitochondrial proteins which share these character­
istics. It has been reported that citrate synthase, a functionally- 
linked enzyme of the citric acid cycle is capable of association with 
PDC under certain conditions. (SOmegi et al., 1980; Siîmegi & Alkonyi, 
1983). This association was demonstrated by co-precipitation with 
polyCethylene glycol) and by gel chromatography of the purified proteins. 
In this interaction, citrate synthase does not bind preferentially to 
the core enzyme, but seems to bind to all components of PDC with similar 
affinities. Citrate synthase is also a dimer of two identical subunits 
M 48,000. (Singh et al., 1970).
In spite of these reports citrate synthase activity was not 
detectable in purified ox heart PDC fractions; this result was also 
confirmed after immunoblotting analysis with anti-citrate synthase serum 
such as shown in Chapter 5 Fig. 5.6,lane 6.
The acetyltransferase component of the branched-chain 2-oxo-acid 
dehydrogenase complex has identical subunits with an estimated 52,000 
(Pettit et al., 1978) which also possess structural similarities to 
the acetyltransferase of PDC (Chuang et al.. 1984).
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After immunoblotting analysis using the specific antiserum 
against the acetyltransferase subunit of the branched-chain 2-oxo-acid 
dehydrogenase complex (Fig. 6.12, B), there was no cross-reaction with 
PDC or purified component X. Moreover, anti-X serum failed to cross- 
react with any subunit of the purified branched-chain 2-oxo-acid 
dehydrogenase complex (Fig. 6.12, C).
This result (see also Chapter 4, Fig. 4.5) was in line with 
evidence from reconstitution studies with the components from the bovine 
pyruvate dehydrogenase and branched-chain 2-oxo-acid dehydrogenase 
complexes which showed that the isolated enzymes do not dnteiact with each 
other to any significant extent. (Cook et al., 1985).
Regarding the possibility that protein X corresponded to the 
catalytic subunit of the PDC phosphatase value 50,000, (Teague et al., 
1982; Pratt et al., 1982) evidence for the absence of detectable 
phosphatase activity in the purified PDC fractions has been discussed 
in Chapter 3, section 3.2.2.
An additional feature of the 50,000 polypeptide that may
provide a clue for its specific function was provided from studies in
14
which incubation of PDC with [2- C] pyruvate, resulted in the covalent 
association of the label, presumably in the form of acetyl groups, with 
both components E2 and X. Studies on the characteristics of this 
reaction and the involvement of component X will be the subject of 
Chapter 7.
Fig. 6.12 Immunological analysis of PDC and branched-chain 2-oxo 
acid dehydrogenase complex with antisera against 
component X and E2 component of branched-chain
2-oxo-acid dehydrogenase complex
Samples of purified branched-chain 2-oxo-acid dehydrogenase 
complex, PDC and component X were electrophoresed on a 10% (w/v) 
polyacrylamide slab gel and analysed by immunoblotting with the 
antiserum against the E2 component of the branched-chain 2-oxo-acid 
dehydrogenase complex (B). The same blot was then processed with 
antiserum directed to component X (C). A similar gel was stained 
with Coomassie Blue (A).
(A) and (B or C), Lane 1, branched-chain 2-oxo-acid dehydro­
genase complex 10^ g  and 0.5yug protein, respectively; lanes 2, 3 and
4, PDC 2.5 ug, 5yug and lOyug, respectively; lanes 5 and 6, purified
125
component X,1.5yug and 3yig; lane S, I-labelled standards.
E2, El a and El g refer to the acetyltransferase and branched- 
chain amino acid dehydrogenase subunits of the branched-chain 2-oxo-acid 
dehydrogenase complex, respectively.
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Chapter 7; STUDIES ON THE INVOLVEMENT OF COMPONENT X IN THE 
ACETYLATION REACTIONS OF PYRUVATE DEHYDROGENASE 
COMPLEX
7.1 Introduction
Investigations on the dihydrolipoyl acetyltransferase from both 
prokaryotic and eukaryotic cells have shown that, besides its structural 
role, the core enzyme contains lipoic acid moieties covalently attached 
by amide bonds to the e -amino groups of lysine residues. This 
cofactor participates in the transfer of electrons and acyl groups 
between the catalytic sites of El and E3.
Current evidence suggests also that the acetyl transfer reactions 
in PDC occur after the initial decarboxylation step, which is catalysed 
by El with the production of CO^ and an enzyme-linked hydroxyethyl TPP 
derivative. Acetyl group generation may be considered as a reductive 
acétylation of E2-bound lipoic acid. It is believed that the reactive 
hydroxyethyl derivative attacks the dithiolane ring of lipoaraide in a 
nucleophilic displacement reaction followed by a reverse condensation 
to form 6,S-acetyl dihydrolipoamide-E2 (Koike & Koike, 1976).
Enzyme El catalyses both the decarboxylation step and the 
subsequent acétylation of the lipoyl groups bound to E2, which mediates 
the transfer of acetyl groups to CoA in a displacement reaction. The 
final step catalysed by a flavoprotein, consists of an oxidation of the 
E2-bound dihydrolipoamide followed by reduction of NAD"'".
Evidence for the scheme illustrated in Fig. 7.1. is based largely 
on model reactions carried out with resolved components (Barrera et al., 
1972; Bleile et al., 1981); identification of the thioester intermediate 
(Gunsalus et al., 1956; Reed & Cox, 1966) and kinetic analysis and 
electron microscopy of the isolated complex and acetyltransferase component 
(Reed & Oliver, 1968; Reed, 1974).
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13
O'Connor et al. (1982) have presented C n.m.r. data which
indicate that both 6-and 8-thiols of dihydrolipoamide are acetylated,
13
following reaction of the dihydrolipoamide with [1- C] AcSCoA in the 
presence of the E2 component of bovine kidney. These findings are in 
conflict with earlier data which indicated that only the 6-S-acetyl 
dihydrolipoamide was formed.
It was reported (Brown & Perham, 1976; Danson & Perham, 1976) 
that the acetyltransferase component of E. coli PDC can be inactivated 
selectively by maleimides in the presence of pyruvate or NADH. The 
E2-bound lipoyl moieties became reductively acetylated and the S-acetyl 
dihydrolipoamide in turn reacted with the maleimide, inactivating the 
enzyme.
Substrate or product-induced sensitisation of the complex to 
sulphydryl reagents has afforded a simple method for determining the 
functionally-active lipoyl content of multienzyme complexes (Danson & 
Perham, 1976; Collins & Reed, 1977), the number of E2 chains per mole 
of complex (Brown & Îterham,l976) and exploring the mobility of lipoyl 
residues in the intact assembly (Ambrose-Griffin & Perham,1976).
The assembly of the E2 subunits into highly-mobile lipoyl domains 
and an inner core constitute unique architectural features of this 
protein that facilitate the interaction of lipoyl moieties with 
successive active sites on the complex in a multiple random coupling 
mechanism (Hackert et al., 1983).
7.2 Studies on the effects of NEM on the acetvlation of PDC
Initial experiments showed that incubation of native PDC in the
lA ++
presence of the substrate [2- C] pyruvate, TPP and Mg in the absence
of CoA was accompanied by a rapid incorporation of the label into a
TCA-precipitable form. Essentially 95% of the radioactivity incorporated
was released when the labelled complex was exposed to vapours of 
performic acid as described by Barrera et al» (1972). Based on 
previous studies these TCA acid-stable groups were assumed to be 
acetylated lipoyl moieties of the complex (Barrera et al., 1972;
Danson & Perham, 1976). As shown in Fig. 7.2, acétylation of native 
PDC occurred in a biphasic manner. A rapid incorporation of label 
(completed within 1 min) was followed by a slower phase of acétylation, 
which was sensitive to the presence of 0.5 mM-NEM.
After examination of the acetylated proteins by fluorography, 
most of the radioactivity was found associated with the E2 component, 
while a second acetylated species of 50,000 co-migrating with the 
band of component X, was also detected (Fig. 7.3).
The instability of the S-acetyl dihydrolipoamide group, 
particularly in the absence of NEM,was demonstrated by the decrease in 
radioactivity associated with these proteins following addition of DTT 
to the Laemmli sample buffer before electrophoresis on SDS/polyacrylamide 
gels (A) or boiling in this buffer (B) as compared with samples in which 
no sulphydryl reagents were added before electrophoresis (C).
The incorporation of radioactivity into E2 and X was very rapid 
as the labelling pattern observed after a 1 min incubation remained 
essentially unchanged after 30 min.
A similar pattern to that shown in Fig. 7.3 was obtained with 
samples incubated in the absence of NE^ (not shown).
Approx. 50-60 mol acetyl groups were incorporated per mol of 
complex in the presence of NEM. In spite of some variability, higher 
levels of acétylation could be obtained routinely after incubation of 
the complex in the absence of NEM for relatively long periods of time 
(approx. 50-100% increase above the values observed in the presence of 
NEM).
Fig. 7.2 Time course of incorporation of acetyl groups from [2-^^C] 
pyruvate into PDC; effects of NEM
Native, NEM-treated or pyruvate-treated PDC were incubated in 
50 mM-potassium phosphate buffer, pH 7.2 containing 0.5 mM-MgCl^,
2.5 mM-EDTA, 0.2 mM-TPP in a final volume of 0.2 ml. [2-^^C] pyruvate 
was added at a final conceiiration of 0.2 mM after a 1 min preincubation 
at 30®C. Pretreatment of the enzyme with NEM or pyruvate were 
performed as described in section 2.215. Reactions were
terminated at the indicated times and 10yil aliquots were assayed for 
protein-bound radioactivity by the filter paper discs method.
( O  ' ) Native PDC (0.2 mg); ( #  —  ) NEM-treated PDC
(0.2 mg); ( ) pyruvate-treated PDC (0.2 mg); ( A  )
native PDC (0.2 mg) incubated with N0i added to 0.5 mM before incubation.
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Fig. 7.3 Analysis of acetylated protein after incubation of native PDC 
with [2-^^Cl pyruvate
PDC (0.2 mg) was incubated as described in legend to Fig. 7.2 in 
presence of 0.5 mM-NEM. Samples containing 25yig protein were with­
drawn at the times indicated, mixed with an equal volume of Laemmli 
sample buffer containing 10 mM-DTT and boiled for 5 rain (B), not boiled 
(A) or mixed with the same buffer containing no sulphydryl reagents (C) 
before resolution by electrophoresis on 10% (w/v) SDS/polyacrylamide gels. 
After staining with Coomassie Blue, the gel was processed for fluorography 
and dried. Radiolabelled bands were detected after 5 days. S, 
^H-labelled PDC.
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Cate & Roche (1979) have reported maximal values of 100 mol 
acetyl groups/mol of complex. These authors interpreted these results 
as due to the presence of two lipoyl groups/E2 chain, This value is 
difficult to reconcile with values approaching 60 acetyl groups/mol 
of complex reported by other authors (Barrera et al., 1972; Stanley 
et al., 1981) and with the value of 1.11 lipoyl residues/E2 chain reported 
by White et al. (1980) by isotopic dilution analysis of the bovine kidney 
and heart PDC.
Although component X participates in the acétylation reactions
of the complex it is clear that it is not responsible for the slow phase
of acétylation, since labelling of this protein is not increased with
respect to E2 as a function of time.
The increased levels of acétylation attained in the absence of
NEM, as compared with those in the presence of NEM cannot be readily
explained on the basis of two lipoyl groups/chain. As shown for the
E. coll complex (Collins & Reed,1977; Danson et al., 1981), the
lA
incubation of native PDC with [2- C] pyruvate resulted in the incorpo- .
ration of 2.0 acetyl groups per E2 chain. Addition of 0.5 mM-NEM to
the incubation mixtures did not modify the extent of acétylation.
Results shown in Fig. 7.2 can be ascribed to either the formation of a
diacetyl lipoamide derivative or to the acétylation of a secondary site
on proteins E2 and/or X (see Fig. 7.1).
O'Connor et al. (1982) have also presented data suggesting that 
13
incubation of [1- C] AcSCoA with dihydrolipoamide produced the 6- and
13
8- monoacetyl derivatives plus low levels of the 6,8-S,S- [1- C] diacetyl 
dihydrolipoamide. The accumulation of this latter species was enhanced 
after long incubation times. They have proposed that enzymatic 
acétylation may occur initially in either thiol. The diacetyl derivative 
may be then a result from a slow intermolecular migration of the acetyl
153
groups (Fig. 7.1).
NEM-sensitive acétylation sites were generated only in the 
presence of the substrate, as pretreatment of the complex with NEM 
did not affect the ability of the complex to attain higher levels of 
acétylation. A lower rate of incorporation was observed in the NEM 
pretreated sample in comparison to untreated PDC (Fig.7.2). A similar 
effect was obtained with a control sample of PDC treated in the same 
way. These results could be due to the partial loss of enzyme activity 
observed after ultracentrifugation since the extent of acétylation 
attained after prolonged incubation was the same for NEM pretreated 
and control PDC.
14
The incorporation of C-labelled acetyl groups in proteins E2 
and X was quantitated in the Coomassie Blue-stained bands of protein 
after resolution of the acetylated complex by SDS/polyacrylamide gel 
electrophoresis.
Table 7.1 shows that the incorporation of radioactivity into 
the isolated E2 and X components when the complex was incubated in the 
presence of 0.5 mM-NEM was about half of the value obtained when 
acétylation was performed in the absence of the reagent. Approx. 15% 
of the total counts were incorporated into protein X both in the 
presence or absence of NEM.
7,3 Acetvlation of components E2 and X at low levels of active PDC
Fig. 7.A shows that the rate of acétylation of PDC after incubation 
with [2-^^C] pyruvate decreased when assays were performed in the absence 
of added TPP. Decreasing the proportion of active El component by prior 
incubation of the complex in the presence of 0.2 mM-ATP, markedly 
decreased the rate of acétylation as the rate-limiting step is the 
generation of the intermediate hydroxyethyl TPP by El. Walsh et al. (1976)
154
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Table 7.1 Incorporation of C-labelled acetyl groups into 
subunits E2 and X
14,
Subunit Additions c.p.m./gel slice % total
Dihydrolipoyl
acetyltransferase
None 1,446 ± 247 85.2 ± 2.8
NEM 613 ± 11 83.6 ± 1.0
Component X
None 250 ± 20 14.7 ± 1.3
NEM 123 ± 9 16.4 ± 1.1
14
Native PDC was incubated with [2- C] pyruvate in the absence or presence
of 0.5 mM-NEM as described in section 2.2.15.a. After 30 min
incubation, samples containing approx. 22yug protein were mixed with
Laemmli sample buffer before resolution on a 10% (w/v) SDS/polyacrylamide
14
slab gel. Radioactivity in C-labelled subunits E2 and X present as 
Coomassie Blue-stained bands was determined by scintillation counting 
as described in section 2.2.5.b.
Pyruvate-treated PDC was used as a control for determination of back­
ground radioactivity.
Values represent means of three separate determinations.
Fig, 7.4 Time course of acetvlation of native or ATP-inactivated PDC; 
effects of TPP
Active PDC or ATP-inactivated complex were incubated with 
[2-^^C] pyruvate as described in section 2.2.15.a. Other details
as described in legend to Fig. 7.2 except those indicated below. 
Incubation mixtures contained active PDC (0.2 mg) in the presence of 
0.5 mM-NEM ( —  ■ 1» ) or in the presence (— (^— ) or absence
( ~ ) of TPP. ATP-inactivated PDC (0.2 mg) was prepared
as described in section 2.2.15.d and incubated in the presence
( A  ) or absence (-- ▲  ) of TPP.
7? 100
S  50
Time (min)
Fig. 7.5 Analysis of acetylated proteins after incubation of native 
or ATP-inactivated PDC with [2-^^C] pyruvate
Samples of native or ATP-inactivated PDC were incubated as described 
in legend to Fig. 7.4. At the indicated times, samples containing 25yig 
protein were mixed with an equal volume of Laemmli sample buffer (without 
reducing agents) and the samples loaded on a 10% (w/v) polyacrylamide slab 
gel. Radiolabelled proteins were detected after fluorographic analysis 
of the dried gel. Native PDC incubated in the presence (A) or absence 
(B) of TPP. ATP-inactivated PDC incubated in the presence (C) or 
absence (D) of TPP.
Heat-inactivated PDC (E). Native PDC incubated in the presence 
of TPP (F) or NEM (G).
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reported that phosphorylation of PDC mainly affects the rate of 
formation of this compound whereas other reactions such as oxido- 
reduction of lipoyl groups and binding of pyruvate are unlikely to 
be modified. However, Roche & Reed, (1972) observed that phosphory­
lation of PDC decreases its ability to bind TPP suggesting that TPP 
binding sites and phosphorylation sites on pyruvate dehydrogenase 
influence each other.
Collins & Reed (1977) and Cate & Roche (1979) have suggested that 
the high levels of acétylation that can be obtained when only a few El 
molecules are active are achieved by intramolecular transfer of acetyl 
groups and electron pairs between the lipoyl residues of E2. Cate 
et al. (1980) have reported also that a slower transfer of El components 
between acetyltransferase cores could also have taken place.
Analysis of the products of acétylation by fluorography (Fig. 7.5)
revealed that incorporation of radioactivity into E2 and X components
was affected in a similar way.
7.4 Deacetylation of PDC
14
Deacetylation of C-labelled PDC was followed by similar assay
procedures to those used for acétylation (section 2.2.15.e). In
these experiments, PDC was acetylated after incubation with [2-^^C]
pyruvate for about 30 rain in the presence or absence of NEM. At the
times indicated by vertical arrows, CoA was added to a final concentration
14
of 1 mM (Fig. 7.6). As shown previously, the C-labelled acetyl groups 
incorporated cannot be removed by CoA from S-acetyl dihydrolipoic acid 
residues that have been-modified with NEM (Collins & Reed, 1977), whereas 
the protein-bound acetyl groups are almost totally released by CoA in 
the absence of NEM.
When NEM was added to the incubation mixtures 15 min before CoA,
14
Fig. 7.6 Time course of deacetylation of C-labelled PDC on incubation 
with CoA
Native PDC (0.2 mg) was incubated with [2-^^C] pyruvate at 30*C 
in the presence or absence of 0.5 mM-NEM. Aliquots of lOyil were 
assayed for protein-bound radioactivity. Other details as described 
in section 2.2.15.e. At the time indicated by the first vertical
arrow,CoA was added to a sample of native PDC incubated in absence of
NEM (---^ --- ) and to the sample incubated in presence of NEM
( — ) To a duplicate sample of native PDC, NEM was added at a 
final concentration of 0.5 mM after 30 min incubation ( —  ^  )
CoA was added to this sample to a final concentration of 1 mM, at the 
time indicated by the second vertical arrow.
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it was observed that deacetylation was not totally inhibited. This 
was an unexpected result suggesting that at least some of the NEM 
sensitive thiol groups were not accessible to the reagent following 
reductive acétylation by pyruvate. However, it should be emphasized 
that these experiments must be interpreted with caution as CoA also 
reacted with free NEM. (CoA was present in 2-fold excess with 
respect to NEM).
To circumvent this difficulty, a similar experiment was performed 
(Fig. 7.7). After acétylation of the complex for 30 min and incubation 
with 0.5 mM-NEM for 15 min at 30°C, excess reagent was removed by 
centrifugation of the complex prior to incubation in the presence of CoA. 
It was demonstrated that the NEM-pretreated PDC was capable of releasing 
the acetyl groups bound to the protein in the presence of CoA to the 
same extent as control PDC.
Analysis of the products obtained after deacetylation of the 
complex in the presence of CoA by SDS/polyacrylamide gel electrophoresis 
and fluorography (Fig. 7.8) indicated that radioactivity associated with . 
the subunits E2 and X was released in a similar way from NEM-pretreated 
and control PDC (lanes 2 and 7).
One plausible explanation for these results in that thiol groups 
sensitive to NEM modification are generated only transiently during the 
reactions of acétylation and deacetylation. It is possible that a 
second acétylation site becomes available in the complex under these 
conditions, like a cysteine thiol group. Alternatively, one must 
consider the possible formation of diacetyl dihydrolipoamide during 
prolonged incubation of the complex. The existence of these species 
would explain the high levels of acétylation and the insensitivity of 
the complex to NEM modification after full acétylation. In this respect
Fig. 7.7 Time course of deactylation of ^^C-labelled PDC; effects 
of NEM pretreatment
Native PDC (2.6 mg) was incubated for 30 min at 30° with [2- 
pyruvate under standard conditions. The sample was separated into two 
portions which were incubated for 15 rain at 30°C in the absence (control 
sample) or presence of 0.5 mM-NEM. PDC was recovered after ultra­
centrifugation as described in section 2.2.15.b and incubated in the 
presence of 1 mM-CoA for 30 min as described in section 2.2.15.e. 
Aliquots of 10yil were assayed for protein-bound radioactivity at the 
indicated times.
Curves correspond to ( - A — ) NEM-pretreated PDC; ( _ ^ —_  ) 
control PDC; and ( ~  ) control PDC incubated in the absence of
CoA.
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Fig. 7.8 Fluorographic analysis of the products of deacetylation 
of PDC in the presence of CoA
Samples from experiments described in Fig. 7.6 and 7.7 containing 
25yig protein were analysed by electrophoresis on 10% (w/v) polyacrylamide 
gels followed by fluorography.
For each sample, it is shown the material labelled, before or 
15 min after the addition of CoA to 1 mM. Lanes 1 and 2, native PDC 
acetylated in the absence of NEM; lanes 3 and 4, PDC sample acetylated 
in the presence of N0i; lane 5, heat-inactivated PDC; lanes 6 and 7, 
NEM-pretreated PDC deacetylated in the presence of NEM; lanes 8 and 9, 
same as 6 and 7 but deacetylation took place in the absence of NEM in 
the assays.
E2
X
1 2 3 4 5 6 7 8 9
157
it may be of interest to determine whether the extent of deacetylation 
depends on the time of incubation of the complex in the presence of 
[2-^^C] pyruvate.
The identification of the groups involved in the second acétylation 
in E2 (and/or X) is necessary to determine the physiological importance 
of this reaction.
7.5 Peptide mapping of acetylated E2 and X subunits
Immunological studies carried out with specific antisera as well 
as other studies presented in Chapter 6 strongly support the idea that 
component X is structurally different from the E2 component. However, 
in functional terms, there is a strong resemblance between these proteins: 
i) the Incorporation of ^^C-labelled acetyl groups is dependent on the 
activity of the El component; ii) the incorporation of these groups is 
reduced in a similar degree when thiol or lipoyl groups associated with 
the complex are modified by NEM (approx. 50%); iii) ^^C-labelled acetyl 
groups are released from both proteins after incubation with CoA. These 
characteristic properties of the acétylation reaction suggest that lipoyl. 
groups are present in both E2 and X components.
Experiments were designed to establish peptide maps of the 
^^C-labelled subunits E2 and X to obtain information about the values 
and time course of degradation of peptides containing the radiolabelled 
acetyl groups from each protein.
For this purpose, approx. 3 mg PDC were incubated in the presence 
of [2-^^ C] pyruvate, concentrated by precipitation with 5% (w/v) 
poly(ethylene glycol), dissociated and resolved on a SDS/ polyacrylamide 
preparative gel. Peptide-mapping was performed as described by Cleveland 
et al. (1977) after elastase digestion of the proteins in the stacking 
gel of a second polyacrylamide slab. The ^^C-labelled peptides derived
ibü
from subunits E2 (A) and X (B) were detected by fluorography (Fig. 7.9).
In spite of the high amount of elastase used for these experiments,
subunit E2 remained largely undegraded. The main product appeared as a
45,000-M peptide that was relatively resistant to further hydrolysis.
14
C-labelled peptide present in component X appeared initially to have
3 1 value of 30,000 and was further degraded to a 25,000-M^ fragment
and then to peptides of values —  10,000 at higher elastase/protein
ratios. These results clearly indicate that the peptides containing
the ^^C-labelled acetyl groups are different in component X as compared
with E2. This constitutes further evidence for structural differences
between these proteins.
In a refinement of this approach, peptide maps of subunits E2 and
X were obtained after isolating the ^^C-labelled proteins from SDS/
polyacrylamide gels.
PDC was labelled after incubation in the presence of [2-^^C]
14
pyruvate and N-ethyl [2,3- C] maleimide. Under the experimental 
conditions used approx. 95% of the incorporated radioactivity was 
detected in components E2 and X (J.A. Hodgson, unpublished results).
This procedure led to stablisation of the radioactivity 
incorporated allowing the electrophoretic resolution of the complex 
and elution of proteins from the gel slices without the large losses 
observed when the complex was labelled with [2- pyruvate and NEM.
These losses were probably due to the heating and long incubation of 
the gel slices at alkaline pH involved in the elution procedure 
(see also Fig. 7.3). Preliminary experiments showed that elastase 
activity was inhibited shortly after addition of the enzyme to the
extracted proteins, presumably caused by the high levels of SDS
o
present in the samples. Therefore, the protease was added in successive 
portions (0.5yig protein each).
Fig. 7.9 Peptide mapping by limited protelysis of subunits E2 and X 
in gel slices
Subunits E2 and X were labelled after incubation of native PDC 
(2 mg) with 0.1 mM- [2- C] pyruvate under standard conditions for 
acétylation (section 2.2.15.a.). The complex was resolved into its
components in.a 10% (w/v) SDS/polyacrylaraide preparative gel. Bands 
corresponding to subunits E2 and X were visualised after brief staining 
with Coomassie Blue. Gel slices of these bands were placed on the 
sample wells of a second 15% (w/v) polyacrylamide slab gel and each 
slice was overlayed with the indicated amount of elastase. Digestions 
were carried out as described in section 2.2.16.a ^^C-labelled
peptides from subunit E2 Q.anes l-5)and X &anes 6-10) were detected 
after fluorography. Ratios protease/protein (w/w) are also indicated.
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14
Fig. 7.10 shows the course of degradation of the C-labelled 
peptides from subunits E2 (lanes 1-6) and X (lanes 7-12) with increasing 
amounts of elastase.
Subunit E2 was rapidly cleaved into a fragment of 45,000 
containing the ^^C-label and an unlabelled peptide 29,000 detectable 
in the Coomassie Blue-stained gel (not shown). The former fragment was 
relatively resistant to further hydrolysis and was cleaved to a fragment 
of M 30,000. At higher elastase levels, this fragment was cleaved 
into smaller peptides < 25,000.
Component X was more resistant to digestion than subunit E2, 
under these experimental conditions. This protein was initially cleaved 
into a fragment of M 28,000 which was then converted into a smaller 
peptide 25,000.
These results are remarkably similar to the peptide maps obtained
by partial digestion with elastase by the Cleveland et al. (1977)
125
technique (Fig. 7.9), with the maps from I-labelled subunits E2 and X 
(Chapter 6, Fig. 6.10,A) and with the immunomaps shown in Fig. 6.9.
Taken together, these results reveal that antisera raised to subunits 
E2 and X strongly cross-reacted with fragments of similar to the 
peptides carrying the acetyl groups. Therefore it is possible to 
speculate that regions of these proteins capable of bearing acetyl 
groups (possible lipoyl domains) are highly immunogenic. These results 
also indicate that the M values for these polypeptide regions are quite 
different between the components E2 and X.
16
Fig. 7.10 Peptide mapping by limited elastase proteolysis of C-labelled
subunits E2 and X
^^C-labelled subunits E2 and X were purified by extraction from 
SDS/polyacrylamide gels as described in section 2.2.10.f, after 
incubation of PDC with 5yiCi each [2-^^C] pyruvate and N-[2,3-^^C] ethyl- 
maleiraide. Samples from the extracts containing 6000 c.p.m. of each 
protein were incubated in a final volume of 160yil in 0.125 M-Tris/HCl 
buffer, pH 7.4, 0.5% (v/v) Triton X-100 at 35°C. Digestions were carried 
out by successive additions of small amounts of elastase (0.5yig) up to 
3.0yig. Aliquots (25-50yul) containing equal amounts (approx. 1000 c.p.m) 
of subunit E2 (lanes 1-6) or component X (lanes 7-12) were removed 5 min 
after each protease addition, mixed with Laemmli sample buffer and boiled 
for 3 min. Samples were loaded onto a 10% (w/v) SDS/polyacrylamide 
slab gel which was stained with Coomassie Blue before fluorography.
Fluorograph was obtained after 15 days.
3 125
S, H-labelled PDC; M, I-labelled markers.
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Chapter 8; STUDIES ON THE BIOSYNTHESIS OF MAMMALIAN PYRUVATE 
DEHYDROGENASE COMPLEX
8.1 Introduction
Mitochondria depend upon the nucleo-cytoplasmic system of gene 
expression for the biosynthesis of the vast majority of their poly­
peptides. Therefore, eukaryotic cells must possess mechanisms for 
sorting newly-formed polypeptides to ensure that the appropriate 
macromolecules reach their mitochondrial location. Once a specific 
polypeptide is recognised, it becomes associated with this organelle 
and routed to its proper intramitochondrial compartment.
Most, but not all, cytoplasmically-synthesised mitochondrial 
matrix proteins are translated initially as larger precursors of
500-10,000 higher than their corresponding mature forms. A specific 
matrix protease is responsible for processing translocated precursors 
to mature mitochondrial proteins during or shortly after entry.
(Neupert & Schatz, 1981).
On examining the import of a particular mitochondrial protein it 
is necessary to determine initially if the polypeptide exists as a 
transient entity of higher M^ value. There are two general approaches 
to this problem, both of which rely on the availability of high-titre 
monospecific antiserum directed against the mature form of the protein 
of interest (see also section 1.6.4).
A) In vitro protein synthesis. Total or poly(A) containing
35
RNA is isolated and translated under suitable conditions with [ S] 
methionine in a rabbit reticulocyte lysate or wheat-germ system. After 
addition of detergents and protease inhibitors, the samples are subjected 
to immunoprécipitation, SDS/polyacrylamide gel electrophoresis and 
fluorography.
161
Radioactive products are compared directly by co-electrophoresis 
with a sample of radiolabelled mature protein, since the value is the 
most prominent feature of the precursor polypeptides which permits them 
to be distinguished from their mature forms.
B) In vivo accumulation of precursors. The biosynthetic 
pathway of proteins can be examined in vivo by incorporating radioactive 
amino acids into newly-synthesised polypeptides followed by immuno­
précipitation, SDS/polyacrylamide gel electrophoresis and fluorography.
35
After short pulses with [ S[ methionine; labelled precursor forms are found 
in the cytosol (Morita et al., 1981; Reid & Schatz,1982b). However, 
most precursors have short half-lives (approx. 1-5 min) and their pool 
sizes are very small.
Import into the mitochondrial matrix, inner membrane and inter­
membrane space requires an electrochemical potential across the inner 
membrane. Precursors destined for these compartments, can be accumulated 
in the cytoplasm if cells are labelled in the presence of uncouplers 
such as CCCP, DNP and FCCP.
If translocation is blocked while translation is allowed to continue, 
the pool size of precursors becomes large enough to be detected in short­
term labelling experiments. Although the stability of different 
mitochondrial precursors accumulating in the cytosol varies considerably, 
many of them appear to be sufficiently stable to allow detection.
Another in vivo strategy has been employed with petite (rho ) 
mutant yeast cells in which import of mitochondrial proteins has been 
blocked with the uncoupler CCCP. Rho mutants of S. cerevisiae contain 
defective mitochondria but normal import/processing mechanisms. In 
the presence of CCCP, these cells can accumulate precursors in substantial
amounts which allow their detection directly by immunoblotting 
techniques. (Reid & Schatz, 1982a).
The physiological importance of a biosynthetic pathway is better 
demonstrated in the in vivo systems using pulse-labelled yeast sphero- 
plasts, primary hepatocytes and various cultured cells. However, only 
a limited number of studies has been carried out in animal cells using 
this approach to date.
The availability of high-quality antisera directed specifically 
against PDC and its individual subunits as well as established cell 
lines that expressed the enzyme were vital prerequisites for undertaking 
these studies using the in vivo approach. Optimisation of biosynthetic 
labelling of cells with radioactive methionine, extraction of cell 
proteins and antigen immunoprécipitation were gradually developed during 
this study until they produced consistent and satisfactory results.
3
8.2 Immunoprécipitation studies with H-labelled PDC
In order to standardise the immunoprécipitation studies, pre­
liminary experiments were conducted with purified PDC using various 
immunoprécipitation protocols. Detection of the immunoprecipitated 
products was facilitated by labelling free thiol groups on the enzyme
3
with N-[ H] ethylmaleimide.
Fig. 8.1 demonstrates the pattern of radioactive polypeptides 
obtained from the native and denatured complex. Fluorographic analysis 
indicated that in the native complex only the El component was labelled 
to a significant extent (in the absence of pyruvate), whereas in the 
dissociated state subunits E2 and E3 were labelled also. This difference 
probably arises from exposure of thiol groups in the E2 and E3 polypeptide 
chains following unfolding of the proteins in the presence of SDS.
No significant incorporation of radioactivity into component X could be 
detected under these conditions.
Fig. 8.1 Subunit labelling of denatured and native PDC with
3
N-[ Hlethylmaleimide
SDS-dissociated and native PDC (100 ug protein) were labelled by
3
treatment with 50 uCi N-[ H] ethylmaleimide as described in section
3
2.2.13. Samples of PDC were mixed with H-labelled enzyme
(approx. 5,000 d.p.ra.) before resolution on a 10% (w/v) polyacrylamide
slab gel. After staining with Coomassie Blue (A), the gel was processed
for fluorography (B).
(A and B) Lane 1, SDS-denatured . PDC sample; lane 3, native
125
PDC sample; lanes 2 and 4, I-labelled standards.
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Immunoprécipitations were performed initially with H-labelled 
PDC in Triton buffer (gee section 2.2.11,e) , by double immuno­
précipitation and S. aureus techniques. The advantages of the latter 
technique in terms of rapidity and lower background due to non-specific 
binding were soon obvious. Furthermore, the large amounts of pre­
cipitating immunoglobulins present in the immunocomplexes using the 
double-antibody technique caused some distortion of resolution in the 
region of 50,000 owing to migration of heavy chains of IgG.
Some of the parameters investigated in this sytem were as follows:
a) amount of antibody required for quantitative recovery of antigen,
b) effects of the composition of the washing buffer and c) type of 
subunit precipitated by the antisera.
Fig. 8.2 shows the polypeptide composition of the immunoprecipitated 
products obtained with antiserum to native PDC (A), anti-El a serum (B) 
and anti-E2 serum (C).
Antiserum to PDC was capable of immunoprecipitating all the 
components of the complex except subunit E3. Analysis of the supernatant 
fraction after immunoprécipitation showed that intact E3 subunit remained
in this fraction and was not selectively degraded during the procedure.
3
Immunoprecipitated products from H-labelled PDC with antisera to 
El o and E2 subunits showed that in each case only the corresponding 
specific protein was selectively immunoprecipitated.
8.3 Biosynthetic labelling and extraction of cell proteins
For studies on the biosynthesis of PDC, it was necessary to 
incorporate radioactive amino acids into the newly-synthesised 
components of the complex, before monitoring the fate of radioactivity 
by selective immunoprécipitation, SDS/polyacrylamide gel electrophoresis 
and fluorography.
3
Fig. 8,2 Immunoprécipitation of subunits from dissociated H-labelled PDC
3
SDS-denatured PDC labelled with N-[ H] ethylmaleimide (approx.
30,000-50,000 c.p.m.) was incubated with anti-PDC (A), anti-El ot (B) 
or anti-E2 sera in Triton-buffer (0.01 M-Tris/HCl buffer, pH 7.4, 1%
(v/v) Triton X-100, 0.3 M-NaCl, 5 mM-EDTA) as described in section
2.2.12.f. Immune complexes were adsorbed onto formalin-treated
S.aureus cells before fluorographic analysis of the proteins resolved 
on 10% (w/v) polyacrylamide slab gels.
3
(A and B) Lane 1, H-labelled PDC before immunoprécipitation; 
lanes 2 and 4, control immunoprecipitates with 10yjl and 5yul pre-immune 
serum, respectively. (A only) Lanes 3 and 5, immunoprecipitates with 
lO^pl and 5yul anti-PDC serum. (EJ) Lanes 3 and 5, immunoprecipitates 
with anti-El a serum, 20yil and 10yil, respectively. (C) Lanes 1 and 
2,immunoprecipitates with 10yjl and 5yul of anti-PDC serum, respectively; 
lanes 3 and 4, immunoprecipitates with 20yil and 10yil anti-E2 serum, 
respectively.
(A) (B)
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Cultured cellswere labelled with [ S] methionine (100-250yUCi/ 
dish). This isotope was chosen since it is available at high specific 
activities (> 1000 Ci/mmol) and its high energy of emission enhanced 
the sensitivity of detection by fluorography. Amino acid composition 
data has revealed a relative abundance of methionine in all PDC 
components (Barrera et al., 1972; Hamada et al., 1975; 1976).
Cells were grown at 37°C in standard medium and labelled in semi­
confluent monolayers at which stage, the cells were still growing 
rapidly.
35
Linear incorporation of [ S] methionine into TCA-precipitable 
material was obtained for periods of up to 8 h. After 16-20 h labelling 
between 80-95% of the tracer was incorporated into protein. For short 
labelling periods (up to 4 h) optimal incorporation was found after 
preincubation for 1 h in a methionine-deficient medium.
Optimisation studfes on the kinetics of incorporation of radio­
activity into proteins in various labelling media indicated that 
radiolabelling was almost as rapid and high in low methionine medium (see' 
section 2.1.2) than in a medium containing no added methionine 
and no serum.
Solubilisation of cells was performed by quickly mixing the 
washed monolayers with sterile lysis buffer containing protease 
inhibitors and inhibitors of processing (PMSF, leupeptin and 1,10- 
phenanthroline) as indicated in section 2.2.11.e. The non—ionic
detergent Triton X-100 completely solubilised the cells while allowing 
the removal of nuclei and many elements of the cytoskeleton by a short 
centrifugation. Preliminary studies also indicated that direct 
solubilisation of the cells' in hot SDS, a procedure normally used for 
yeast spheroplasts and Neurospora hyphae, led to high backgrounds in
165
immunoprecipitates caused by non-specific binding. The nuclear pellets 
lacked any detectable PDC as checked by immunoblotting analysis of this 
fraction.
Incorporation of radioactivity into cell protein was usually
determined by direct counting of 5yul of the labelled extract.
Approx. 95-98% of the counts were TCA-precipitable.
8.4 Immunoprécipitation of mature PDC polypeptides
Preliminary studies showed that the composition of the extraction-
washing buffer was critical in optimising the detection of PDC poly-
35
peptides by immunoprécipitation techniques from S-labelled cell extracts.
3
Even when good yields (70-80%) of immunoprecipitated H-labelled PDC
35
were obtained in Triton buffer, immunoprecipitates from S-labelled 
cell lysates using this buffer system were not satisfactory. High 
levels of background radioactivity were found which could not be ascribed 
to poor specificity of the antiserum.
The background radioactivity in the form of contaminating 
polypeptides that associated non-specifically with immunocomplexes was 
very characteristic of the type of cell. Persistent contamination with 
the 44,000-M^ actin band which appears to have strong affinity for 
immunocomplexes was found (Barber & Delovitch,l978).
Preincubation of the extracts with fixed S. aureus cells for 2 h 
at room temperature followed by removal of the cells before adding the 
antibody (pre-adsorption) was not effective in reducing contamination 
and led to a decrease in recovery of antigen. Therefore, a number of 
modifications were attempted by changing the pH, salt concentration and 
type and concentration of detergents.
A 3-D TKM immunoprécipitation system implemented in this study 
(section 2.2.l2.f) gave satisfactory results. The increased 
sensitivity of the detection following reduction of the background by
166
stringent washing conditions did not seem to alter the binding of the 
antibody and also promoted dissociation of the complex. Good yields
3
(approx. 80%) of immunoprecipitated H-labelled PDC were also obtained 
in the 3-D TKM buffer system.
Cultured cells were labelled for 16-20 h in the presence of 100 uCi
35
[ S] methionine. Aliquots of the cell extracts (100-200 ul) containing 
6 35
10 X 10 c.p.m. S-labelled proteins were immunoprecipitated with lOyil 
anti-PDC serum and 50yil of a 10% (w/v) suspension of S. aureus cells.
Fig. 8.3 shows the results obtained with bovine kidney cells.
Bands corresponding to the values for subunits E2, E3, El a and 
El 6 were clearly seen in the immunoprécipitation products. Identity 
of these bands with PDC polypeptides was confirmed as excess unlabelled 
PDC or isolated PDC components competed with the in vivo immunoprecipit­
ated products for interaction with the antibody.
Effective immunocompetition was dependent on the amount of 
unlabelled protein. Binding of subunit E2 was poorly competed out by 
either PDC or subcomplex E2-X at the levels of protein used in the 
experiment shown in Fig. 8.3.
No bands corresponding to the M values of component X could be 
identified in the immunoprecipitates.
8.5 In vivo synthesis of precursors to PDC
It has been reported that the import of some mitochondrial matrix 
proteins can be inhibited by CCCP or DNP (Reid & Schatz, 1982b;
Jaussi et al.. 1982; Fenton et al., 1984) or p-aminobenzamidine
(Raymond & Shore, 1981). Since preliminary pulse-labelling experiments
35
using high levels of [ S] methionine were unsuccessful, precursors to 
PDC were accumulated after incubation of cultured cells in the presence 
of varying concentrations of FCCP and DNP during the labelling period.
Fig. 8.3 Identification of mature PDC components in bovine kidney cells 
by immunocompetition
Semi-confluent monolayers of bovine kidney cells (NBL-1) were
35
labelled in low-methionine medium for 18 h with 100 uCi [ S] methionine 
per dish. Cells were disrupted and aliquots (10 x 10 c.p.m.) of the
extracts were subjected to immunoprécipitation with 10yil of anti-PDC 
serum as described in sections 2.2.11.e and 2.2.12.f. Before the 
addition of antiserum, various subunits of PDC were added at the levels 
indicated below. Labelled proteins present in the immunocomplexes were 
adsorbed to S.aureus cells and analysed by fluorography after resolution
on SDS/polyacrylamide gels.
3
Lane S, H-labelled PDC; lane 1, immunoprecipitate with anti-PDC 
serum with no additions; lane 2, plus 5yig PDC; lane 3, plus 5yig 
component X; lane 4 and 5 plus 2.5 yjg and 5yig Peak II from gel 
filtration (El plus E3) respectively; lanes 6 and 7, plus pig heart E3 
5yig and 10yig, respectively; lane 8, plus 5yig of subunit El 6 ; lanes 
9 and 10, plus pyruvate dehydrogenase component (El) 6yig and 12yig, 
respectively; lane 11, plus Peak I from gel filtration (E2 plus X) 15yig.
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Approx. 150-250 x 10 c.p.m. [^^S] methionine were incorporated/ 
dish in the absence of uncouplers. The inclusion of FCCP or DNP 
caused marked morphological changes in the cells and reduced the 
incorporation of label significantly (up to 50%).
Fig. 8.4 shows that in the presence of lOyiM-FCCP, four slowly 
migrating bands are observed in the immunoprécipitation when compared 
with the mature subunits (lanes P and P^) detected in the absence of 
uncoupler. Similar results were obtained with extracts from cells 
labelled in the presence of 1-2 mM-DNP. This narrow range of effective 
uncoupler concentration was chosen after preliminary experiments 
showing that concentrations of FCCP below 5yiM had no effect on 
processing of precursors. Similarly, concentrations of 4 mM-DNP, used 
by previous authors, proved to be toxic and drastically reduced the 
viability of the cells.
Labelling in the presence of 2 mM-DNP for 4 h, followed by a 
40 rain chase in the absence of uncoupler showed that conversion of these 
bands into the mature proteins was complete (Fig. 8.3, B, lane ch).
Similar results were obtained with pig kidney cells with one 
major difference. While Fig. 8.5 shows that the subunit E3 was absent 
from the final immune complexes isolated from untreated cells (lanes 
P and Pj^ ), this band was present in the immunoprecipitates from NBL-1 
and BRL cells.
In Fig. 8.5, it was also possible to detect that only partial 
inhibition of processing had occurred in the presence of 1 mM-DNP.
Higher M^ bands were clearly detectable as well as bands corresponding
to the mature proteins. If cells were incubated in 2 mM-DNP, the
mature bands disappeared and only bands corresponding to the unprocessed
polypeptides were visible. Partial processing was also observed after 
incubation in the presence of 10^M-FCCP. After a subsequent chase
Fig. 8.4 Dectection of precursor and mature forms of PDC components 
in cultured bovine kidney cells
Semi-confluent monolayers of bovine kidney cells (NBL-1) were
35
labelled for 4 h in a medium containing 200^Ci [ S] methionine in
the absence or presence of FCCP (A) or DNP (B) at the final concentrations
indicated.
Immunoprécipitation with anti-PDC serum, electrophoresis of the 
dissociated immunocomplexes and fluorography were performed as indicated 
in sections 2.2.12.f and 2.2.6.e (see also legend Fig. 8.3).
3
Lane S, H-labelled PDC; lane C, immunoprecipitates with pre- 
immune serum; lanes P and P^, immunoprecipitates from cells labelled 
in the absence of uncouplers for 4 h or 18 h, respectively; lane ch, 
immunoprecipitates from extracts of DNP-treated cells after a 40 min 
chase in the absence of uncoupler.
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Fig. 8.5 Biogenesis of PDC components in cultured pig kidney cells
Monolayers of pig kidney cells (PK-15) were incubated for 4 h in
35
a medium containing 200yiCi [ S] methionine in the presence of DNP 
or FCCP at the indicated concentrations. Some dishes were "chased" 
for a 40 rain period in the absence of uncouplers. Immunoprécipitation 
with anti-PDC serum or pre-lramune serum, electrophoresis and fluorography 
were performed as described in sections 2.2.12.f and 2.2.6.e.
3
Lane S, H-labelled PDC; lane C, control immunoprecipitates; 
lanes P and P^; immunoprecipitates from cells labelled in the absence of 
uncouplers for 4 and 18 h, respectively; lanes ch, immunoprecipitates 
after chase from DNP-treated or FCCP-treated cells, respectively.
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period of 30 min the precursor forms were converted completely to the 
mature forms (lanes ch).
It was obvious that small changes in the concentration of 
uncouplers seemed to cause dramatic effects in the processing of 
precursors to PDC polypeptides. Moreover, in different cell types, 
differential effects on processing could be achieved for a given 
concentration of inhibitor. This can be attributed to particular 
characteristics of the cells regarding their sensitivity to the 
uncoupler and/or variability in the experimental parameters e.g. cell 
density, viability and rate of growth.
8.6 Time course of precursor processing in cultured cells
The kinetics of disappearance of precursor forms was determined
35
after incubating the cells with [ S) methionine in the presence of 
2 mM-DNP, followed by different times of chase after release of 
inhibition.
Fig. 8.6 shows the results of such experiments performed in rat 
liver (A) and pig kidney (B) cells. Lane 0 indicates the accumulated 
precursors present at the start of the chase while the following lanes 
correspond to the products which were recovered at various times 
thereafter. In the absence of the uncoupler, newly-processed enzyme 
was observed with a concomitant decrease in the amount of precursor. 
This strongly suggested that the import was an energy-dependent process, 
as has been shown previously for many other matrix proteins.
Precursor forms were rapidly converted into the mature forms 
with a half-lives (ti) of 15-20 min in rat liver and 10-12 min in 
pig kidney cells. At present, it is not known if these differences 
arise from experimental variability or reflect differences in the rate 
of processing of PDC precursors in the two types of cell.
Fig. 8.6 Kinetics of processing of precursors to mature PDC subunits in 
pulse-chase experiments
Rat liver (A) or pig kidney cells (B) were labelled for 4 h with 
35
200yiCi [ S] methionine in the presence of 2 mM-DNP. The medium was 
removed and the cells chased in normal growth medium containing no 
uncoupler. Cell extracts were obtained at the indicated times 
(0-40 min) and subjected to immunoprécipitation with anti-PDC serum 
followed by electrophoresis and fluorography as described in section 
■2.2.12.f.
3
Other lanes; lane H-labelled PDC; lane C, control immuno­
precipitates; lane P, immunoprecipitates from cells labelled in the 
absence of DNP.
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Half times for in vivo processing of precursor to mature 
mitochondrial matrix enzymes have been estimated as 2-10 min. These 
include pre-ornitine transcarbamylase (approx. 2 min; Mori et al., 1981a); 
pre-carbamyl phosphate synthetase (2 min; Raymond & Shore, 1981; Mori 
et al., 1981a); pre-aspartate aminotransferase (1 min; Jaussi et al..
1982); pre-methyl-malonyl-CoA mutase (6-9 min; Fenton et al., 1984) 
and 10 min for serine: pyruvate aminotransferase (Oda et al», 1984).
It is possible that the half times for processing and transport of 
mitochondrial precursors differ between mitochondrial proteins. Another 
possibility is that the inhibitor may have additional toxic effects on 
the cells that may prevent rapid reversal. In this respect, it may be 
of interest to determine the kinetics of processing after shorter 
labelling periods in the presence of uncouplers.
The kinetics observed for the individual precursors seem to be 
similar, which suggests that processing in vivo occurs in a coordinated 
manner for the various components of the complex.
8.7 Stability of precursor forms in cultured cells
Data presented in Fig. 8.7 shows that precursor forms of PDC 
were very stable in rat liver and pig kidney cells when processing was 
inhibited by DNP. Even after a 4.5 h chase, a substantial amount of 
the pre-E2 could still be found, suggesting a half-life of several 
hours under these conditions. However, as shown in Fig. 8.7 B, 
after 2 h, appreciable degradation of the precursor to El a subunit 
had taken place. After 3 h, additional bands presumably corresponding 
to degradation products were also apparent.
These results are similar to those reported for pre-methyl- 
malonyl-CoA mutase in rat liver cells, but contrasts with several 
other studies on the stabilities of rat liver pre-carbamyl phosphate 
synthetase (Raymond & Shore, 1981) and pre-aspartate aminotransferase
Fig. 8.7 Stability of precursor forms to PDC components in the 
presence of DNP
Rat liver (A) or pig kidney (B) cultured cells were labelled 
35
with 200yiCi of [ S] methionine in the presence of 2 mM-DNP, Cêlls 
were then "chased" for the indicated times (0-4.5 h) in a normal growth 
medium containing the same concentration of uncoupler. Cell extracts 
were immunoprecipitated with anti-PDC serum and analysed by fluorography 
after electrophoresis in SDS-polyacrylamide gels as described in sections
2.2.12.f. and 2,2.6.e.
3
Lane S, H-labelled PDC; lane P, immunoprecipitates from cells 
labelled in the absence of DNP; lane C, control immunoprecipitates.
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in chicken embryo fibroblasts (Jaussi et al., 1982). In those two 
cases, blockage of processing led to destruction of the precursors 
within 5-15 min. Several possibilties to explain this long term 
stability have been discussed by Fenton et al. (1984). One is that 
the precursors may be protected from degradation by endogenous proteases 
by their interaction with mitochondria or that precursors have confor­
mations that avoid proteolytic attack from endogenous proteases.
8.8 Identification of precursor forms with subunit-specific antisera
Conclusive identification of the precursor forms corresponding 
to the individual subunits of the complex was achieved by performing 
immunoprécipitation studies with subunit-specific antisera.
Fig. 8.8 shows the immunospecific products obtained with 
antiserum to subunit E2 in bovine kidney (A) and pig kidney (B) cells.
When the cells were labelled in the presence of 2 mM-DNP a component 
M 78,000 appears in the immunoprecipitated products, corresponding to 
the precursor to subunit E2 (lanes 2). The precursor has a similar 
size in these two cell lines. Its identity was confirmed as it was 
competed out from the final immunoprecipitates with 5yig of subcomplex 
E2-X. The mature form was only competed effectively when 15yig of 
sub-complex E2-X were added (lanes 3 and 3').
In immunoprecipitates with this antiserum an additional band 
of variable intensity appeared at values of 48,000. Assuming 
that this is a contaminating protein that binds non-specifically to the 
immunoprecipitates, harsher conditions of washing or previous purification 
of the anti-E2 IgG from serum may prove to be effective.
Fig. 8.9 shows the results with antiserum to lipoamide dehydro­
genase in pig kidney and rat liver cells. Gel (A) shows that anti-E3 
antiserum is capable of immunoprecipitating the mature (lanes 1, 3 and 
4) and precursor form (lanes 2) 57,000 for E3 component in both
Fig. 8.8 Identification of precursor to subunit E2 by immunoprécipitation 
with anti-E2 serum
Bovine kidney cells (A) or pig kidney cells (B) were labelled for
35
4 h in a medium containing 200yiCi [ S] methionine and 2 mM-DNP. Cell 
extracts were obtained and subjected to immunoprécipitation with anti-E2 
serum. Imraunocotnplexes were dissociated and labelled proteins analysed 
by fluorography after electrophoresis on 10% (w/v) polyacrylamide slab 
gels.
3
Lane S, H-labelled PDC; lane C, control immunoprecipitates; 
lane P, immunoprecipitates with anti-PDC serum from cells labelled in 
the absence of uncoupler; lane 1, immunoprecipitates with anti-E2 serum 
from cells labelled for 4 h in the absence of uncoupler; lane 2, 
immunoprecipitates with anti-E2 from cells labelled in the presence 
of DNP; lane 3 immunoprecipitates with anti-E2 from cells labelled for 
18 h in the absence of uncoupler; lanes 1*, 2' and 3’, as lanes 1, 2 
and 3, except that 5yug, 5yig or 15yig of subcomplex E2-X were added 
before antiserum, respectively.
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Fig. 8.9 Identification of precursor form to lipoamide dehydrogenase
(E3) using subunit-specific antiserum
Monolayers of pig kidney cells (A) or rat liver cells (B) were
35
labelled in the presence of 2 mM-DNP and 200yuCi [ S] methionine.
After 4 h, the medium was removed from some dishes and replaced by 
normal growth medium for a chase period of 30 min. After immuno­
précipitation, proteins were resolved in a 7% (w/v) SDS/polyacrylamide 
gel (16 cm X 17 cm) and the gel was processed for fluorography as 
described in Methods section 2.2.6.e.
3
Lane S, H-labelled PDC; lane C, control immunoprecipitates;
lanes P^ (A and B) immunoprecipitates from cells labelled in the absence
of uncoupler with antiserum to PDC; lane P^ as P^ except that 5yag of
pig heart E3 was added before antiserum; lane P^ as lane P^ except
that a cell extract from rat liver was used instead; lanes 1, 2, 3 and
4 correspond to immunoprecipitates with anti-E3 serum from cells labelled
in the absence of uncoupler, in the presence of 2 mM-DNP, DNP-treated
after chase and in the absence of uncoupler for 20 h, respectively;
125
M, I-labelled M^ standards.
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types of cell. In rat liver as well as in bovine kidney cells 
(see Fig. 8.3), subunit E3 is detectable with the other components of 
the complex when anti-PDC serum is employed for immunoprécipitation, 
but this component is absent from the immunoprécipitation obtained from 
pig kidney cells (lanes and P^). In Fig. 8.9 (B), a direct comparison 
between rat liver and pig kidney cells is possible (lanes P^ and P^), 
there was also a slight difference in the values of the mature E2 
subunit, as detected previously by immunoblotting experiments (Fig. 4.4). 
Fig. 8.10 shows the results obtained with antiserum to subunit El a in 
rat liver cells. The precursor form M 45,000 was detectable with 
antiserum to PDC (lane P^) and also with anti-El a serum when the cells 
were labelled in the presence of 1-2 mM-DNP. After a chase period of 
30 min, a band corresponding to mature El a subunit was clearly seen 
(lane ch).
The presence of a contaminating band at M 44,000 presented 
difficulties in assigning an accurate value to the precursor of 
subunit El a (Fig. 8.10, B). The inclusion of non-radioactive actin 
(2.5yig) in the immunoprécipitation assays, substantially reduced this 
contamination permitting a more reliable estimate (not shown).
Fig. 8.11 shows the results obtained with antiserum to subunit 
El B in bovine kidney cells. Precursor to this protein was identified 
as a band of 40,000 (lane 1) which is converted to the mature 
component after a 30 rain chase (lane 2).
Table 8.1 summarises data on the determination of values for 
precursors to individual PDC polypeptides in the cultured cells studied.
Values of 59,000 for the pre-E3 polypeptide has been reported 
by Matuda et al. (1983) for the rat liver enzyme using an in vitro 
translation system. This estimate is slightly higher than the value 
determined from in vivo studies. The small difference in value
Fig. 8.10 Immunoprécipitation of precursor and mature forms of El a
in rat liver cells with subunit-specific antiserum
Semi-confluent monolayers of rat liver cells were labelled for 
35
4 h with 150yiCi [ S] methionine in the presence of the indicated 
concentrations of DNP. In (B) DNP-treated cells were "chased" for 
30 min in the absence of uncoupler before harvesting. Immunoprécipitation, 
electrophoresis and fluorography were performed as described in sections
2.2.12.f and 2.2.6.e.
3
Lane S, H-labelled PDC; lane C, control immunoprecipitates.
(A and B), Lanes 1 and 2, immunoprecipitates with anti-El a 
serum from cells labelled in the absence of uncoupler for 4 h or 18 h 
respectively. (B) Lane P^, immunoprecipitates with antiserum to PDC; 
from cells labelled in the absence of uncoupler lane P^ as P^ but the 
cells were labelled in presence of 2 mM-DNP; lane ch,immunoprecipitates 
with anti-El o serum from DNP-treated cells after chase.
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Fig. 8.11 Identification of the precursor and mature forms of El 6 
with subunit-specific antiserum
Monolayers of bovine kidney cells were incubated with 200 uCi
35
[ S] methionine in the presence of 2 mM-DNP. After 4 h labelling, 
cells were "chased" for 30 min before harvesting. Immunoprécipitation, 
electrophoresis and fluorography were performed as described in sections
2.2.12.f. and 2.2.6.e.
3
Lane S, H-labelled PDC; lane C, control immunoprecipitates; 
lane P^ immunoprecipitates with anti PDC serum from cells labelled 
in the absence of uncoupler; lane P^ as P^ except that 5yug of 
purified El B protein were added before antiserum; lanes 1, 2 and 3, 
immunoprecipitates with anti-El 6 serum from cells labelled in the 
presence of 2 mM-DNP, DNP-treated cells after chase and cells labelled 
for 18 h in the absence of uncoupler, respectively.
pre-El/3
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Table 8.1 of precursors to PDC polypeptides as estimated by
SDS/polyacrylamide gel electrophoresis
Polypeptide
Apparent M
Mature Precursor
Dihydrolipoyl acetyltransferase 70,000
Lipoamide dehydrogenase
Component X
55.000
52.000
78.000 ± 1,000
57.000 ± 1,000
Pyruvate dehydrogenase 
subunit El a 42,000 45,000 ± 1,000
Pyruvate dehydrogenase 
subunit El g 36,000 40,000 ± 1,000
* In rat liver cells, these values correspond to 68,000 and 76,000 ± 1,000 
for the mature and precursor forms, respectively.
with respect to the mature enzyme is reflected in the difficulty in 
separating the two proteins in 7% (w/v) SDS/polyacrylamide gels 
(Fig. 8.9).
Component X remained undetected in the immunoprecipitated 
products using anti-PDC serum. Occasionally, a band at the expected 
value was observed (as in Fig. 8.9, lane P^). This could be related 
to the low abundance of this polypeptide in comparison with the other 
subunits of PDC and/or to its low content of methionine as indicated 
by preliminary amino acid composition data (J.A. Hodgson, unpublished 
results) •
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Chapter 9; GENERAL DISCUSSION
Mammalian PDC has been studied extensively during the last 
fifteen years. In particular its enzymatic and physicochemical 
characteristics have been the subject of detailed examination following 
its isolation from several tissues (Koike & Koike, 1976).
The regulation of this multienzyme complex by phosphorylation/ 
dephosphorylation has also received considerable attention, as a result 
of its importance in the conservation of glucose in starvation and 
diabetes (Reed et al., 1980; Denton et al., 1981; Wieland, 1983). 
However, studies on the areas related to the biosynthesis, transport 
and assembly of the complex, as well as aspects of its long term 
regulation have been largely neglected (Hu et al.,1983).
The production of well-characterised specific antibodies against 
the native complex and its individual subunits was a necessary pre­
requisite for monitoring the events involved in the biosynthesis of 
the complex. During the immunological analysis of the complex, 
additional important features were revealed, which were relevant to 
the structure function and intracellular location of this enzyme.
9.1 Immunological studies on mammalian PDC
A major observation from our early immunological studies was 
that the lipoamide dehydrogenase subunit elicited a poor immunological 
response relative to the other major polypeptides of the complex. 
Evidence for this conclusion was obtained by immunoblotting analysis 
and direct immunoprécipitation studies of the dissociated multienzyme 
complex, in which E3 was excluded from the final immune complexes.
35
However, immunoprecipitates with anti-PDC serum from [ S] methionine- 
labelled cell lysates from cultured bovine and rat cells, but not from 
porcine kidney cells, showed a band corresponding to this subunit.
1/5
These results could be attributed to the use of later bleedings of the 
antiserum for these experiments,containing a higher titre for this 
protein and/or lower cross-reactivity with the pig kidney as compared 
to the bovine and rat enzyme. It is also possible that interaction 
with the pig kidney enzyme may involve primarily low affinity anti­
bodies. Thus immune complex formation, in this case, may be disrupted 
by the stringent washing conditons used for immunoprécipitation.
The low immunogenicity of the E3 component was also observed
3
after imrauno-blotting analysis and immunoprécipitation of the H-labelled 
2-oxoglutarate dehydrogenase complex (De Marcucci et al., 1985a). This 
property of the E3 component may be interpreted as resulting from a high 
degree of conservation of amino acid sequence in this polypeptide.
The complete sequence of the E. coli enzyme has been determined 
by analysis of the cloned gene (Stephens et al., 1983). A remarkable 
degree of sequence homology was detected with tryptic peptides of the 
pig heart enzyme. Since E3 is a common component of the three 2-oxo- 
acid dehydrogenase complexes, it is feasible that this property has 
imposed constraints on amino acid substitdion during evolution to 
preserve its differing and multiple interactions with the other subunits 
in these complexes.
Interactions between PDC and its specific antisera could also 
be useful for studies on structural/functional aspects of the enzyme, 
nature of lesions in inborn errors of metabolism and to assess 
evolutionary relationships between various organisms. The value of 
these studies would depend on the experimental approach on which they weie 
based and on the heterogenous population of antibodies present in each 
particular antiserum. Application of immunological methodology to 
solve these problems has been discussed in excellent reviews by 
Cinader (1977) and Nagradova & Grozdova (1978).
17b
Results described in this study demonstrate immunological 
relationships between the El S , E2 and E3 subunits of the S. cerevisiae 
PDC and the El subunit of the E. coli PDC with the ox heart complex.
The major method of examining evolutionary homologies between 
proteins is to investigate similarities in their amino acid sequence, 
either directly or by DNA sequencing. However, homologies can also 
be studied by immunological methods. The identification of common 
antigenic determinants is not necessarily indicative of a close 
relationship between species, as the same or related determinants 
could have arisen independently several times during evolution.
In this study, preservation- of common antigenic determinants 
of PDC from prokaryotic to higher eukaryotic organisms was demonstrated 
by immunoreplica analysis. It may be interesting to extend these 
studies to several other species and to quantitate their immuno- 
reactivity.
Quantification by immunoblotting analysis is difficult in view 
of the incomplete or variable transfer of proteins from polyacrylamide 
gels to nitrocellulose (Ghersone & Palade, 1983). Therefore, this 
could be attempted by other methods such as the nitrocellulose enzyme- 
linked iromunoadsorbent assay developed recently for studies on 
immunological differences between cytochrome c oxidase isoenzymes 
(Kuhn-Nentwig & Kadenbach, 1985).
Of particular interest are the challenging opportunities for 
for application of immunological techniques to the study of inherited 
defects of PDC. A number of cases of children with persistent lactic 
acidosis and pyruvic acidosis, developmental retardation and neuro­
logical disease have been described. In several of these patients, 
deficiencies of PDC component enzymes (or pyruvate carboxylase) have 
been detected by activity measurements of the enzymes in tissue
extracts (Cederbaum et al., 1976; Koike et al., 1981; Borud &
Pettersen, 1982; Matuda et al., 1984). It seems apparent that 
deficient oxidation of pyruvate leads to impaired production of 
AcSCoA and to accumulation of lactate in the blood.
9.2 Functional and structural studies on component X
An unexpected and interesting observation in this study was that 
ox heart PDC contained an extra polypeptide M^ 51,000±1,000 of unknown 
function (component X). Its immunological identity was established by 
employing highly sensitive immunoblotting techniques with several 
monospecific antisera (De Marcucci & Lindsay, 1985).
Component X may be a unique polypeptide of this multienzyme complex 
as no similar protein was detected in the analogous species of 2-oxo-acid 
dehydrogenase complexes: 2-oxoglutarate dehydrogenase complex, responsible
for oxidative decarboxylation of 2-oxoglutarate in the citric acid cycle
and the branched chain 2-oxo-acid dehydrogenase complex involved in the
catabolism of leucine, isoleucine and valine. This may indicate a role
for component X in the metabolism of two-carbon units.
A peptide subunit M 50,000 has also been detected in the yeast 
( .^ cervisiae and _S. carlsberguensis) complex (Kresze & Ronft, 1981a;
Keha et al., 1982). It is still an attractive possibility that this 
polypeptide may be immunologically and functionally related to the 
mammalian component X.
On the structural aspects, protein X seems to be associated with 
the remaining components of the complex in reproducible amounts.
The protein co-elutes with the peak fraction, 8.5 x 10^, in the 
final step of purification of the complex by gel filtration chromatography 
on Sepharose CL-2B columns. It also co-migrates with the peak of enzyme 
activity after sucrose-density gradient centrifugation in the presence
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of 0.1 M-KCl and 1% (v/v) Triton X-100.
Based on quantitative scanning of Coomassie Blue-stained bands 
of the complex in SDS/polyacrylamide gels, it appears that 6% of the 
total absorbance^ is represented by this component using the Laemmli 
gel system. On the other hand, component X retains 14-16% of the 
total radioactivity associated with the complex after labelling in the 
presence of [2- C] pyruvate. Assuming one "acetylatable" group per 
molecule of X, an estimate of 8-10 molecules of polypeptide/core is 
obtained which agrees with the value calculated on the basis of 
densitometric scans of 8-12 molecules of component X per core. This 
is a provisional conclusion, since more reliable stoicheiometric 
analysis is necessary by methods already available in the literature 
(Bates et al.. 1975; Hale et al.. 1979).
The accessibility of component X to proteolytic attack by papain 
or elastase in the native assembly and its binding to specific anti­
bodies, suggests that at least part of its polypeptide chain is 
exposed on the surface of the complex.
Incubation of the complex in the presence of [2-^^C] pyruvate 
promotes acétylation of covalently-bound lipoyl groups in E2 while also 
acetylating component X. This may be the main reason for the previous 
suggestion that component X was a degradation product of E2 (Machicao & 
Wieland, 1980; Bleile et al., 1981). Inactivation of the complex by 
phosphorylation by the intrinsic protein kinase, causes a parallel 
decrease in the acétylation of E2 and X, indicating that this latter 
protein can participate in the acetylation/deacetylation reactions of 
the complex. This result suggests that loading of protein X must 
proceed through the formation of hydroxyethyl groups on the El component. 
As shown in the scheme below, it is not clear if X is acting as an 
intermediate in this process, i.e. if El can transfer acetyl groups
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directly onto component X and then pass them onto E2, reactions 2, 3 
and 4 in the scheme below, where X is an essential intermediate 
of the catalytic process. Alternatively, X may be an associated 
enzyme in equilibrium with E2 (reactions 1, 3 and 4).
 CoA.^
1 X E2 *■-------- AcSCoA
XN'*' .CoA
2 * X : :::± acSCoa
pyruvate-------- »■ El^
Other physiological 
hypothetical acceptors
reactions
Component X may be directly involved in transferring acetyl 
groups into CoA (reaction 5) and/or to other unknown physiological 
acceptors (reaction 6).
At present, several compounds have been tested for their capacity 
to promote deacetylation of the complex. Carnitine and acetoacetate 
have proven to be ineffective. Various thioesters were capable of 
facilitating release of radioactivity from the enzyme, but none were 
shown to promote preferential deacetylation of component X. This 
result could be due to their content of free CoA (0.5-5%; Ellman, 1959) 
or to the capacity of these compounds to acylate these proteins. 
Rahmatullah et al. (1985b) have reported that acylation of both the 
core component and protein X follows incubation' of the enzyme in the 
presence of radioactive propionyl-CoA, malonyl-CoA and acetyl-CoA.
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The relative abundance of component X in prejarations of the 
complex (approx. 6%) argues against its possible role as a regulatory 
component of the complex. However, Roche and co-workers have advanced 
the idea that PDC may be regulated by the degree of acétylation of the 
complex. In support of this concept, they have shown that pyruvate 
dehydrogenase kinase activity is stimulated at low levels of acétylation 
of the complex. They have suggested the involvement of a few lipoyl 
groups in this effect or the participation of a protein containing 
lipoyl groups which functions as a regulatory subunit of the kinase 
(Cate & Roche, 1978; 1979).
The probable identity of this putative protein with component X 
is now being under experimental investigation by this research group 
(Roche & Rahmatullah, 1985; Rahmatullah et al., 1985a; Rahmatullah 
et al.,1985b).
It does not seem unreasonable to suppose that component X is an 
isoenzyme of E2, particularly since it is probable that it also contains 
lipoic acid (J.A. Hodgson, unpublished results). In this respect, 
there could be two subpopulations of PDC arising from complexes containing 
either E2 or X core subunits. However, at present, immunological 
inspection of PDC in several cell lines and rat tissues does not favour 
this idea, as component X shows no apparent preferential distribution 
between these types of cells.
An additional finding from studies on the acétylation of the complex 
in the presence of [2-^^C] pyruvate suggests that a slow accumulation 
of a diacetyl dihydrolipoamide derivative takes place after relatively 
long incubation times. Alternatively, acétylation of a secondary thiol 
group could be postulated.
Further studies carried out in our laboratory seem to favour the 
former mechanism (J.A. Hodgson, unpublished results). However, more
investigations of this reaction are necessary to assess its physiological 
importance for the mechanism of catalysis.
9.3 Subcellular localisation of mammalian PDC
The possible interaction of PDC with the inner mitochondrial 
membrane has been suspected for many years, partly stemming from 
difficulties encountered in trying to solubilise the enzyme from heart 
mitochondria (Addink et al., 1972; Pettit & Reed, 1982) or by histo- 
chemical studies (Nestorescu et al., 1973). More recently, this 
association has been shown by means of binding studies in which purified 
enzyme is found to interact with inverted inner membrane vesicles 
(Sù’megi & Srere, 1984b).
Application of immunological techniques to study the subcompart- 
mentalisation of mitochondrial enzymes has not been so far exploited.
In this study, preliminary data using this approach have made it 
possible to obtain firm evidence for the strong interaction of PDC with 
inner mitochondrial membranes from heart. The possibility of 
quantitative estimation of the total amount of protein rather than the . 
fraction of activity bound and its high sensitivity provide a valuable 
experimental tool for studying the nature of this association at the 
molecular level. This may prove to be a successful approach for 
understanding the organisation of the complex in the mitochondrion in 
the intact cell.
9.4 Biogenesis of mammalian PDC
Studies on the biogenesis of PDC polypeptides have revealed 
that the enzymes are synthesized as larger precursors in various 
cultured cells. The precursors appear to have values 2,000-8,000 
larger than their mature counterparts.
The larger size for the extension of the E2 component of PDC is 
similar to that found for the transsuccinylase component of the 
2-oxoglutarate dehydrogenase complex which has a M^ value of 7,000
lOZ
larger than the mature enzyme (Hunter,A. & Lindsay, J.G., Eur, J. 
Biochem., submitted for publication).
Precursor to subunit E2 seems to remain stable in the cytoplasmic 
compartment in the presence of DNP for several hours. This may indicate 
that the precursor adopts a particular conformation which protects it 
from degradation by endogenous proteases.
There are reports that the precursor polypeptides of some mito­
chondrial matrix and inner membrane enzymes formed aggregates in vitro, 
exhibiting considerably larger values than the oligomeric mature 
proteins. These include: carbamyl phosphate synthetase (MLura et al..
1981), ornithine transcarbamylase (Kalousek et al.,1984) and fumarase 
(Ono et al., 1985) in animal cells and the ADP/ATP carrier and subunit 
9 of the Fj-ATPase complex in Neurospora crassa (Zinunermann & Neupert, 
1980; Schmidt et al..1983).
In contrast, precursor to malate dehydrogenase was found to be 
only slightly larger than the dimeric form of the mature protein 
(Chien & Freeman, 1984). It is not known whether this aggregation 
occurs in vivo also or there are other factors involved as part of 
the mechanism of import of these proteins (Argan et al.. 1983).
Therefore, it would be of interest to examine the state of aggregation 
of precursors to PDC polypeptides in cells. This could conceivably 
be done after pulse-labelling cells in the presence of uncouplers 
followed by gel filtration chromatography of the cytosolic fractions 
coupled with immunoprécipitation of the eluted fractions with anti- 
PDC serum.
As discussed previously, component X has evaded detection in the 
immunospecific products obtained from several cell lines. It would 
also be interesting to further investigate whether this protein is 
synthesized as a larger precursor and if it can be found associated
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with the core before translocation. The low methionine content and
abundance of component X may have hindered the identification of the
precursor form of this protein. Therefore, it would be interesting
14
to perform similar studies on cultured cells by including C-labelled 
amino acids during the labelling period. The demonstration that many 
of the events involved in the biosynthesis of the main polypeptides 
of the complex can be studied iji vivo makes one hopeful that this system 
will permit us to obtain an answer to these questions in the near future. 
This would allow to clarify definitively the identity of protein X 
and probably to establish whether it has a role in the assembly of the 
complex inside the mitochondrion.
Finally, the observation that some cross-reactivity exists 
between the antisera to ox heart PDC and the equivalent yeast enzyme 
also makes it possible to visualize accumulation of precursors in these 
cells by immunoblotting techniques. Preliminary data, not included in 
this study, suggests that rho mutants of cerevisae are capable 
of accumulating substantial amounts of precursors to subunits E2 
and El 6 in the present of CCCP. The for the precursors detected 
are approx. 3,000 and 5,000 larger than their mature-sized counterparts, 
respectively. These studies will allow direct comparison of the 
biosynthetic pathways of the same enzyme between lower and higher 
eukaryotes.
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